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Abstract 
 
Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiovascular disease 
carrying a significant risk of sudden cardiac death (SCD) due to arrhythmias. The ACTC (cardiac 
actin) E99K transgenic (TG) mouse reproduces many aspects of HCM observed in humans. The 
most striking characteristic is the high probability of SCD at 25-45 days old. The primary effect of 
this mutation is increased myofilament Ca2+ sensitivity, which we hypothesise will disturb 
intracellular Ca2+ homeostasis. This thesis investigates the role of altered Ca2+ handling in the 
pathogenesis of HCM and the development of lethal arrhythmias. 
 
Cardiomyocytes from 8-12 week old TG animals showed prolonged relaxation with no differences 
in maximum sarcomere shortening. Fura-2AM loaded TG cells displayed smaller Ca2+ transients 
and SR load than their NTG littermates. Cells from 25-45 day old TG mice showed increased 
sarcomere shortening and faster relaxation. Ca2+ transient amplitude was greater in TG cells 
however there were no differences in SR load. In both age groups, cells from TG mice displayed 
reduced diastolic [Ca2+], slower efflux of Ca2+ via the Na+/Ca2+ exchanger and no differences in 
SR Ca2+-ATPase function.  
 
Frequency of spontaneous Ca2+ sparks and waves was greater in TG cells than in NTG cells. The 
increased diastolic Ca2+ release was not mediated by enhanced phosphorylation of RyR at serine-
2808 or Ca2+ overload. To assess whole heart arrhythmogenicity, multi-electrode array and ECG 
recordings were made at baseline and in the presence of isoprenaline. Both genotypes displayed 
a low level of baseline arrhythmic activity. The ECG demonstrated increased propensity for 
arrhythmias during β-adrenergic stimulation in TG animals.  
These data show that intracellular Ca2+ handling changes with age and with stage of disease. 
Cardiomyocytes from young TG mice are hypercontractile with increased Ca2+ transient amplitude 
which, coupled with increased propensity for spontaneous Ca2+ release, could predispose the 
heart to arrhythmias.  
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1.1 Excitation-contraction coupling  
 
Cardiac excitation-contraction (EC) coupling is the process by which electrical excitation of the 
cardiomyocyte leads to contraction of the heart muscle, with Ca2+
 
ions playing a central role in 
this process (Figure 1.1). Ca2+ enters the cell during the cardiac action potential (AP) through L-
type Ca2+ channels (LTCC) which are activated by depolarisation (Rosenberg et al. 1988). This 
can be measured as an inward Ca2+ current, which contributes to the plateau phase of the AP 
(Reuter & Beeler 1969). The Ca2+ which has entered the cell triggers Ca2+ release from the SR by 
a process known as Ca2+ induced Ca2+ release (CICR) (Fabiato 1983). The Ca2+ influx combined 
with the Ca2+ released from the SR increases the free intracellular Ca2+ favouring its binding to 
troponin C (Pan & Solaro 1987). This Ca2+ binding activates the contractile apparatus of the 
myofilament, which results in contraction (Solaro 1991). Relaxation occurs as Ca2+ is removed 
from the environment of the myofilaments by efflux from the cell or uptake into intracellular 
stores. These actions cause a decline in intracellular Ca2+, favouring the dissociation of Ca2+ from 
troponin C (Bers, 2000).  
 
1.1.1 Ca2+ removal from the cytosol 
Ca2+ is removed from the cytosol by several mechanisms: the sarco-endoplasmic reticulum Ca2+ 
ATPase (SERCA), Na+/Ca2+ exchanger (NCX), sarcolemmal Ca2+ ATPase and the mitochrondrial 
Ca2+ uniporter (Figure 1.1). The relative importance of each removal system varies between 
species. In rabbit ventricular myocytes, SERCA removes 70% of the Ca2+ and the NCX removes 
28%, while only about 1% is removed by the sarcolemmal Ca2+-ATPase and mitochondrial Ca2+ 
uniporter (Bassani et al. 1994). The latter two transport proteins are collectively known as the 
„slow systems‟ because the amount of Ca2+ they remove from the cytosol is negligible on a beat-
to-beat basis. The individual contributions of the fluxes in rabbit are similar to those found in 
human ventricle (Pieske et al. 1999). The maximum rate (Vmax) of SERCA uptake is higher in rat 
than in rabbit ventricle due to a greater concentration of pump molecules (Hove-Madsen & Bers 
1993). Flux studies in rat have shown that about 92% of Ca2+ is removed by SERCA, 7% by NCX 
and 1% by the slow systems (Bassani et al. 1994). These individual contributions to the process 
of Ca2+ efflux are similar to those found for mouse ventricular cells (Li et al. 1998). To maintain 
steady state, the amount of Ca2+ effluxed from the cell during twitch relaxation must equal the 
amount of Ca2+ which enters with every beat (Delbridge et al. 1996).  
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Figure 1.1 Ca2+ transport in the cardiomyocyte. Red arrows indicate the movement of Ca2+ within 
the cell. LTCC, L-type Ca2+ channel; RyR, ryanodine receptor; SR, sarcoplasmic reticulum; SERCA, 
sarco-endoplasmic reticulum Ca2+ ATPase; NCX, Na+/Ca2+ exchanger 
 
 
1.1.2 The role of Ca2+ in EC coupling 
Ca2+ is essential in cardiac electrical activity and is essential to EC coupling. As well as acting as 
the switch which activates the myofilaments, Ca2+ affects the force of contraction. The strength of 
cardiac contraction can be altered by changing the amplitude or duration of the Ca2+ transient or 
by shifting the Ca2+ sensitivity of the myofilaments (Yue et al. 1986). However, the myofilaments 
do not fully equilibrate with Ca2+ during a normal twitch, due to the rapid kinetics of the Ca2+ 
transient. There are also many other Ca2+-binding moieties in the cell which compete with 
troponin C (TnC) causing Ca2+ to be heavily buffered (Fabiato 1983). Therefore, although changes 
in contractile force are indicative of changes in cytoplasmic Ca2+ transients, the relationship is 
not one-to-one because of a dynamic interaction between Ca2+, the myofilaments and other Ca2+ 
binding proteins during the cardiac cycle (Bers 2000). 
 
Myofilament Ca2+ sensitivity can be increased by stretching the myofilaments, which occurs as 
the heart fills with blood, resulting in a stronger contraction (Hibberd & Jewell 1982). This so-
called “length-dependent activation‟‟ is probably partly due to the transverse filament lattice 
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compression that occurs during stretch, which enhances the likelihood of actin–myosin 
interaction (Fukuda et al. 2001). Stretching also allows more interdigitation between actin and 
myosin increasing the number of cross-bridges formed. These mechanisms are thought to 
underlie the length-dependent activation of cardiac muscle also known as the Frank-Starling 
response (de Tombe 2003), which allows the heart to adjust its force of contraction to changes in 
diastolic filling.  
 
 
1.2 The cardiomyocyte 
 
The main cellular constituents of the heart include fibroblasts, myocytes, endothelial cells and 
vascular smooth muscle cells. The cardiac myocytes occupy approximately 75% of normal 
myocardial tissue volume, but constitute only 30-40% of cell numbers (Vliegen et al. 1991). The 
remaining 70% of cells are non-myocytes, predominantly fibroblasts (Camelliti et al. 2005).  
 
The use of enzymatically isolated cardiomyocytes has been established in many lines of basic 
cardiological research, and has achieved prominence as an experimental model of myocardial EC 
coupling. Cardiac myocytes are the contracting cells in the heart, appearing rod shaped with 
defined cross-striations. Individual myocytes are connected together by intercalated discs, 
allowing them to work as an electrical syncytium. The intercalated discs are divided into three 
types of cell junctions; gap junctions, fascia adherens and desmosomes (Severs 1985). The 
desmosomes and fascia adherens appear to be of importance in the mechanical connection of 
one cell to the next, whereas the gap junctions serve as low resistance electrical pathways which 
enable the rapid spread of APs between cells by allowing ions to pass through (Bernstein & 
Morley 2006). Therefore depolarisation of the muscle and synchronised contraction of the 
myocardium can occur. The cells are arranged in a three-dimensional network of fibroblasts, 
endothelial cells, vessels and extracellular matrix (ECM), with the close attachment of myocytes 
to their neighbouring cells and also to the ECM allowing the efficient transmission of force during 
muscle contraction. 
 
1.2.1 Sarcomere structure 
The sarcomere makes up the basic functional unit of the cardiomyocyte. Repeating units of actin 
and myosin filaments form the backbone of sarcomere structure (Figure 1.2), and the alignment 
and overlap of the thick and thin filaments gives the myocyte its striated appearance. The thin 
filaments consist of a helical polymer of approximately 300 globular actin (G-actin) subunits 
associated with the regulatory proteins tropomyosin, and the troponin complex which is 
composed of three proteins, troponin-C (TnC), troponin-T (TnT) and troponin-I (TnI). During 
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diastole, tropomyosin blocks the myosin binding site which prevents cross-bridge formation. 
When an AP triggers the release of Ca2+ into the cytosol, the binding of Ca2+ to troponin C causes 
the complex to change shape, which exposes the myosin binding site on the actin filament. This 
regulatory mechanism confers the Ca2+ sensitivity of the myofilament.  
 
Actin is anchored at the Z-line, which is mainly composed of the actin cross-linking protein α-
actinin. The thin filaments form sliding interactions with the thick filaments, which are composed 
of myosin molecules. The region of the sarcomere which contains the entire length of a thick 
filament is called the A-band (anisotropic), whereas the I-band (isotropic) is the region containing 
actin where no myofilament overlap occurs. At the centre of the sarcomere is the M-line, which 
contains the protein myomesin, that crosslinks the adjacent myosin filaments to maintain their 
regular array. Titin connects the Z-line to the M-line in the sarcomere and contributes to the 
passive stiffness/elastic properties and force production of the sarcomere. The coordinated 
shortening of the sarcomere creates contraction.  
 
 
 
Figure 1.2 Structure of the sarcomere. Figure from (Braun & Gautel 2011) 
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1.2.2 Actin 
The amino acid sequence of actin is amongst the most conserved of all proteins. G-actin is a 
42kDa protein stabilised by binding ATP and Mg2+ or Ca2+ (Pardee & Spudich 1982). The G-actin 
molecule is composed of four subdomains surrounding a nucleotide binding pocket (Figure 1.3). 
Monomeric actin polymerises under physiological salt concentrations, with hydrolysis of the ATP, 
to form filamentous actin (F-actin). Actin performs many biological functions in the filamentous 
form, including muscle contraction, cell motility, morphological changes, cell division and 
intracellular movements. F-actin filaments are arranged as a double helix which repeats every 
36nm, having 13 monomers per turn of the helix. Subdomains 1 and 2 are positioned on the 
outside while subdomains 3 and 4 are in the centre, allowing interactions to occur both between 
strands and along the actin filament in each strand. Subdomain 1 is located at the periphery of 
the filament and is available for interaction with myosin (Geeves & Holmes 1999). In F-actin the 
monomers of both filaments are arranged with a polarity which is important in determining how 
myosin interacts with the filament. Actin filaments are anchored at their plus ends to the Z-line by 
α-actinin, which has distinct binding sites on adjacent actin monomers. The anti-parallel cross-
linking of actin with α-actinin forms the Z-disc and allows force to be propagated along the 
myofibril. The opposite orientation of actin on either side of the Z line is necessary for the sliding 
filaments, allowing the relative orientation of myosin and actin filaments to be the same on both 
halves of the sarcomere. The motor activity of myosin moves its head groups along the actin 
filament in the direction of the plus end. This movement slides the actin filaments from both 
sides of the sarcomere toward the M-line, shortening the sarcomere and resulting in muscle 
contraction. 
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Figure 1.3 Structure of G-actin. G-actin is composed of 4 subdomains: subdomain 1 (blue), 
subdomain 2 (green), subdomain 3 (yellow) and subdomain 4 (magenta). ADP is bound at the 
centre of the molecule where the 4 actin subdomains meet. Figure from (Otterbein et al. 2001) 
 
 
1.2.3 Myosin 
The myosin molecule consists of two myosin heavy chains (MHC), each of which is associated 
with an essential light chain and a regulatory light chain. Myosin consists of two structurally and 
proteolytically defined domains; sub fragment 1 (S1), which is a globular domain that contains 
the motor domain, and the rod which is a long α-helix, that forms a coiled-coil dimer (Figure 1.4). 
Helices of the protein myosin-II comprise the thick filaments.  The myosin molecules in each thick 
filament are oriented so that the S1 heads point towards the end of the filament and the tails 
point towards the centre. This results in a bipolar thick filament with a bare region in the centre, 
where no myosin heads are present, known as the M-region. This arrangement ensures that thin 
filaments are pulled towards the centre of the sarcomere from both ends. 
 
 
23 
 
 
 
 
Figure 1.4 Structure of myosin II. The S1 domain is composed of the globular head domain and 
the neck (N) domain which is associated with the light chains. The tail domain is a coiled-coil rod 
structure. Figure from (Lodish et al. 2000). 
 
 
1.2.4 Cross bridge cycle 
The sliding filament theory of muscle contraction was initially developed 60 years ago  (Huxley & 
Hanson 1954). The filament sliding observed during muscle contraction is caused by the 
interaction of myosin heads with actin, a process regulated by Ca2+ and driven by the hydrolysis 
of adenosine triphosphate (ATP). This process is known as the cross-bridge cycle and is shown in 
Figure 1.5.  In the absence of ATP the myosin head binds tightly to actin producing a state known 
as rigor (A). ATP binding to myosin heads results in conformational changes occurring which 
causes the very rapid and almost irreversible dissociation of myosin from actin (B) (Geeves & 
Holmes, 2005). This detachment from actin is followed by the hydrolysis of ATP to adenosine 
diphosphate (ADP) and inorganic phosphate (Pi), by the myosin ATPase (C). Hydrolysis is rapid, 
reversible and is accompanied by a major conformational change (Geeves & Holmes, 1999). The 
myosin-ADP-Pi complex can bind to actin (D) and this is followed by the powerstroke; the lever 
arm of myosin moves and Pi is released (E). The power stroke involves the release of ADP which 
causes the thin filaments to slide past the thick filaments, thus leading to sarcomere shortening 
and the generation of force.  
 
 
S1 Coiled-coil rod domain  
Essential light chain 
Regulatory light chain 
Head N Tail 
130 nm 
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Figure 1.5 Cross-bridge cycle. The filament sliding observed during muscle contraction is caused 
by the interaction of myosin heads (orange) with actin (blue). ATP, adenosine triphosphate; ADP, 
adenosine diphosphate; Pi, inorganic phosphate. Figure from (Stanfield 2010).  
 
 
1.2.5 Mutations in the sarcomere 
Mutations in the genes encoding the protein components of the sarcomere can cause both 
skeletal and cardiac myopathies (Laing, 1995). Mutations in sarcomeric proteins are now known 
to cause around 20 different skeletal muscle diseases (Laing & Nowak, 2005). In addition to 
these, mutations in proteins of the sarcomere in cardiac muscle can cause hypertrophic 
cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (Morimoto 
2008). Of note is that mutations in the same disease gene can be found in different clinical 
phenotypes of cardiomyopathy.  For example, mutations in actin are associated with HCM, DCM, 
nemaline myopathy and actin myopathy (Marston & Hodgkinson, 2001).  
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HCM is considered a disease of the sarcomere because 65-75% cases are caused by pathogenic 
mutations, and most of these causal mutations are within genes encoding sarcomeric proteins 
(Seidman & Seidman 2011). These genes include MYH7 (β-MHC), MYBPC3 (cardiac myosin-
binding protein C), ACTC1 (cardiac α-actin), TPM1 (α-tropomyosin), MYL3 (essential myosin light 
chain), MYL2v (regulatory myosin light chain), and TNNT2, TNNI3 and TNNC1 (the cardiac 
isoforms of TnT, TnI and TnC).  So far, over 1000 HCM-causing mutations have been identified 
(Ashrafian et al. 2011). The mutant protein in HCM is expressed from birth but any functional 
deficiencies it produces are often offset by other mechanisms for varying periods of time. Indeed, 
sometimes symptoms never develop. This variable penetrance highlights the significance of 
genetic background to the outcome of HCM mutations. 
 
The majority of these HCM-causing mutations are missense alleles that result in dominant 
negative mutant peptides. It is widely believed that the mutant protein exerts its pathological 
effect by acting as a poison peptide, which becomes incorporated into the sarcomere and 
adversely affects the function. The exceptions to this are MYBPC3 truncation mutations which 
reduce the amount of full length protein resulting in haploinsufficiency,  a condition in which the 
gene product of the wild-type allele cannot compensate for the decreased product from the 
mutant allele (Marston 2011; Marston et al. 2012) 
 
1.3 Hypertrophic cardiomyopathy 
 
Hypertrophic cardiomyopathy (HCM) is the most common form of inherited heart disease, and 
affects an estimated 1 in 500 of the population. The overall risk of fatal complications of HCM is 
1–2% per year (Maron 2002b). HCM is also the most common cause of sudden cardiac death 
(SCD) in individuals under 35 years of age. Although hypertrophy and SCD are both caused by 
HCM mutations, the connection between them is unclear. HCM is defined clinically as the 
presence of unexplained ventricular hypertrophy (Figure 1.6A), in the absence of any cardiac or 
systemic cause. Normal thickness of the LV is 12 mm or less; whereas in HCM, the LV thickness 
can range from mild (13-15 mm) to massive (≥ 30 mm) (Maron 2002b). Histologically, HCM is 
characterized by myocyte disarray and interstitial fibrosis (Figure 1.6B). 
 
The most commonly observed symptoms in patients include exertional dyspnea and chest pain. 
The hypertrophy causes decreased LV volume and may lead to LV outflow tract obstruction 
(LVOTO), which is caused by contact between the anterior mitral valve leaflet and the 
interventricular septum in systole. As the disease progresses, relaxation becomes impaired which 
can lead to heart failure (HF).  
26 
 
 
 
 
 
 
Figure 1.6 Characteristic pathology of HCM. (A) Heart from an individual with HCM displaying 
massive asymmetric LV hypertrophy with associated reduction in LV cavity size compared with a 
normal heart (B) Histological heart sections stained with Masson‟s trichrome show interstitial 
fibrosis and myofibre disarray in HCM. Figure taken from (Chung et al. 2003).  
 
 
1.3.1 Proposed mechanisms of HCM pathogenesis 
The pathogenic mechanisms by which HCM-associated mutations cause the disease remain 
unclear and controversial although many studies have shown that HCM mutations lead to 
increased Ca2+ sensitivity of the myofilaments, faster cross-bridge turnover rates and increased 
ATPase activity (Robinson et al. 2002; Marston 2011). The major common paths leading to the 
anatomic and functional characteristic of HCM appear to involve energy deficiency and altered 
Ca2+ handling (Ashrafian et al. 2011). Increased myocardial fibrosis, altered sensing of 
biomechanical stress and microvascular dysfunction may also be involved in the pathological 
manifestation of HCM (Frey et al. 2012). These processes are not mutually exclusive and a 
combination may be involved during the progression of the disease. 
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1.3.1.1 Impaired Ca2+ cycling 
A substantial number of studies have shown that HCM mutations increase myofilament Ca2+ 
sensitivity (Fraysse et al. 2012; Schober et al. 2012; Liu et al. 2012), which is probably due to a 
higher affinity of Ca2+ for troponin C and slower Ca2+ dissociation (Marston 2011). This is 
particularly significant as the sarcomeres can powerfully sequester Ca2+ with a 100 bound: 1 free 
ratio. Troponin C is considered the main Ca2+ buffer (Smith et al. 2000) and changes to 
intracellular buffering may cause knock-on effects on Ca2+ homeostasis and Ca2+ signalling. For 
example, the increased affinity of Ca2+ for troponin C may lead to „Ca2+ trapping‟ which can affect 
the size of the Ca2+ transient in addition to the diastolic levels of Ca2+ in the cytosol (Fatkin et al. 
2000). Increased cytosolic Ca2+ buffering is expected to lead to reduced Ca2+ transient 
magnitude with a slow rate of decay and increased cytosolic Ca2+ during diastole (Ter Keurs & 
Boyden 2007).  
 
Studies in human HCM pluripotent stem cells have shown irregular Ca2+ transients and elevated 
diastolic Ca2+ prior to the onset of other characteristic features of HCM. The increased diastolic 
Ca2+ was found to induce hypertrophy and arrhythmia (Lan et al. 2013). Human HCM 
cardiomyocytes also displayed higher diastolic Ca2+ in addition to prolonged Ca2+ transients, 
which were related to enhanced CAMKII activity (Coppini et al. 2013). The sustained elevation of 
intracellular Ca2+ is also a known trigger for activation of calcineurin (Sussman et al. 1998). 
Therefore, impaired intracellular Ca2+ regulation can activate Ca2+ sensitive signalling pathways 
such as Ca2+/calmodulin dependent protein kinase II (CaMKII), calcineurin and protein kinase C 
(PKC), which can contribute to the development of hypertrophy in HCM.  
 
Alterations in Ca2+ cycling and homeostasis have been shown to contribute to ventricular 
arrhythmias in transgenic (TG) mice expressing human cardiac troponin T containing the 179N 
mutation. This mutation has been linked to familial HCM and a high incidence of SCD in patients. 
The effects in TG mice were observed in the absence of hypertrophy indicating that arrhythmias 
were not a secondary effect of structural changes of the myocardium (Knollmann et al. 2003). A 
likely mechanism for the development of arrhythmias in individual cells is increased diastolic 
Ca2+ which can induce delayed afterdepolarisations (DADs). Baudenbacher et al demonstrated 
that ventricular tachycardia could be reproduced in cardiomyocytes by the addition of Ca2+ 
sensitizing agents, suggesting that myofibrillar Ca2+ sensitization was likely to be the underlying 
molecular mechanism of the arrhythmias in this model (Baudenbacher et al. 2008).  
 
1.3.1.2 Altered energy homeostasis 
A consequence of increased myofilament Ca2+ sensitivity is slower Ca2+ dissociation from 
troponin C, leading to impaired cellular relaxation. A slower rate of dissociation of Ca2+ from 
troponin C allows more cross-bridges to form and increases ATPase activity (Belus et al. 2008). 
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Residual cross-bridge cycling in diastole may account for the diastolic dysfunction often observed 
in the HCM heart.  Increased cross-bridge activation for a given Ca2+ level will consume more ATP 
without producing a proportionally greater stroke volume (Song et al. 2013; Crilley et al. 2003). 
Increased consumption of ATP by the sarcomere could compromise the ability of cardiomyocytes 
to maintain the necessary energy levels for other vital homeostatic functions, such as Ca2+ 
reuptake (Ashrafian et al. 2003), especially under conditions of increased energy demand. An 
energy deficit can compromise normal ion transporter function which can lead to heterogeneity 
of membrane potentials, contributing to the formation of arrhythmias.   
 
Several studies have demonstrated mitochondrial abnormalities (Unno et al. 2009) and impaired 
myocardial energy metabolism in HCM (Ashrafian et al. 2003). HCM patients have been found to 
exhibit an approximately 30% reduction in the phosphocreatine to ATP ratio, which is an 
established marker of cellular energy (Crilley et al. 2003; Shivu et al. 2010). A reduction in 
cellular energy would be expected to compromise the regulation of ion channels and transporters 
and activate cellular energy sensors such as AMP-activated protein kinase (AMPK). Animal 
models of HCM have illustrated impaired energetics before the onset of characteristic cardiac 
pathology (Frey et al. 2006; Luedde et al. 2009; Spindler et al. 1998). HCM mutations are 
therefore predicted to generate higher tension costs, which could potentially trigger hypertrophic 
signalling pathways (Ashrafian et al. 2003). 
 
1.3.1.3 Myocardial fibrosis 
Myocardial fibrosis, the collagen-rich ECM, is a hallmark of HCM.  Both interstitial fibrosis, which 
surrounds individual myocytes, and focal fibrosis, which replaces dead myocytes, develop in 
HCM. Although the molecular trigger for the development of fibrosis in HCM has not been 
completely elucidated, the extent of myocardial fibrosis has been shown to correlate with 
impairment of cardiac relaxation. Patients with HCM as well as TG mouse models of HCM have 
shown early pro-fibrotic cardiac remodelling, which preceded the typical histopathological 
changes including the development of hypertrophy (Ho et al. 2010; Teekakirikul et al. 2010; Kim 
et al. 2007). Transcriptional profiling revealed increased expression of genes involved in ECM 
formation and increased RNA levels of connective-tissue growth factor, transforming growth 
factor β1 and β2, fibronectin, and type I collagen before fibrosis or LV hypertrophy developed. 
These studies suggest that fibrosis is not only a secondary event, but might be an integral feature 
of HCM that emerges early in the course of the disease.  
 
Cardiac MRI data from HCM patients have also demonstrated a close correlation between the 
extent of myocardial fibrosis (measured by a technique known as late gadolinium enhancement) 
and adverse outcome (O‟Hanlon et al. 2010; Green et al. 2012) Arrhythmias in HCM patients are 
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also commonly attributed to increased level of fibrosis (Prinz et al. 2013). These findings suggest 
that early detection of fibrosis might improve individual risk prediction and identify those patients 
who might benefit from an implantable cardioverter defibrillator (ICD).  
 
1.3.1.4 Disturbed biochemical stress sensing 
The sarcomere is a critical component of cardiomyocyte signalling pathways. In particular, the 
sarcomeric M-band and the Z-disc have been implicated in sensing and transduction of 
biomechanical stress (Will et al. 2010; Frank & Frey 2011). It is possible that mutations in 
components of these structures may lead to impaired stress sensing and an enhanced 
hypertrophic response. 
 
1.3.1.5 Microvascular dysfunction 
Many HCM patients display microvascular dysfunction of the coronary arterioles, which typically 
leads to thickening of the vessel wall and reduced intraluminal area. This feature, combined with 
reduced capillary density in the hypertrophied heart and increased energy demand, can lead to 
cardiac ischaemia. Microvascular ischaemia is regarded as another predictor of an adverse 
outcome in patients with HCM (Cecchi et al. 2003), because it impairs ATP production, cell 
energetics and, ultimately, systolic and diastolic function and promotes arrhythmia formation 
(Cecchi et al. 2009).  
 
1.3.2 Sudden cardiac death (SCD) 
SCD is a major and often the only complication of HCM. This disease is considered the most 
common cause of SCD in young people, usually due to ventricular tachycardia or ventricular 
fibrillation. Many factors can contribute to the high incidence of arrhythmias in HCM including 
genetic, functional, environmental, and haemodynamic alterations. At the cellular level, 
arrhythmias can be produced by abnormal automaticity, triggered activity or re-entry, all of which 
have been observed in HCM (Figure 1.8). Perhaps the most likely mechanism of arrhythmia 
formation in HCM is by the sarcomeric gene mutation altering cellular Ca2+ homeostasis  which 
can promote after-depolarisations (Fatkin et al. 2000). Histopathologic changes, such as 
myocardial fibrosis, myocyte disarray and hypertrophy, which are often present in HCM hearts, 
can also contribute to the formation of re-entry arrhythmias (Wolf & Berul 2008).  
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Figure 1.7 Cellular mechanisms of arrhythmias in inherited cardiomyopathies. At the cellular 
level, tachyarrhythmias can be caused by abnormal automaticity, triggered activity or re-entry. All 
three mechanisms can cause arrhythmias in hypertrophic cardiomyopathy (HCM). If, pacemaker 
(funny) current; ICa, T, T-type (transient) Ca2+ current; DCM, dilated cardiomyopathy; LQT, Long QT 
syndrome; CPVT, catecholaminergic polymorphic ventricular tachycardia; ARVD/C, 
arrhythmogenic right ventricular dysplasia/cardiomyopathy. Figure from (Wolf & Berul 2008) 
 
 
1.4 ACTC E99K mutation 
 
Although mutations in the cardiac actin gene (ACTC1) are not a common cause of HCM, eleven 
mutations have been identified in this gene, including the E99K mutation. The clinical 
consequences of this mutation have been studied in a large population and is the subject of an 
extensive on-going  clinical study (Monserrat et al. 2007). Glutamic acid (E) is the 99th amino acid 
in the actin molecule. In its tertiary structure the amino acid is located on the surface of the actin 
monomer on the outside edge of subdomain 1 (Figure 1.9) and is believed to be involved in the 
initial non-stereospecific binding of myosin·ADP·Pi to actin during the cross-bridge cycle. 
Consequently, the charge reversal of glutamic acid to lysine (K) at this location may affect the 
binding of myosin to actin. 
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Figure 1.8 Location of the E99K mutation in the actin filament. (A) Model of a 5 actin monomer 
segment of the actin filament. Glutamic acid 99 (red, arrows) is located at the surface of the 
tertiary structure on the edge of subdomain 1. Figure from (Song et al. 2011) (B) S1 of myosin 
(yellow) interacts with two actin monomers (red, green). Glutamic acid 99 (red, arrow) is part of 
the secondary binding site, interacting with the positively charged residues in the lower 50-kDa 
domain of S1. Figure from (Bookwalter & Trybus 2006) 
 
 
The ACTC E99K mutation is associated with a unique form of hypertrophy where the apex of the 
heart is thickened rather than the septum, with a phenotype overlapping both apical HCM and 
left ventricular non-compaction (LVNC). LVNC is a distinct form of cardiomyopathy occurring in-
utero when segments of spongy myocardium fail to transform into compact, mature musculature 
resulting in prominent myocardial trabeculae, deep intra-trabecular recesses, and decreased 
cardiac function. In the patient cohort studied, a variable degree of wall thickening and 
trabeculation was observed without any cases of LVOTO. This apical hypertrophy has been found 
to co-segregate with the ACTC E99K mutation in unrelated families, therefore the phenotype 
does not seem to be caused by a specific genetic background (Arad et al. 2005). The origin of 
this specific hypertrophic morphology is currently not known. 
 
A B 
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The E99K mutation was initially identified in one family, six members of which showed clinically-
defined apical HCM and one who had isolated trabeculation of the LV apex. Although mutations 
in ACTC appear to be a rare cause of HCM, ACTC mutations were disproportionally high in apical 
HCM patients (Olson et al. 2000). Subsequent DNA sequence analyses from a cohort of 15 
patients with apical HCM identified the presence of the E99K mutation in two families (Arad et al. 
2005). Within these two families, 16 members showed clinical manifestations of HCM, all of 
which had apical thickening. A later large clinical study screened for the E99K mutation in 247 
families with HCM, DCM, or LVNC (Monserrat et al., 2007). This mutation was found in 43 
patients, 23 of which fulfilled criteria for LVNC and 22 diagnosed with apical HCM. To date, 
hypertrophy has been reported in 62 of 76 mutation carriers within 10 families. ECG 
investigation showed abnormalities in 53 of 61 carriers, atrial fibrillation or flutter was found in 
7/53. The 22 adverse events reported included eight sudden deaths (five of which were in a 
single family).  
 
1.4.1 E99K mouse model 
A TG mouse model was generated expressing the apical HCM-causing ACTC E99K mutation in 
50% of total heart actin (Song et al. 2011). The mutation was expressed at a level similar to that 
expressed in patients, without any adducts that could alter function. Uniquely among the 
contractile proteins, both skeletal and cardiac actin have identical amino acid sequences in 
humans and mice and an identical isoform distribution in the heart (25% skeletal muscle actin 
ACTA1 and 75% ACTC) (Suurmeijer et al. 2003; Copeland et al. 2010). A further advantage of 
the ACTC mutation is that TG over-expression of actin in the heart has been extensively studied. 
Over-expression of actin in the heart does not lead to any alteration in the stoichiometry or 
structure of the myofibrils or any accumulation of actin in the cytoplasm (Kumar et al. 2004). In 
vivo there are no post-translational modifications of actin that regulate activity. In functional 
studies, the thin filaments were reconstituted with mutant actin and tropomyosin and troponin 
from human heart muscle so that the human mutant thin filament was reproduced (described in 
Section 1.4.2). This allows the phenotype of the TG mice to be compared with the patient 
population. In addition, patient biopsies were obtained enabling a direct comparison of the 
functional properties of an HCM-causing mutation in hearts from humans and mice at the 
molecular level. 
 
The ACTC E99K mice show a distinctive progression of the disease phenotype. The TG mice 
exhibit a striking predisposition to SCD at 4–6 weeks old, which is more pronounced in females 
(Figure 1.10). However, not all mice die during this „vulnerable‟ period and survivors have normal 
mortality. It is possible that their life span is partly determined by the hybrid genetic background 
of the C57BL/6 x CBA/Ca mice used in this study. At 21 weeks old, the surviving TG mice showed 
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cardiac hypertrophy, diastolic dysfunction and fibrosis. The hypertrophy was confined to the apex 
of the heart, consistent with findings in humans carrying the mutation, confirming that apical 
hypertrophy is a direct consequence of the ACTC E99K mutation (Monserrat et al. 2007). At 29–
38 weeks, the mice showed evidence of arrhythmia, dilation and progression to HF. The 
occurrence of ECG abnormalities in the surviving ACTC E99K mice suggests that the mutation per 
se may induce arrhythmias although the SCD may depend upon additional factors.  
 
The presence of hypertrophy and fibrosis are hallmarks of HCM as described in Section 1.3. ECG 
abnormalities were commonly detected in human E99K carriers, and HF associated with severe 
diastolic dysfunction was present in some patients (Monserrat et al. 2007). Since the occurrence 
of premature death is much greater in the TG mouse than in the humans, the model provides a 
unique opportunity in which to study the mechanism for sudden death. Overall, this model 
reproduces many features of HCM as found in patients. 
 
 
 
 
 
Figure 1.9 Kaplan-Meier plot showing mortality in male and female E99K mice. Blue box 
highlights the period of increased sudden death. Figure from (Song et al. 2011) 
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1.4.2 Myofilament Ca2+ sensitivity 
The ACTC E99K mutation caused a higher Ca2+ sensitivity in reconstituted thin filaments 
measured by the in vitro motility assay (2.3-fold for mice and 1.3-fold for humans) and in skinned 
papillary muscle (Figure 1.11). The mutation also eliminated the change in Ca2+ sensitivity 
normally linked to troponin I phosphorylation (Song et al. 2011). Thin filaments were 
reconstituted with mouse actin, human cardiac tropomyosin, and human donor heart 
troponin. The motility of NTG and E99K actin-containing thin filaments was indistinguishable at 
both activating and relaxing Ca2+ concentrations. When the Ca2+ concentration dependence of 
thin filament motility was assayed, the E99K actin thin filaments had a consistently higher 
Ca2+sensitivity (EC50 NTG/EC50 E99K actin = 2.3 ± 0.6, p = 0.02). Ca2+ regulation of isometric 
force was also measured in skinned mouse heart papillary muscles and again, Ca2+ sensitivity 
of ACTC E99K muscle was significantly higher than NTG muscle (EC50 NTG/EC50 E99K muscle = 
1.30 ± 0.03, p = 0.003). In agreement with these data, measurements of isometric force in 
isolated myofibrils showed that Ca2+ sensitivity was 2.5 times higher and relaxation was slower 
(Song et al. 2013). These results are also consistent with those from other HCM mutations, most 
of which have myofibrillar Ca2+ sensitivity increased by 1.5 to 2.5-fold.  
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Figure 1.10 Ca2+ activation curves show increased sensitivity to Ca2+ in E99K reconstituted thin 
filaments and papillary muscle. (A) Reconstituted thin filaments containing mouse E99K or NTG 
actin (B) Reconstituted thin filaments containing human E99K or donor actin (C) Isometric force 
from E99K or NTG mouse heart papillary muscle strips. Figure from (Song et al. 2011) 
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The mechanism by which increased myofibrillar Ca2+ sensitivity leads to muscle growth and 
pathological hypertrophy is not completely understood. Ashrafian et al proposed that HCM 
causes an energy compromise in the myocyte because the abnormal contractility of HCM muscle 
is less efficient in converting the energy of ATP hydrolysis into mechanical work. Further studies 
using the fully characterised ACTC E99K mouse examined the contractile performance of 
papillary muscle to test this hypothesis (Song et al. 2013).  In isometric twitches, ACTC E99K 
papillary muscle produced three to four times greater force than NTG muscle under the same 
conditions, independent of stimulation frequency and temperature. ACTC E99K muscle relaxed 
slower than NTG muscle in both papillary muscle (1.4 fold) and myofibrils (1.7 fold).  
Measurement of the energy released in the actively cycling heart muscle showed that for both 
genotypes the amount of energy turnover increased with work done, but efficiency decreased as 
energy turnover increased. Consequently, ACTC E99K mouse heart muscle produced 3.3-fold 
more work than NTG muscle, and the energy turnover cost was disproportionately higher than in 
NTG muscle. The efficiency for ACTC E99K muscle was therefore 11–16% and 15-18% in NTG 
muscle.  
 
Section 1.3.1 described several theories proposed to be involved during the development of 
HCM. Although energy turnover was found to be higher and energy efficiency was lower in the TG 
muscle, the E99K mutation may have more widespread effects, and perturbed energetics may 
not be the sole cause of HCM.  Therefore, it is necessary to determine whether altered Ca2+ 
handling plays a role in the pathogenesis of HCM in this model.  
 
 
1.5 Hypothesis 
 
The higher myofibrillar Ca2+ sensitivity in E99K mice is probably coupled to a higher Ca2+ affinity 
for and slower Ca2+ dissociation from troponin C. These changes may disturb intracellular Ca2+ 
homeostasis and alter the function of key regulatory proteins in the SR and sarcolemma, causing 
alterations to the Ca2+ transients and the AP. Changes to the shape of the ventricular AP can 
result in shorter effective refractory periods, greater beat-to-beat variability of action potential 
duration (APD), and increased dispersion of ventricular conduction velocities at high HR (Huke & 
Knollmann 2010). In addition, the HCM mutation may provoke compensatory responses that 
contribute to an abnormal Ca2+ handling phenotype. These changes would provide a setting for 
the formation of after-depolarisations which can predispose the heart to potentially fatal 
arrhythmias. 
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We therefore believe that constitutively high myofilament Ca2+ sensitivity is the trigger for the 
major symptoms of HCM, potentially lethal arrhythmias and development of hypertrophy. 
Increased Ca2+ sensitivity also affects the modulation of Ca2+ sensitivity by PKA phosphorylation 
of troponin I (Layland et al. 2005) which is essential in the lusitropic response to β-adrenergic 
stimulation, the length-dependent modulation of Ca2+ sensitivity (de Tombe et al. 2010) and 
intracellular Ca2+ homeostasis. 
 
1.5.1 Main Aim  
To investigate if basic mechanisms of EC coupling and Ca2+ regulation are different in the ACTC 
E99K mouse model of HCM and if these alterations provide a setting for arrythmogenesis that 
may lead to SCD of the mouse. 
 
1.5.1.1 Aims  
For each of the following experiments, the different groups (genotype, gender and age) will be 
compared, and differences that may suggest arrhythmogenic events will be identified.  
 
 Measure cellular contractility, Ca2+ transients and SR loading in TG and NTG mice  
 Determine function of key Ca2+ handling proteins (SERCA and NCX) in TG and NTG mice  
 Measure the frequency and properties of spontaneous Ca2+ sparks and waves in TG and 
NTG mice  
 Record field potentials from the epicardial surface of whole heart preparations from TG 
and NTG using the multi electrode array (MEA) system 
 Record ECG in anaesthetised TG and NTG mice  
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Chapter 2: Materials and 
Methods 
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2.1 Animals 
 
All procedures were carried out in accordance with Home Office Regulations under the Animals 
Scientific Procedures Act, UK (1986). 
 
2.1.1 Generation of the transgenic mouse 
The ACTC E99K transgenic mice were generated as previously described in (Song et al. 2011). 
The mutant cardiac actin cDNA construct was provided by Dr Kristen Nowak (University of 
Western Australia) in a pBSII KS vector. The ACTC E99K mutation was inserted into the human 
cardiac actin sequence by Dr Charles Redwood (University of Oxford). The transgene expression 
vector was initially cut with Hind III then partly filled in with two nucleotides (A, G) using the 
Klenow fragment. Once purified, the vector was then digested with the restriction enzyme, Sal1. 
The mutant cardiac actin cDNA was removed from the pBSII KS vector by digesting with Spe I 
followed by the use of the Klenow fragment to fill the 3‟ ends with two nucleotides (C, T). The 
vector was digested with Sal1 again after purification. This allowed directional cloning of the 
mutant actin construct into the transgene expression vector using a Sal1 site at the 5‟ end and a 
Spe1/Hind III hybrid at the 3‟end. The transgene expression was restricted to the heart using an 
α-myosin heavy chain (α-MHC) promoter construct provided by Dr Mike Gollob and originally 
produced in the lab of Dr Jeffrey Robbins. The promoter region of the α-MHC started with the 3‟ 
untranslated region of the β-myosin heavy chain and the first three exons of α-MHC that were 
non-coding. Transgenic mice were generated by pronuclear microinjection of gel-purified 
transgenic constructs (after removal of the plasmid backbone with Not I) into the pronucleus of 
fertilised mouse eggs on a C57BL10 x CBA/Ca hybrid background. Treated embryos were 
returned to a pseudopregnant CD-1® (Charles River) foster mother, generated by mating with a 
vasectomised male mouse. The pups produced were identified and genotyped by PCR from ear 
notch samples. To maintain the colony, wild-type first generation hybrid (C57Bl6 x CBA/Ca) 
female mice were mated with an E99K heterozygous C57Bl6 x Cba/Ca male. 
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2.1.2 Genotyping of transgenic mice 
The process of genotyping allows the presence or absence of the mutant gene to be confirmed, 
thus allowing accurate identification of NTG and TG animals. Ear notch samples were taken using 
an ear punch and stored at -20ºC in 2ml tubes. Each ear sample provided 2mm2 of tissue, 
producing approximately 5µg DNA which was sufficient for PCR. Prior to DNA extraction and PCR, 
the work surfaces and pipettes were cleaned with 70% ethanol to minimise contamination. 
 
2.1.2.1 DNA extraction 
DNA extraction was performed using a Qiagen DNeasy Blood & Tissue kit (Qiagen, UK) according 
to the manufacturer‟s instructions for purification of total DNA. DNA purified using this kit is free 
from contaminants and enzyme inhibitors and is therefore suitable for PCR. The ear samples 
were lysed using 20µl proteinase K in 180µl Buffer ATL and mixed thoroughly by vortexing. The 
mixture was then incubated at 56ºC on a thermomixer overnight. After vortexing for 15 seconds, 
400µl premixed 96% ethanol and lysis buffer, Buffer AL (50:50) was added. This mixture was 
then vortexed again before transferring it onto the DNeasy Mini Spin column placed in a 2ml 
collection tube. This was then centrifuged for 1 minute at 8000rpm. The flow-through and 
collection tube were then discarded and the spin column was placed in a new collection tube. 
The following wash steps provide optimal removal of contaminants. 500µl Buffer AW1 was added 
to the spin column and the tube centrifuged again for 1 minute at 8000rpm. Again the flow-
through and collection tube were discarded before placing the spin column into a new collection 
tube. 500µl Buffer AW2 was then added followed by centrifugation at 14,000 rpm for 3 minutes, 
to dry the DNeasy membrane and remove residual ethanol that would otherwise contaminate the 
eluted DNA. The flow-through and collection tube were again discarded and the spin column 
placed in a clean 2ml Eppendorf tube. Finally 200µl Buffer AE, a low-salt elution buffer, was 
pipetted directly onto the DNeasy membrane and incubated for 1 minute at RT, followed by 
centrifugation at 8000rpm for 1 minute to elute. To increase the overall yield of DNA, the final 
step was repeated by pipetting the eluate back onto the DNEasy membrane. The extracted DNA 
was then stored at 4ºC until required for PCR. 
 
2.1.2.2 Principles of the polymerase chain reaction (PCR) 
PCR is a technique used to amplify small segments of DNA. The first step involves heating the 
DNA template which disrupts the hydrogen bonds between complementary bases, yielding single-
stranded DNA molecules.  The reaction temperature is then lowered allowing annealing of the 
primers to the single-stranded DNA template. The polymerase enzyme binds to the primer-
template hybrid and begins DNA formation. During the extension step, DNA polymerase 
synthesizes a new DNA strand complementary to the DNA template strand, by adding dNTPs that 
are complementary to the template in the 5' to 3' direction, condensing the 5'phosphate group of 
the dNTPs with the 3'hydroxyl group at the end of the nascent DNA strand. This process results in 
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the duplication of the original DNA, with each of the new molecules containing one old and one 
new strand of DNA. The cycle of denaturing and synthesizing new DNA is repeated until the 
required quantity of exact copies of the original DNA segment has been produced. A final 
extension step is performed after the last PCR cycle to ensure any remaining single stranded DNA 
is fully extended. 
 
2.1.2.3 Primer design 
Primers were obtained from Invitrogen (UK) and made using a desalted purification method, 
which removes residual by-products from the synthesis and cleavage procedures. Desalting is 
suitable for oligonucleotides less than 35 bases in length, as the abundance of full-length 
oligonucleotides outweighs any contributions from shorter products.  The forward primer was 
located in the α-MHC promoter element of the transgene (5‟-3‟) TGACAGACAGATCCCTCCTATCTCC 
and the reverse primer was located in the mutant actin (5‟-3‟) GGCATCTTAGAAGCATTTGCGG. 
Each primer was reconstituted by adding PCR-grade water (UltraPure™ DNase⁄RNase-Free 
Distilled Water, Invitrogen, UK). The resulting primer concentration was measured using a 
spectrophotometer (Scientific NanoDrop® ND-1000, ThermoFisher, UK). The reconstituted 
primers were diluted to 10μM with PCR-grade water before use in PCR. The primers were 
validated previously and mutant actin expression was verified by Emma Dyer using 2-D SDS-
PAGE (Song et al., 2011; Dyer 2008 thesis). 
 
2.1.2.4 PCR protocol 
The following steps were carried out with the reagents on ice.  A master mix was made containing 
all the components described in Table 2.1 except the DNA template. 46µl of the master mix was 
aliquotted into each thin-walled 0.2ml PCR tube. DNA samples (4 µl) were subsequently added to 
the PCR tubes for a total reaction volume of 50 µl. For each PCR run, four controls were used. 
The negative control contained 4µl PCR grade water and the three positive controls contained 4µl 
plasmid DNA (1ng/µl, 1pg/µl and 0.1pg/µl). The thermocycler was run using the program 
settings shown in Table 2.2. The protocol allows the primers to bind to the regions flanking the 
mutant actin within the murine DNA. After 35 successive rounds of replication the copy number 
of the mutant gene will be in vast excess of any other DNA fragments. The PCR cycling step ran 
for 2 hours 20 minutes and samples were stored in the fridge until required. 
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Reagent 
 
Volume (µl) 
 
PCR grade water   
 
32.75 
10x PCR Buffer (Qiagen, UK) 5 
2.5mM dNTPs (Qiagen, UK) 4 
Forward primer  2 
Reverse primer  2 
Taq DNA polymerase (Qiagen, UK) 0.25 
Template 4 
 
 
Table 2.1 Reagents required for PCR  
 
 
 
 
Initial denaturation 
 
 
5mins at 94°C 
 
Denaturation 
 
1 min at 94°C 
 
Annealing 1 min at 58°C 
 
Extension 1.5mins at 72°C 
 
 
Final extension 
 
 
5mins at 72°C 
 
Store 
 
4°C 
 
 
Table 2.2 PCR program  
35 cycles 
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2.1.2.5 Gel electrophoresis 
A 1% agarose gel (1g agarose in 100ml 0.5x TBE buffer) was prepared in advance which 
contained 7µl GelRed DNA stain (GelRed™, Biotium). 10µl loading buffer was added to each 
sample tube.  The gel was placed into the electrophoresis tank (Bio-Rad) filled with 0.5x TBE 
buffer. 10µl DNA ladder (TrackIt™ 1Kb Plus DNA ladder, Invitrogen) was added into the first well 
on the gel, followed by 20µl of the samples in subsequent wells. Electrophoresis was carried out 
at 70V for 40 minutes (Bio-Rad power supply). The gels were subsequently visualised using a UV 
trans-illuminator (UVIdoc, UVITEC, Cambridge, UK) and the image displayed on screen using 
GeneSnap software (Syngene). 
 
 
 
 
Figure 2.1 Representative agarose gel. (A) DNA ladder (B) Positive control - 0.1pg/µl plasmid DNA 
(C) Positive control - 1pg/µl plasmid DNA (D) Positive control - 1ng/µl plasmid DNA (E) Negative 
control – PCR grade water (1-10) Samples using DNA extracted from E99K mouse ear notch. The 
bands in lanes 4,6 and 7 correspond to a molecular weight of 1,300bp indicating the presence of 
the mutant gene.  
 
 
2.1.3 Tissue collection 
For determination of mRNA abundance and protein expression (Section 2.8 and 2.9), heart 
samples from both TG and control animals were required. Mice were anaesthetised using 5% 
isoflurane in 100% oxygen in an anaesthetic induction chamber. The animal was weighed and 
the body weight recorded. They were then killed by cervical dislocation and the hearts were 
rapidly removed and placed in ice cold heparinised normal Tyrode (NT) solution (for composition 
see Section 2.10) containing 1mM Ca2+  and 500 units of heparin per 50ml. The heart was gently 
squeezed in the Tyrode solution to expel excess blood, then blotted dry and weighed. This 
allowed calculation of the heart weight/body weight ratio. The atria were then removed and the 
ventricles were put into either RNAlater® (Invitrogen) or snap frozen in liquid nitrogen. Samples 
in RNAlater were subsequently stored at -20ºC and those snap frozen were stored at -80ºC to 
allow optimum preservation of the tissue.  
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2.2 Isolation of cardiac myocytes 
 
The myocyte isolation protocol was based on previously described methods (Terracciano et al. 
2001; Terracciano et al. 1998). Mice were anaesthetised using 5% isoflurane in 100% oxygen in 
an anaesthetic induction chamber and subsequently killed by cervical dislocation. The hearts 
were rapidly excised and placed in ice cold heparinised 1mM Ca2+ NT solution (500 units of 
heparin in 50ml NT). Excess tissue was cut away and the ascending aorta was cannulated with a 
blunted 21g needle. Perivascular fat and other tissues were carefully trimmed away and the 
aorta secured to the needle cannula by tying with fine surgical suture. The heart was then 
attached to a Langendorff apparatus (Figure 2.2) via the cannula and retrogradely perfused with 
heparinised NT solution containing 1mM Ca2+ for 2 minutes. All solutions were bubbled with 
100% oxygen and perfused at 37ºC at a rate of 4ml/min using a peristaltic pump. The heart was 
then perfused with low Ca2+ solution (for composition see Section 2.10) for 1 minute. This was 
followed by perfusion with enzyme solution (1 5mg vial of Liberase TL, Roche Ltd, resuspended in 
50ml enzyme solution) for 5-8 minutes. Liberase TL contains highly purified collagenase I and II 
blended in a precise ratio with a low concentration of thermolysin. Collagenase breaks down 
collagen, the major constituent of the extracellular matrix. This particular blend of enzymes 
allowed for maximum yield and viability of isolated cells and greater experimental reproducibility. 
The heart was then removed from the perfusion apparatus and the ventricles cut into small 
pieces using a scalpel blade. The pieces were then triturated in enzyme solution for 1 minute 
then the solution filtered through gauze and spun down using a centrifuge at 300rpm for 1 
minute. The supernatant was discarded and the pellet was resuspended in enzyme solution 
(without Liberase) and stored at room temperature (RT). Experiments were carried out up to 8 
hours after the isolation procedure.   
 
The isolation of TG cells had a lower success rate, thought to be due to structural remodelling 
(atrial enlargement) affecting the perfusion. The myocytes from both TG and NTG hearts were 
chosen for experiments using the following criteria (Davies et al, 1995) to ensure optimal 
tracking and for cells to be comparable between experiments. 
 
 Rod shaped cell, no large blebs or areas of hypercontracture 
 Defined and regular striations 
 Quiescent when unstimulated in 1mM Ca2+ solution 
 Separate from any other cell or debris 
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Figure 2.2 Langendorff system for isolation of cardiomyocytes. Arrows indicate direction of 
solution flow. Solutions: orange – NT solution containing 1mM Ca2+, blue – low Ca2+ solution, 
yellow – enzyme solution 
 
 
2.3 Myocyte contractility 
 
The isolated cardiomyocyte provides an intact system in which to study cellular contractility 
independently from the extracellular matrix, abnormal whole heart chamber geometry and 
neurohormonal effects. The contractile performance of the single myocyte can provide insight 
into the cellular basis for changes in ventricular function which occurs during disease. Cell 
contraction can be measured by tracking the movement of the cell edge or by measuring 
changes in sarcomere length. The latter method was chosen as it provided a more reliable 
recording throughout the duration of the protocols described in Section 2.3.3 and 2.3.5.  
 
The fundamental unit of contraction in cardiac muscle is the sarcomere. Due to the repetition of 
sarcomeres in the muscle, the dark A‐bands and light I‐band alternations result in a striated 
appearance. The IonWizard SarcLen software estimates the frequency of the striation pattern. 
Sarcomere length is measured from a user-defined region of interest (ROI) and all the 
Water bath 37ºC 
Peristaltic 
pump 
4ml/min 
100% 02 
Water-jacketed 
bubble traps 
Water-jacketed 
heart chamber 
Needle cannula 
Valve 
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calculations are performed on a density trace derived from this region. Each pixel in the image is 
assigned a value to indicate its brightness and these pixel values from a horizontal line in the 
image are plotted to give the density trace. Due to the alternation of the dark and light bands, the 
density trace has a sinusoidal appearance with the wavelength of the sine representing the 
sarcomere length. The density trace is used to calculate the average frequency of the sine wave 
which can then be converted to wavelength (sarcomere length). The frequency can be evaluated 
by a fast Fourier transform (FFT), which requires the periodic signal to be infinite. The density 
trace is multiplied with a cosine function (known as a Hamming window) to make both ends of 
the trace approach zero, thus appearing infinite from a mathematical point of view. The FFT 
analysis also requires that the number of points upon which it is performed is a power of two, so 
zero values are added until the next power of two is reached. The FFT transforms the density 
trace from the spatial domain to the frequency domain, producing the power spectrum as the 
output. The sharp peak at intermediate frequency represents the most dominant pattern in the 
density trace, which are the dark to light transitions of the sarcomeres. The average sarcomere 
length is derived from the peak of the power spectrum. The sarcomere length found from the 
power spectrum is in “sarcomeres per pixel” however the software automatically converts this to 
µm per sarcomere using the value determined in the length calibration. 
 
The use of the FFT allows changes as small as 10-20nm to be resolved. This difference cannot 
be measured optically due to the diffraction limit, the fundamental maximum resolution of an 
optical system due to diffraction. With conventional microscopy lenses, the lowest value of this 
limit is about 200nm. The IonWizard SarcLen software averages the optical information to 
improve the signal to noise ratio, thus the effective resolution limit can be improved by an order 
of magnitude. This is important to allow very small changes in sarcomere length to be detected 
and measured precisely.  
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Figure 2.3 Example of sarcomere shortening measurement using IonOptix. (A) Video image of cell 
with region of interest enclosed in magenta box (B) Density trace (black), Hamming window 
(blue), FFT power spectrum (red) and power spectrum thresholds (green).  
 
 
2.3.1 Experimental apparatus for single cell contractility  
A superfusion chamber was mounted on the stage of an inverted Nikon microscope. Two 
platinum electrodes fixed to either side of the bath allowed field stimulation of the cells using the 
IonOptix MyoPacer (IonOptix corp. Milton, MA, USA). Solutions maintained at 37ºC flowed through 
the chamber via insulated tubing controlled by solenoid switches. Waste solution was removed 
from the bath by a tube connected to a suction pump and an aspirator bottle. A charge-coupled 
device (CCD) video camera (MyoCam-S, IonOptix corp. Milton, MA, USA) was connected to the 
side port of the microscope allowing the cell to be visualised on the computer screen running 
IonWizard software, and the data was acquired at 240 Hz. The image was observed using a x 40 
oil objective. The calibration of the IonOptix system for sarcomere shortening was carried out 
using a stage micrometer. The number of pixels/µm were then entered as a fixed parameter in 
the software. 
 
2.3.2 Sarcomere shortening protocol 
3µl laminin (Laminin mouse protein, Gibco®) was applied to the glass coverslip that formed the 
floor of the perfusion chamber. Several drops of cell suspension were added to the bath and left 
for 3 minutes to allow the cells to slowly adhere to the chamber floor. The cells were then 
superfused with NT containing 1mM Ca2+ at 37ºC. The cells were usually paced at 1Hz using 
approximately a 15V, 7.0ms pulse from the IonOptix MyoPacer stimulation unit until steady-state 
contractions were obtained. The camera was rotated to allow the selected cell to be positioned 
parallel with the field of view.  The ROI was adjusted to the appropriate size and sarcomere 
B
A
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shortening was recorded for 30 seconds. For each recording, five transients were analysed then 
the average values of the five were taken. 
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IonWizard 
 
 
Parameter 
 
Explanation 
 
Bl 
 
Diastolic sarcomere length 
 
The resting sarcomere length prior to stimulation 
  
 
Peak h 
 
Peak amplitude of contraction 
 
Maximum amplitude of contraction 
 
 
Peak t 
 
Time to peak shortening 
 
Time for the transient to reach peak sarcomere 
shortening during the deflection phase of the 
contraction 
 
 
T to bl 50% 
 
Time to 50% relaxation 
 
Time for the cell to return to 50% of the baseline 
sarcomere length during the relaxation phase of 
the contraction 
 
 
T to bl 90% 
 
Time to 90% relaxation 
 
Time for the cell to return to 90% of the baseline 
sarcomere length during the relaxation phase of 
the contraction 
 
 
 
Figure 2.4 Sarcomere shortening parameters. Parameters measured using IonWizard transient 
analysis.  
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2.3.3 Shortening-frequency protocol 
The experiment was carried out as described for the sarcomere shortening protocol, but with the 
following alterations. The chosen cell was paced at the first stimulation frequency for 2 minutes 
(to allow the cell to reach steady-state contraction) and then 10 seconds of sarcomere 
shortening was recorded. The pacing was stopped and the recording continued for 30 seconds in 
order to detect spontaneous, non-stimulated Ca2+ waves described in Section 2.4.9. This 
sequence was repeated using the same cell for a total of four pacing rates – 0.5Hz, 1Hz, 2Hz and 
5Hz. The order of pacing rates used was rotated between cells to ensure any changes in 
contractility were not caused by run down due to repeated activation/high stimulation rates. Any 
cells which did not survive all four sequences were discarded. For each recording, 3 transients 
within the 10 second initial recording phase were analysed and averaged to provide the 
shortening-frequency data.  
 
 
 
 
  
Rate 1 
 
Rate 2 
 
Rate 3 
 
Rate 4 
 
Cell 1 
 
0.5Hz 
 
1Hz 
 
2Hz 
 
5Hz 
 
Cell 2 
 
1Hz 
 
2Hz 
 
5Hz 
 
0.5Hz 
 
Cell 3 
 
2Hz 
 
5Hz 
 
0.5Hz 
 
1Hz 
 
Cell 4 
 
5Hz 
 
0.5Hz 
 
1Hz 
 
2Hz 
 
 
Table 2.3 Field-stimulation pacing protocol. The order of stimulation rates was rotated as 
displayed in the table 
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2.4 Intracellular Ca2+ measurements using the IonOptix system 
 
The dynamics of intracellular Ca2+ is an important determinant of EC coupling but during disease, 
the physiologic control of Ca2+ may be altered. The [Ca2+]i during each contraction can be 
monitored using a Ca2+ sensitive fluorescent dye, allowing the kinetics of the Ca2+ transients to 
be studied at the cellular level. By manipulating the extracellular solutions, the SR Ca2+ content 
and function of NCX and SERCA can also be determined.  
 
Fluorescence occurs when a molecule which has absorbed the energy from a photon, relaxes 
from its excited state and releases a photon. The energy of the released photon is always lower 
than the energy absorbed, causing the emitted photon to always have a longer wavelength; this 
phenomenon is called the Stokes shift (Lacowicz, 2006). The fluorescent properties of a dye are 
determined by its chemical structure and affected by its chemical surroundings. The intensity of 
the fluorescent dye depends on its molar extinction coefficient (a measure of how strongly it 
absorbs light at a given wavelength), the optical path length and how many dye molecules are 
inside the cell, the quantum yield of the dye, the intensity of the excitation source and the 
efficiency of the photon collection process of the whole instrument. Binding of the ion to which 
the dye is sensitive induces a structural change which changes its fluorescent properties. The 
affinity of the dye for a specific ion species is defined by the dissociation constant of the dye, Kd. 
An ion specific dye can reliably measure between 0.1 x Kd and 10 x Kd. Ion binding changes the 
fluorescent properties of the dye either by increasing the quantum efficiency of the dye (making it 
brighter) or by changing its spectral characteristics.  
 
Some dyes have different emission or excitation spectra for free and ion-bound forms. With this 
type of dye, a ratio of optical signals can be used to monitor the ratio of the free to bound forms 
and to calculate ion concentrations. Such ratiometric measurements eliminate distortions of data 
caused by changes in path length (i.e. cell movement), photobleaching, variations in dye loading 
and retention in cells and factors arising from different measuring devices such as the stability of 
the excitation illumination.  
 
2.4.1 Properties of Fura-2 
Fura-2 is an example of a dual excitation dye. The Ca2+-free form of Fura-2 has a peak excitation 
wavelength of about 380nm, whereas the peak excitation wavelength for Ca2+-bound Fura-2 is 
about 340nm. An increase in intracellular Ca2+ concentration increases Fura-2 emission 
fluorescence when the indicator is excited at 340nm, with a corresponding decrease in 
fluorescence at 380 nm excitation.  
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The absorption at 360nm is the same for all Ca2+ concentrations and this is called the isosbestic 
point, where the fluorescence is independent of the Ca2+ concentration. Fura-2 fluorescence can 
be measured at 380nm excitation, a wavelength at which light is less affected by transmission 
through glass but where absorption is lower. The ratio is normally calculated by measuring the 
fluorescence emitted from the dye at 520nm when it is excited using 340nm or 360nm light. 
This fluorescence value is used as the numerator. At almost the same time, a measurement is 
made of the fluorescence emitted from the dye at 520nm when it is excited using 380nm light. 
This fluorescence value is used as the denominator. 
 
The Ca2+ concentration can then be calculated using the following equation originally derived by 
Grynkiewicz et al (1985):  
 
[    ]       
        
      
   
   
   
 
 
 
 
 
 
Kd 
 
Dissociation constant for the Fura-2-Ca2+ binding 
Usually 225nM is used, we have used 386nM 
 
 
Rmax 
 
Ratio value measured under the condition of saturating Ca2+ 
 
 
Rmin 
 
Ratio value measured under the condition of zero Ca2+ 
 
 
Sf2 
 
Proportional to the fluorescence excited by 380nm in the 
absence of Ca2+ (f = free) 
 
 
Sb2 
 
Proportional to the fluorescence excited by 380nm in 
saturating Ca2+ (b = bound) 
 
 
Table 2.4 Parameters used in the Grynkiewicz equation 
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Fura-2 allows quantitative measurements of intracellular Ca2+ concentrations which can be 
compared between experiments. For the following experiments, a Kd of 386nM was chosen 
(Kajita & Yamaguchi, 1993). 
 
2.4.2 Loading of Fura-2 into isolated cells 
Fura-2AM (Molecular Probes®) was dissolved in 50µl DMSO to produce a 1mM stock and added 
to the cell suspension in its membrane permeant acetoxymethyl ester form to give a final 
concentration of 5µM Fura-2. The tube was wrapped in aluminium foil to protect from light and 
placed on a rocking platform at 22ºC for 15 minutes. To end the loading process, the cell 
suspension was centrifuged for 1 minute at 300rpm, and the supernatant discarded. The pellet 
of cells was resuspended in fresh enzyme solution. Once the dye crosses the cell membrane, the 
ester groups are hydrolysed and the Fura-2 becomes trapped within the cell, therefore 
experiments were started after 20 minutes to allow for this de-esterification. 
 
2.4.3 Measuring Ca2+ using the IonOptix system   
This setup allowed the simultaneous measurement of sarcomere shortening combined with Fura-
2 fluorescence detection. Excitation with 360 and 380nm UV light at a ratio sampling rate of 
1000Hz was achieved with the IonOptix µStep light source (Figure 2.5A). The light from a 75W 
Xenon arc bulb was focused through a filter switcher. This allows light of either 360nm or 380nm 
to be passed via a fibre optic light guide to the cell chamber on the microscope. The emitted 
fluorescence light from the microscope was reflected by a dichroic mirror onto a photo multiplier 
tube (Figure 2.5B). The Cell Framing Adapter (Figure 2.5C) was used to optimize the cell 
fluorescence recording. It has an adjustable iris to frame a rectangular area of the microscope 
field of view allowing the selected cell to be isolated from other fluorescent objects by masking 
the background. The analogue output signals from the PMT were digitised and recorded by the 
IonOptix Fluorescence System Interface (Figure 2.5D) connected to the PC (Figure 2.5E). Light of 
longer wavelengths passed the dichroic mirror and was sent to the camera (Figure 2.5F). A red 
filter in the microscope condenser allowed the transmitted image to be visualized simultaneously 
with the cell fluorescence.  The IonWizard software calculated the ratio of the fluorescence 
intensities at 360 and 380nm excitation and this ratio was used for comparison between groups. 
All components of this setup were from IonOptix Corporation, Milton, MA, USA.  
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Figure 2.5 Schematic of IonOptix setup. This setup was used for the simultaneous measurement 
of sarcomere shortening and fluorescence detection.  
 
 
IonOptix equipment allows two methods of collecting data when using Fura-2 dye, interleaved 
and interpolated numerator. For these experiments the interpolated numerator method was 
selected. At the isosbestic point, changes in fluorescence occur slowly (due to bleaching or 
leakage) and therefore they do not need to be sampled continuously. Data collection starts by 
measuring the emitted fluorescence while exciting the fluorophore at the isosbestic wavelength 
(360nm for 100ms). 100 data points are averaged and the value is stored. The light source is 
then switched to excite the fluophore at 380nm, measuring Fura-2 fluorescence at 1000Hz. At 
the end of the sampling epoch the light source briefly switches to the isosbestic point again to 
collect another value. All the data points for the numerator are then interpolated between the 
beginning and end values and the ratio is calculated for each interpolated point and the 
corresponding measurement at 380nm. As the wavelength only needs to be changed twice in 
one epoch, high sampling rates can be achieved with the advantage of the interpolated 
numerator being noise free. However this method does cause a loss in dynamic range. Several 
factors were considered to ensure the validity of this interpolation method. As bleaching does not 
occur in a linear manner, the interpolation point was sampled regularly (every 30 seconds) and it 
was vital to keep the entire cell within the field of view and to keep the focus constant during 
each recording.  
 
(B) PMT 
(A) Light source  
(F) MyoCam 
(C) Cell Framing 
 Adapter  
(D) Fluorescence 
System Interface  
(E) Computer + 
IonWizard software 
(G) MyoPacer 
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2.4.4 In vitro calibration  
The intracellular Ca2+ levels can be determined using the ratio calculated from the Fura-2 
fluorescence intensity measurements. The relationship between the ratio and Ca2+ can be 
expressed by the „Grynkiewicz‟ equation detailed above. This equation can generate Ca2+ values 
in nanomolar. The calibration process was carried out under conditions closely matched to the 
experimental conditions which allows for reproducible Ca2+ measurements. The calibration 
constants depend on the specific optical elements (filters, dichroic mirrors, objective lens) within 
the system therefore these were kept the same during calibration and all subsequent 
experiments.  
 
The calibration solutions were made to mimic the intracellular conditions. Fluorescence 
recordings were made from the same volume of each solution placed in thin-walled capillary 
tubes. Background levels were obtained from a capillary tube containing distilled water 
containing no Fura-2. Background values with wavelength 360nm and 380nm were subtracted 
from the raw fluorescence signals in the two solutions containing Fura-2. The fluorescence ratio 
Rmax was then calculated from the high Ca2+ values and Rmin is calculated from the zero Ca2+ 
values. Sf2/Sb2 is the ratio between the background subtracted wavelength 380nm excited 
fluorescence in zero and high Ca2+ solutions respectively.  
 
 
Saturating Ca2+ 
 
Zero Ca2+ 
 
KCl 150mM 
 
KCl 150mM 
NaCl 10mM NaCl 10mM 
MgCl2 3mM MgCl2 3mM 
HEPES 10mM HEPES 10mM 
Fura-2 Pentapotassium salt 1uM Fura-2 Pentapotassium salt 1uM 
CaCl2 1mM 
 
EGTA 10mM 
pH 7.4 
 
pH 7.4 
 
Table 2.5 Composition of calibration solutions 
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2.4.5 Protocol for field-stimulated Ca2+ transients 
Before recording the fluorescence of the cell, the frame producing a rectangular area of the 
microscope field of view was adjusted to fit around the chosen cell. The field of view was then 
moved to an empty part of the bath (containing no cells) and the fluorescence levels recorded, 
ensuring the frame size remains the same. The denominator value at this background level of 
fluorescence was entered into the allocated dialog box within the Fura-2 settings. Background 
subtraction was carried out in this way for each cell. 
 
Ventricular myocytes were studied whilst being field-stimulated at 1Hz and superfused with NT 
containing 1mM Ca2+. After 2 minutes of pacing to establish steady state contractions, the 
fluorescence was recorded for 30 seconds. For each Fura-2 ratio recording, the average of 5 
analysed transients was taken. Transient analysis was carried out using the Ionwizard software 
and the parameters studied include the baseline Fura-2 ratio, peak transient amplitude, time to 
peak and time to 50% and 90% transient decay (Figure 2.6). 
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IonWizard 
 
Parameter 
 
Explanation 
 
 
bl 
 
Diastolic Ca2+ concentration 
 
Baseline fluorescence ratio prior to 
stimulation  
 
 
Peak h 
 
Peak Ca2+ transient amplitude 
 
Maximum amplitude of fluorescence ratio 
 
 
Peak t 
 
Time to peak Ca2+ 
 
Time for the Ca2+ transient to reach peak 
fluorescence ratio during the rising phase 
of the transient 
 
 
T to bl 50% 
 
Time to 50% Ca2+ decay 
 
Time for the Ca2+ transient to return to 
50% of the baseline fluorescence ratio 
during the decay phase of the transient 
 
 
T to bl 90% 
 
Time to 90% Ca2+ decay 
 
Time for the Ca2+ transient to return to 
90% of the baseline fluorescence ratio 
during the decay phase of the transient 
 
 
Figure 2.6 Ca2+ transient parameters. Parameters measured using IonWizard transient analysis 
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2.4.6 Protocol for determining SERCA function 
The cells were paced at 1Hz for 2 minutes to establish steady state contractions and to ensure 
the SR was filled. The pacing was paused and the fluorescence recording was started. 5 seconds 
from cessation of stimulation, the solution was switched from 1mM Ca2+ NT to 10mM caffeine in 
zero Ca2+ zero Na+ solution (for composition see Section 2.10) for 5 seconds before switching to 
zero Ca2+ zero Na+ solution without caffeine. This final solution was left perfusing until the Ca2+ 
returned to baseline levels. The caffeine causes the immediate release of Ca2+ from the SR by 
activating the RyR while the zero Ca2+ zero Na+ solution prevents NCX from effluxing Ca2+. When 
caffeine is no longer present in the solution, the activation of RyR is ceased allowing Ca2+ 
reuptake via SERCA to occur and the SR to be refilled. To determine the function of SERCA, tau 
was fitted to the second phase of the decay (Figure 2.7) to give an indication of the rate at which 
reuptake of Ca2+ into the SR occurs through SERCA. 
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Figure 2.7 SERCA function and SR Ca2+ content. To determine SERCA function, Tau was fitted to 
the second phase of the decay. The Ca2+ release caused by 10mM caffeine in zero Ca2+ zero Na+ 
solution was measured as Peak h which indicates total SR Ca2+ content.  
 
 
 
2.4.7 Protocol for measuring SR Ca2+ content 
The protocol was repeated as for the determination of SERCA function. SR load was calculated as 
the baseline subtracted from the peak Ca2+ release (when caffeine in zero Ca2+ zero Na+ solution 
was switched on). 
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2.4.8 Protocol for determining NCX function 
The cells were paced at 1Hz for 2 minutes to establish steady state contractions and to ensure 
the SR was filled. The pacing was paused and the fluorescence recording was started. 5 seconds 
from cessation of stimulation, the solution was switched from 1mM Ca2+ NT to 10mM caffeine in 
1mM Ca2+ NT. This solution was left to perfuse until the Ca2+ transient returned to baseline. The 
caffeine causes immediate total release of Ca2+ from the SR by activating the RyR. The continued 
perfusion of caffeine leads to the continued release of Ca2+ from the SR through RyR, therefore 
the Ca2+ transient decay will be mainly due to NCX effluxing Ca2+ out of the cell. To determine the 
function of NCX, time to 50% baseline was calculated from the peak of the Ca2+ transient to give 
a measure of Ca2+ efflux through NCX. 
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Figure 2.8 NCX function. Time to 50% baseline of the caffeine induced Ca2+ transient was 
measured to give an indication of Ca2+ efflux through NCX 
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2.4.9 Spontaneous Ca2+ waves 
In addition to normal EC coupling providing Ca2+ influx, fluctuations in [Ca2+]i can occur 
spontaneously, without external stimulation. Diastolic Ca2+ release in the form of Ca2+ waves can 
be measured in single cells, using the IonOptix system. It is important to determine the 
propensity of myocytes to spontaneously release Ca2+, as it constitutes a potential 
arrhythmogenic process in the heart.  
 
The experiments were carried out as described for the force-frequency protocol, using cells 
loaded with Fura-2 (Figure 2.9A). The chosen cell was paced at the first stimulation frequency for 
2 minutes and then 10 seconds of Ca2+ transients was recorded. The pacing was stopped and 
the recording continued for 30 seconds in order to detect spontaneous, non-stimulated Ca2+ 
waves. This sequence was repeated using the same cell for a total of four pacing rates – 0.5Hz, 
1Hz, 2Hz and 5Hz. The wave is clearly identifiable from the baseline Fura-2 ratio, allowing wave 
frequency to be determined.  
 
This protocol was also repeated using unloaded cells to detect non-stimulated propagated 
contractions using the sarcomere shortening trace. This allowed a more physiological 
determination of diastolic Ca2+ waves, without Fura-2 potentially altering intracellular buffering 
which could then affect spontaneous Ca2+ release. Due to the evident movement of the cell when 
a Ca2+ wave passes along its length, the wave displays as a clear deflection in the baseline 
sarcomere length, allowing spontaneous contraction (SC) frequency to be determined (Figure 
2.9B). 
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Figure 2.9 Protocol for the detection of spontaneous Ca2+ waves. (A) Representative Fura-2 ratio 
recording showing 2 diastolic Ca2+ waves (B) Simultaneous sarcomere shortening trace showing 2 
corresponding non-stimulated contractions 
2.5 Ca2+ spark measurements using confocal microscopy 
 
Confocal microscopy possesses several advantages over conventional optical microscopy, 
including shallow depth of field and improved resolution by the elimination of out-of-focus light. 
This allows the detection and measurement of Ca2+ sparks; the fundamental SR Ca2+ release 
events. It is useful to study sparks as their temporal and spatial summation are thought to result 
in Ca2+ release during spontaneous Ca2+ waves in addition to Ca2+ release during normal EC 
coupling.  
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The excitation light is provided by a laser, to achieve the high intensities required by this system. 
Laser light is also very coherent allowing it to stay in a narrow beam over long distances. The 
beam of light reflects off a dichroic mirror and from there it is directed to reflect off two mirrors 
mounted on motors which scan the light beam across the cell. The dye in the cell fluoresces and 
the emitted light passes back across the mirrors and through the dichroic. The light is then 
focused to pass through a pinhole and the light which reaches the other side of the hole is 
measured by the PMT. This method allows one point of the cell to be observed at a given time, 
and the image is built up one pixel at a time. 
 
2.5.1 Experimental apparatus for Ca2+ spark measurements 
Cardiomyocytes were observed through a x 40 oil immersion objective (numerical aperture =1.4) 
on a Nikon microscope with a Bio-Rad Radiance confocal attachment. The cells were placed on a 
bath mounted on the stage of the microscope, with platinum wires attached to the bath to allow 
field stimulation via a custom made bipolar stimulator. Fluo-4, a single excitation dye, was the 
Ca2+ sensitive dye used in these experiments. When it binds Ca2+, the efficiency with which 
photons are absorbed is increased, resulting in an increased brightness. Fluo-4 was excited using 
the 488nm line of an argon laser and the emitted fluorescence was collected through a 505nm 
long-pass filter. Fluo-4 has a large fluorescence intensity increase in response to Ca2+ binding 
therefore it is well suited to confocal microscopy experiments with a shallower plane of emission 
and has been widely used in studies to detect Ca2+ sparks. 
 
2.5.2 Loading of Fluo-4 into cells 
Like Fura-2, Fluo-4 as a salt cannot cross cell membranes, so the cell permeant acetoxymethyl 
ester of Fluo-4 was used. After entering the myocytes the lipophilic groups are cleaved by non-
specific esterases and Fluo-4 is able to bind Ca2+. In this Ca2+ binding form, the dye can 
accumulate inside the cell. 
 
Fluo-4AM (Molecular Probes®) was dissolved in 44µl DMSO to give a 1mM stock concentration. 
A final concentration of 10µM Fluo-4 was used when added to cell suspension. The tube was 
wrapped in aluminium foil to protect from light and placed on a rocking platform at RT for 30 
minutes. To end the loading process, the cell suspension was centrifuged for 1 minute 300rpm, 
and the supernatant discarded. The pellet of cells was resuspended in fresh enzyme solution and 
experiments were started after 20 minutes to allow for de-esterification. 
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2.5.3 Protocol for recording Ca2+ sparks 
The Fluo-4 loaded cells were superfused with 2mM Ca2+ NT at 37ºC while being paced at 0.5Hz 
to allow for steady state contraction. 12000 lines were scanned which included 2-3 transients 
followed by a pause in stimulation. The latter section of the line scan without transients was 
selected for spark analysis. Line scans were exported as TIFF files. 
 
Analysis of the image was performed in ImageJ (NIH, USA) using the SparkMaster plugin (Picht et 
al. 2007). Detection criteria for Ca2+ sparks were set at 4.2 times the standard deviation above 
the mean background value. Detection criteria is most commonly 3.8 but, using this criterion, 
random background noise often resulted in pixels being wrongly identified as Ca2+ sparks. The 
macro generates images of the line scans with sparks labelled for identification which allows 
visual assessment to ensure automatic detection is correct. The parameters calculated include 
Ca2+ spark frequency, amplitude (F/F0), full width at half maximal amplitude (FWHM) and full 
duration at half maximal amplitude (FDHM). From these parameters, spark mass and SR leak 
were calculated using the formulae below (Hollingworth et al, 2001). 
 
Spark mass = Amplitude x 1.206 x FWHM3 
 
Spark-mediated SR leak = Mass x FDHM 
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Figure 2.10 3-D representation of a Ca2+ spark generated from a line scan. F/F0, spark 
amplitude; FWHM, full width at half maximal; FDHM, full duration at half maximal 
 
 
2.6 Multi electrode array (MEA) 
 
It is important to integrate results obtained from the single myocyte into more physiological 
models that take into account the complexities associated with the intact tissue. The MEA allows 
the measurement of field potentials on the epicardial surface of whole hearts, providing detailed 
information about the origin and spread of excitation, in addition to the detection of arrhythmias. 
This is achieved by the electrodes detecting changes in voltage in the extracellular environment 
of the cells in which they are in contact with. The voltage changes are caused by ion fluxes 
through cell membranes.  
 
  
200 ms 
20 µm 
FDHM 
FWHM 
F/F0 
1 
2 
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2.6.1 Hardware set up for flex-MEA 
The MEA (EcoFlexMEA36, Multi Channel Systems) consists of 36 separate electrodes arranged in 
a 6x6 configuration. The inter-electrode distance is 300µm and the electrode diameter was 
50µm (Figure 2.11A). The array was connected to a 32-Channel Miniature Preamplifier MPA32I-
Flex (Multi channel systems, bandwidth: 0Hz-50kHz). The array was attached to a custom built 
platform on a micromanipulator. This allowed fine movements for optimising contact and 
accurate positioning on the heart surface while reducing movement artefacts. The field potentials 
recorded by each electrode are then displayed on the computer using MC_Rack. As The Y axis is 
voltage (mV) and the X axis is time (ms), the field potentials are viewed in real time. 
 
 
 
 
 
Figure 2.11 Multi-electrode array. (A) The electrode layout of the FlexMEA36. There are 32 
recording electrodes, 2 reference electrodes and 2 ground electrodes (B) Location of MEA 
recording sites on the mouse heart (C) Representative 36 electrode recording 
 
65 
 
2.6.2 Protocol for MEA 
The heart was dissected and cannulated as described for cell isolation. The heart was attached 
to the Langendorff system and perfused with NT containing 1mM Ca2+ and bubbled with 100% O2 
at 37ºC. Once the heart was beating at its own intrinsic rate, the MEA was placed at Site A on the 
heart (Figure 2.11B) for 5 minutes and the field potentials were recorded for the last 30 seconds. 
10nM isoprenaline was then perfused through the heart for 5 minutes and again the last 30 
seconds of field potentials were recorded. The isoprenaline was washed out for 10 minutes and 
the protocol was repeated at Site B (Figure 2.11B) of the same heart. The starting site of the MEA 
was alternated between hearts, to minimize changes due to the possible incomplete wash out of 
isoprenaline. MC_Rack software was used to view the recordings which allowed the identification 
of arrhythmogenic events and the measurement of QT interval and heart rate.  
 
 
2.7 Electrocardiography (ECG) 
 
As cardiac contraction is a multi-scale process, it is important to link changes in EC coupling at 
the cellular level to the effect on the heart both ex vivo and in vivo. The ECG allows cardiac 
rhythm to be monitored and the detection of electrical abnormalities in the whole animal.  During 
each cardiac cycle, the heart muscle depolarises producing electrical changes on the skin 
surface. This allows for electrical activity of the heart to be visualised using limb leads. Lead II 
ECG was used as it provides a positive P wave and QRS complex, while allowing the assessment 
of heart rhythm and arrhythmias. In both human and mouse, the ECGs show P waves (spread of 
atrial depolarisation) and subsequently the QRS complex (ventricular depolarisation). Often in the 
murine ECG there is a distinct J wave present following the QRS complex but this is not commonly 
seen in humans. The T-wave in the mouse is either not visible or joined onto the end of the QRS 
complex due to the fast ventricular action potential causing a gradual time course of 
repolarisation. Although this makes measurement of the QT interval more difficult in mice, the QT 
can be redefined as the start of the Q wave to the point of return to the isoelectric baseline prior 
to the following P-wave. 
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Figure 2.12 Schematic representation of sinus rhythm in human and mouse ECG. The 
parameters can be adjusted in LabChart according to the specific mouse ECG allowing the 
correct measurements of the labelled intervals and amplitudes.  
 
 
2.7.1 Recording baseline ECG 
The ECG needle electrodes were connected to the signal conditioner (Animal Bio Amp), which in 
turn was connected to the PowerLab data acquisition unit attached to a PC. The data was 
visualised on the computer screen using LabChart software which allows real time monitoring of 
the ECG and the heart rate. The software was also used to calculate QRS interval, QT interval, 
QTc, P, R and S wave amplitude, and heart rate. All components of this setup (hardware and 
software) were from ADInstruments Ltd, UK. 
 
The mouse was anaesthetised with 5% isoflurane in 100% oxygen using an anaesthetic induction 
chamber. The animal was then placed in the supine position on the heated blanket with 
temperature maintained at 37 +/- 0.5ºC. The limbs were secured with tape placed over the paws 
and anaesthesia was maintained using a custom made nose cone. For the surgical isolation of 
the subclavian vein the isoflurane was maintained at 2.5% (in 100% oxygen, 0.5ml/min) and 
reduced to 1.5% (in 100% oxygen, 0.5ml/min) for ECG recordings. To ensure adequate depth of 
anaesthesia before dissection the toe pinch reflex was tested. To facilitate access to the left 
subclavian vein for the IV drug injection, a small (<1cm) submandibular incision was made and 
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blunt dissection used to separate the skin from the underlying fascia. The primary cutaneous 
incision was then continued to the top of the rib cage and the subclavian vein isolated by careful 
blunt dissection of surrounding tissues and perivascular. The ECG needle electrodes were 
inserted into the right forelimb and left hindlimb of the animal (Lead II ECG). The ECG was 
recorded continuously throughout the experiment and 5 minutes was extracted for baseline ECG 
analysis during a period of steady heart rate. 
 
2.7.2 Isoprenaline challenge 
Once the baseline ECG had been recorded, 2.5mg/kg isoprenaline was injected into the 
subclavian vein using a Lo-dose insulin syringe (Terumo Myjector U-100 0.3ml, Becton, Dickinson 
and Company, UK). This protocol is consistent with Song et al (2011), allowing the effect of β-
adrenergic stimulation on the ECG to be compared at different stages of disease in the E99K 
animal. The injection was made in the distal portion of the vein, through the pectoral muscles 
superior to the vein and the bolus was injected in a retrograde direction to facilitate confirmation 
of correct delivery. The ECG was recorded for at least 15 minutes post injection. The injected 
volume was kept constant by making up the required dose of isoprenaline to 50µl using 0.9% 
saline. To ensure the volume of solution and the insertion of the needle were not causing any 
change in heart rate, 0.9% saline was injected as a control. No change was observed; therefore 
any changes observed in the ECG were due to the action of the isoprenaline. At the end of the 
experiment the isoflurane was brought back to 5% and the heart excised for storage as described 
previously. 
 
 
2.8 Protein expression 
 
Western blotting is a technique used to quantify the level of expression of a protein. For these 
experiments, the key proteins involved in Ca2+ homeostasis, NCX, SERCA and RyR, were the 
proteins of interest. It is important to determine whether protein expression is altered in disease, 
and whether underlying changes in expression correlate with changes in protein function. The 
procedure begins by isolation of the protein by lysis of the cells and solubilisation of the proteins. 
This is followed by an assay to determine protein concentration so the same amount of total 
protein can be loaded for each sample during SDS-PAGE. This method of electrophoresis leads to 
larger molecular weight proteins passing more slowly through the pores of the gel than lighter 
proteins, thereby leading to separation. The gel and sample buffer contain sodium dodecyl 
sulphate to negatively charge all proteins so that separation is by molecular weight only. A 
current is passed across the gel which causes the negatively charged proteins to migrate towards 
the positive electrode. After separation, proteins are then transferred onto a polyvinylidene 
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fluoride (PVDF) membrane. Finally, blots are stained with a primary antibody, then hybridised with 
a secondary antibody to be visualised.  
 
2.8.1 Protein extraction 
10µl extraction buffer per mg of tissue (Phosphosafe extraction reagent, Novagen) was added to 
the sample. The buffer also contained protease inhibitor cocktail (Sigma-Aldrich) at a dilution of 
1:1000. The buffer efficiently extracts cytosolic proteins from cells while preserving their 
phosphorylation state. The tissue was homogenised using a TissueLyser LT (Qiagen, UK) at 50Hz 
for 2 minutes. The homogenized sample was stored on ice for 10 minutes, followed by a second 
homogenisation at 50Hz for a further 2 minutes. The lysate was then centrifuged for 1 minute at 
12000rpm. An aliquot of the supernatant was taken for protein measurement using the Bradford 
Assay, and the remaining protein was snap frozen and stored at -80ºC. 
 
2.8.2 Bradford Assay 
The samples were kept on ice. 800µl of water was pipetted into the cuvette and 1µl sample was 
added. For the blank 1µl lysis buffer was added instead of sample. 200µl Roti-Quant (Carl Roth) 
was then added to the cuvette and the solution mixed thoroughly by pipetting. This was then 
incubated for 5 minutes at RT. The Bradford method on the photometer (Smart Spec Plus, Bio-
Rad) was chosen and a stored standard curve was used. The cuvette with the blank was read 
first followed by the samples. 
 
A new standard curve was prepared for each new batch of Roti-Quant. The standards were 
prepared using 100mg/ml bovine serum albumin (Sigma-Aldrich) and distilled water at the 
concentrations shown in Table 2.6, and vortexed to mix. 800µl water was pipetted into the  were 
incubated for 5 minutes at RT. Using the photometer, a new standard curve was produced with 
for 1 blank and 7 standards. The standard curve so produced had a value of the correlation 
coefficient of ≥ 0.95. 
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Table 2.6 Bovine serum albumin (BSA) dilutions for standard curve 
 
 
2.8.3 SDS-PAGE 
The glass plates were fixed into the casting frames and then set into the casting stand. The 
combs (to create the sample wells) were prepositioned before pipetting the polyacrylamide gel 
between the glass plates, ensuring no air bubbles. For NCX and GAPH an 8% gel was made 
(3.5ml distilled water, 1.95ml Tris/0.4% SDS, 2ml Rotiphorese gel 30 (Carl Roth), 50µl 10% APS, 
5µl TEMED), a 6% gel for SERCA and a 5% polyacrylamide gel was used for RyR. A higher 
percentage polyacrylamide gel results in larger proteins migrating more slowly, thus a lower 
percentage polyacrylamide gel was used for 565 kDa RyR, allowing it to migrate. After around 30 
minutes of polymerisation, the gel with the glass plates was removed from the casting stand and 
fixed into the electrophoresis chamber (Bio-Rad). The internal space was filled with 1x SDS-PAGE 
electrophoresis buffer (for composition see Section 2.10) until the gel was covered. The comb 
was removed and the wells were rinsed. The samples and the ladder (Precision Plus Protein 
WesternC Standards, Bio-Rad) were thawed on ice. 17.5 µl 3x reduced blue loading buffer (10µl 
30x Reducing Agent added to 100µl 3x Blue Loading Buffer, NEB) was mixed with a variable 
volume of water and sample (30ng protein per lane) to give a constant volume of 21µl and final 
concentration of 1x blue loading buffer. The samples were then incubated for 5 minutes at 95ºC, 
cooled on ice and centrifuged. The ladder was loaded into the first well of the gel, followed by the 
samples in subsequent wells. Empty lanes were filled with 1x blue loading buffer to ensure 
uniform running of the gel. The gel was placed into the electrophoresis chamber containing 1x 
SDS-PAGE electrophoresis buffer and run at 30mA, with maximum voltage (300V) for ~1.5 hours.  
 
Concentration 
(mg/ml) 
 
Water µl 
 
BSA µl 
 
 
0 
 
100 
 
- 
1 99 1 
2 98 2 
4 96 4 
8 92 8 
10 90 10 
12 88 12 
20 80 20 
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2.8.4 Western blotting 
The membrane was activated for 1 minute in methanol, rinsed for 2 minutes in distilled water 
and then incubated for 5-10 minutes in cold 1x Western blot transfer buffer (for composition see 
Section 2.10). The glass plates were separated and the plate with the gel was transferred to a 
basin containing cold 1x Western blot transfer buffer and incubated for 5-10 minutes. Sponges 
and filter paper were also incubated for 5-10 minutes in cold transfer buffer. The blot was 
packed in the order illustrated in Figure 2.13. The chamber was filled with cold 1x Western blot 
transfer buffer, connected to the power pack and set to run at 30V overnight at 4ºC. Once the 
transfer was complete, the cassette was removed from the chamber. The membrane was placed 
into a basin of 1x TBST (for composition see Section 2.10) with 5% milk and incubated on a 
shaker for 1 hour at RT. For RyR, 5% BSA (Sigma-Aldrich) was used instead of milk for blocking, 
as it is more suitable for phosphorylated proteins. The blocking solution was then discarded and 
the membrane washed for 3 x 5 minutes with 1x TBST on the shaker. The primary antibody was 
prepared in a 50ml falcon tube with 1x TBST. The membrane was transferred into the tube and 
placed on a rolling mixer overnight at 4ºC. The membrane was then washed again 3x 5 minutes 
with 1x TBST on the shaker.  The secondary antibody was prepared in 10ml 1x TBST with 5% milk 
in a 50ml centrifuge tube. The membrane was transferred into the centrifuge tube and placed on 
the rolling mixer for 1 hour at RT. The membrane was washed again with 1x TBST on the shaker 
3 x 5 minutes.  
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Cathode (-) 
 
 
Sponge 
 
 
Filter paper 
 
 
Gel 
 
 
PVDF membrane 
 
 
Filter paper 
 
 
Sponge 
 
 
Anode (+) 
 
 
 
Figure 2.13 Order of packing the blot within the cassette 
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Protein of interest  
 
Primary Antibody 
 
Secondary Antibody 
 
 
NCX 
 
 
 Monoclonal anti-NCX (Swant) 
1:1000 
 
 
Polyclonal goat anti-mouse 
(Dako) 1:1000  
 
SERCA 
 
 
Polyclonal anti-SERCA2A 
(Badrilla) 1:5000 
 
 
Polyclonal goat anti-rabbit 
(Dako) 1:2000  
 
RyR 
 
 
Polyclonal anti- RyR2 Phospho 
Ser-2808 (Badrilla) 1:5000 
 
 
Polyclonal goat anti-rabbit 
(Dako) 1:2000  
 
GAPDH 
 
 
Monoclonal anti-GAPDH 
(Santa Cruz) 1:500 
 
 
Polyclonal goat anti-mouse 
(Dako) 1:1000 
 
Table 2.7 Antibodies used in Western blotting. Primary and secondary antibodies used to detect 
NCX, SERCA, RyR and GAPDH 
 
 
The membrane was added to 4ml of Amersham ECL Western Blotting Detection reagent 1 and 
reagent 2 (2ml each) in a 50ml falcon tube and put on the shaker at RT for 5 minutes. These 
reagents use enhanced luminol-based detection. The membranes were dried and then 
positioned inside the gel documentation system (G-Box, Syngene). A serial exposure time protocol 
was used; 1, 2, 3, 4 and 5 minutes, from which the most appropriate exposure time was selected 
and used for all membranes to maintain consistency in obtaining measurements of the different 
proteins. Images were saved and exported to ImageJ to determine the band intensity.  
 
2.9 Quantification of mRNA  
The abundance of Ca2+ handling proteins may be altered in disease therefore is useful to 
quantify the mRNA transcript levels of NCX and SERCA in addition to the protein expression 
levels. Altered RNA levels of key proteins involved in EC coupling may underlie changes in Ca2+ 
homeostasis, through knock on effects to protein expression and function. The strategy used 
here was to initially isolate the RNA followed by the use of TaqMan® fluorogenic probes, to 
fluorescently label the reaction products. This method uses target specific oligonucleotides that 
produce a fluorescent signal only when the target DNA is amplified during qPCR.  Data collected 
in the exponential phase of the reaction yield quantitative information on the starting quantity of 
the amplification target. 
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2.9.1 Isolation of RNA 
Prior to RNA isolation, all surfaces and pipettes were cleaned using RNAseAway (Sigma-Aldrich) 
to eliminate any potential RNAse and DNA contaminants. The tissue was placed into the 
homogeniser and 1ml Trizol (Invitrogen, UK) was added. The tissue was homogenised then 
transferred to a 1.5ml Eppendorf tube. The lysate was incubated for 5 minutes at RT. 200µl 
chloroform was added to the lysate and the tube inverted several times. This was incubated for 
2-3 minutes at RT then centrifuged for 15 minutes at 11000g at 4ºC. The supernatant was 
transferred to a new 1.5ml tube and 500µl isopropanol was added. This was mixed together and 
incubated for 10 minutes at RT, followed by centrifugation for 10 minutes at 11000g at 4ºC. The 
supernatant was removed and 1 ml 75% ethanol was added. After mixing, this was centrifuged 
for 5 minutes at 7300g at 4ºC. The supernatant was completely removed and the pellet dried for 
5-10 minutes at RT. 20µl DEPC treated water was added and the pellet was dissolved by 
pipetting. For measurement of RNA, 2µl DEPC treated water was pipetted onto 2 spots of the 
Take3 plate (BioTek Instruments Inc) and the blank was measured using the photometer. Next, 
2µl RNA sample was pipetted onto a spot of the Take3 plate and the sample was measured. 
 
2.9.2 qPCR 
The components described in Table 2.8A were aliquotted into each thin-walled 0.2ml PCR tubes. 
The Applied Biosystems® High-Capacity cDNA Reverse Transcription Kit is a sensitive reverse 
transcription system, which allows 100-2000ng total RNA to be reverse transcribed. The 
thermocycler was run using the program settings shown in Table 2.8B. The protocol allows cDNA 
to be generated from the RNA template. For all samples, the RNA concentration was normalised 
to 20ng/µl and 200ng reverse transcribed. 
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Reagent 
 
Volume (µl) 
 
10x RT Buffer 
25x dNTP Mix (200mM) 
 
2 
0.8 
10x Random Primer 2 
Multiscribe Reverse Transcriptase 
enzyme (50 U/µl) 
Nuclease free water 
200ng RNA + Nuclease free 
water 
Total per reaction 
 
 
1 
4.2 
 
10 
20 
 
 
 
Incubation 
 
 
10 mins at 25°C 
 
Reverse transcription 
 
 
120 mins at 37°C 
 
Denaturation 
 
5 mins at 85°C 
 
 
Hold 
 
4°C 
 
 
 
Table 2.8 Reagents and thermocycler protocol for reverse transcription. (A) Reagents required for 
reverse transcription (B) Protocol for reverse transcription  
 
 
 
The samples were diluted 1:3 with nuclease-free water and 2 µl was taken from every sample for 
the preparation of the dilution series (1:5, 1:25 and 1:125). For each gene of interest and the 
house-keeping gene GAPDH, a standard curve was produced from the dilution series. The cDNA 
was combined with the reagents (Table 2.9A) and the protocol for qPCR was then carried out 
using the program shown in Table 2.9B. The TaqMan® Gene Expression Master Mix (Applied 
Biosystems, Life Technologies) contains AmpliTaq Gold® DNA Polymerase for hot start activation 
and a blend of dNTPs and buffer at optimal concentrations for real-time PCR. Each TaqMan 
A 
B 
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probe (Applied Biosystems, Life Technologies) was specific for each gene of interest to allow 
quantification of NCX (gene: Slc8a1), SERCA (gene: Atp2a2) and GAPDH in mouse. The amount of 
DNA is measured after each cycle via fluorescent dye molecules attached to the PCR probes that 
hybridize with PCR products during amplification. The fluorescent reporters yield increasing 
fluorescent signal in direct proportion to the number of PCR product molecules generated.  
  
 
 
 
 
Reagent 
 
Volume (µl) 
 
TaqMan® Gene Expression 
Master Mix 
 
5 
Nuclease free water 
Specific TaqMan probe 
2.5 
0.5 
cDNA 
Total  
2 
10 
 
 
 
Heat activation of 
polymerase 
 
 
3 mins at 95°C 
 
Annealing 
 
15 sec at 95°C 
 
Extension 1 min at 60°C 
 
 
Hold 
 
15°C 
 
 
 
Table 2.9 Reagents and thermocycler protocol for qPCR. (A) Reagents required for qPCR (B) 
Protocol for qPCR  
 
  
40 cycles 
A 
B 
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2.10 Experimental solutions 
All chemicals were supplied by Sigma-Aldrich.  
 
10 x TBE 
Tris Base 50, boric acid 50, EDTA 200µM 
 
Tyrode Solution (containing 1mM Ca2+) 
NaCl 140, KCl 6, glucose 10, Hepes 10, MgCl2 1, CaCl2 1 ; pH adjusted to 7.4 with NaOH 
 
Low Ca2+ solution 
NaCl 120, KCl 5, MGSO4 5, Na pyruvate 5, glucose 20, taurine 20, HEPES 10, NTA 5, CaCl2 
35µM; pH adjusted to 6.96 with NaOH 
 
Enzyme solution 
NaCl 120, KCl 5, MGSO4 5, Na pyruvate 5, glucose 20, taurine 20, HEPES 10, NTA 5, CaCl2 
200µM; pH adjusted to 7.4 with NaOH 
 
0Na+ 0Ca2+ solution 
LiCl 140, KCl 6, glucose 10, HEPES 10, MgCl2 1, EGTA 1 
 
Tris + 0.4% SDS 
Tris 1.5M, SDS 14; pH adjusted to 8.8 with 37% HCl 
 
1x SDS-PAGE electrophoresis buffer 
Tris 25, glycine 192, SDS 35 
 
1x Western Blot transfer buffer 
Glycine 192, Tris 25 
 
1 x TBST 
Tris 20, NaCl 138, Tween-20 892µM 
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2.11 Statistical Analysis 
 
The analysis was performed using Prism 6 software (GraphPad Software Inc., San Diego, Ca, 
USA). All data are expressed as mean ± standard error of the mean. P<0.05 was considered 
significant. For the single cell experiments, data was analysed using n = cells, because it is 
important to consider variation of cells within an isolation and this method allows the 
independent behaviour of individual cells to be taken into account. As the cell data is multi-level, 
it was also analysed by grouping cells per isolation, which provides evidence that significant 
findings are not quirks of high cell numbers (shown in the Appendix).  
2.11.1 Two-way ANOVA 
For all of the previously described cellular experiments, hearts from both male and female 
animals were used to isolate cells. This allows the in-depth study of the effect of genotype within 
a gender, as well as the effect of gender within a genotype, for each measurement. A two-way 
ANOVA with Tukey‟s multiple comparison test was used to determine the interaction of the two 
independent variables and their individual effect on the parameter of interest.  When using this 
test, three null hypotheses are examined: 
1. The mean of each column (genotype)  is the same in the overall population  
2. The mean of each row (gender)  is the same in the overall population  
3. There is no interaction between the two factors (genotype and gender) 
The p-values calculated are adjusted for multiple comparisons. By employing the post hoc test 
the following comparisons can be made: 
 NTG female vs TG female 
 NTG male vs TG male 
 NTG female vs NTG male 
 TG female vs TG male 
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Chapter 3: Contractility and 
Ca2+ handling in 
cardiomyocytes from ACTC 
E99K adult mice 
 
In this Chapter, the contractility and Ca2+ handling properties of cardiomyocytes isolated 
from 8-12 week old ACTC E99K animals are examined. At this age, the ACTC E99K mice 
have survived the sudden death window but show the typical features of HCM. 
Sarcomere shortening, Ca2+ transients and functions of the main Ca2+ handling proteins 
are studied. These experiments test the hypothesis that Ca2+ handling is altered due to 
the increased myofilament sensitivity.   
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3.1 Introduction 
 
Myofilament mutations commonly enhance Ca2+ sensitivity and maximal force production. The 
main hypothesis of this study proposes that the increased myofilament Ca2+ sensitivity would be 
coupled to a slower Ca2+ dissociation from troponin C, leading to disturbances in intracellular 
Ca2+ homeostasis. This could consequently alter the function of key regulatory proteins involved 
in the transport of Ca2+, which may change the properties of the Ca2+ transient. It has been 
suggested that changes in Ca2+ handling and energy deficiency ultimately produce the anatomic 
and functional characteristic features of HCM. Sustained alterations in cellular Ca2+ levels can 
activate hypertrophic signalling pathways which lead to the development and progression of the 
hypertrophy found in the heart. 
 
Published studies have characterised the mechanical properties of ACTC E99K papillary muscles 
from 8-12 week old animals (Song et al., 2013).  In isometric twitches, TG muscle produced 3-4 
times greater force but relaxed more slowly than NTG muscle. This indicates the hypercontractile 
phenotype expected from a model of HCM is present at the intact muscle level. The adult ACTC 
E99K mouse has also been previously characterised to show the progression of disease in terms 
of function (Song et al. 2011). At 21 weeks old, the hearts display apical hypertrophy with 
enlarged atria. End-diastolic volume was found to be reduced, end-diastolic pressure was 
increased and relaxation rates were slower, consistent with diastolic dysfunction commonly seen 
in HCM. Histological techniques showed an increased interstitial fibrosis and myocyte disarray, 
characteristic features of the disease.  Further progression of the disease sees mice above 29 
weeks old developing systolic dysfunction which is associated with DCM and HF.  
 
The next step of the investigation into the disease causing molecular mechanism of HCM in the 
ACTC E99K mouse model was therefore to study the contractile and Ca2+ handling properties 
within the single cell. The cardiomyocyte is the fundamental unit of the heart, allowing the study 
of Ca2+ within an intact system. Cells were isolated from 8-12 week old mice; these animals have 
survived the SCD window and demonstrate normal survival, presenting with HCM before it 
decompensates to the HF phenotype. By studying the contractility of the isolated cell, we can 
determine whether the mechanical changes seen at the muscle and whole heart level are caused 
by underlying mutation-induced alterations in the myocyte itself. Changes observed within cells 
isolated from animals in this age group may contribute to the development of hypertrophy and 
progression of the disease.  
 
It is also important to study both male and female mice in the subsequent experiments.  From 
the survival curve (Figure 1.10), it is clear that more females die than males. As almost 50% of 
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the females die and only 25% of the males, it is possible that there will be marked gender 
differences in other aspects of the disease which may contribute to the differing predisposition to 
SCD. Therefore, it is essential to determine whether there are gender differences, as well as 
mutation-induced changes, within other parameters such as cellular contractility, Ca2+ transient 
parameters, the function of NCX and SERCA and the load of the SR. 
 
Aims 
 Measurement and comparison of sarcomere shortening using unloaded myocytes 
stimulated at 1Hz 
 Measurement and comparison of Ca2+ transients using Fura-2 loaded myocytes 
 Measurement and comparison of SR Ca2+ content, NCX and SERCA function 
 
3.2 Materials and methods 
 
3.2.1 Isolated cell experiments  
8-12 week old ACTC E99K male and female mice were used in all experiments. The cells were 
isolated as described in the Methods section 2.2. The experiments were carried out using the 
IonOptix system, superfusing the cells with NT containing 1mM Ca2+ at 37ºC. The sarcomere 
shortening and Ca2+ transient protocols were carried out as described in Methods section 2.3.2 
and 2.4.5 respectively. 
 
NCX function: The mean time taken for the caffeine-induced transient to decay by 50% was 
measured as described in the Methods section, which indicates the efflux of Ca2+ through NCX 
and therefore NCX function. Due to the shape of the Ca2+ decay, tau did not provide a good fit to 
the curve. Often, an initial fast spike in Ca2+ decline was observed, so fitting tau to the final 50% 
of the decay curve would not take this into account. Therefore R50 was considered a better 
measurement to indicate NCX function.  
 
SERCA function: The mean time constant of the decay in 0Na+ 0Ca2+ solution of the caffeine-
induced transient was measured, as described in the Methods section. Tau was derived by fitting 
a single exponential curve to the second phase of the transient decay. This measurement 
represents the uptake of Ca2+ through SERCA and therefore indicates SERCA function. A 
limitation of the IonOptix software meant R50 could not be measured on the second phase of a 
two part experiment, therefore tau was used instead because it provided a good fit to the curve.  
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Fractional release calculation: Fractional release was calculated using the Ca2+ transient 
amplitude and SR Ca2+ content measurements, to demonstrate the percentage of total Ca2+ 
stored in the SR which is released in a stimulated Ca2+ transient. If both measurements were not 
recorded for a single myocyte, the cell was excluded from the calculation. 
3.2.2 Protein expression & mRNA transcript levels 
Hearts from 8-12 week old ACTC E99K male and female mice were collected as described in the 
Methods section 2.1.3. The protein expression and mRNA transcript levels of NCX and SERCA 
were determined using the protocols described in Methods section 2.8 and 2.9 respectively. 
These experiments were carried out by Adam Mills, Imperial College London. 
3.2.3 Statistical analysis 
A two-way ANOVA was used to determine the interaction of the two independent variables 
(genotype and gender) and their individual effect on the parameter of interest. The effect of 
genotype was examined first to determine whether there were overall differences between the TG 
and NTG groups. 
 
3.3 Results 
 
3.3.1 Sarcomere shortening 
Table 3.1 shows that genotype had an effect on all of the measured parameters except for peak 
contraction amplitude. Figure 3.1B shows that resting sarcomere length was smaller in TG cells 
compared with NTG cells (1.65 ± 0.01 vs 1.71 ± 0.01 µm, p<0.001). The peak amplitude of 
contraction was similar between the control and TG groups as shown in Figure 3.1C. Figures 
3.1D-F show that time to peak (TTP) (102 ± 2 vs 88 ± 2 ms, p<0.001), time to 50% relaxation 
(80 ± 3 vs 62 ± 3 ms, p<0.001) and time to 90% relaxation (178 ± 9 vs 125 ± 7 ms, p<0.001) 
were prolonged in TG cells when compared with NTG cells. 
 
Table 3.1 shows that for all of the studied parameters, there was no interaction between gender 
and genotype. There was also no effect of gender on resting sarcomere length. However, for the 
remaining parameters the effect of gender was significant.   
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Parameter Interaction Gender Genotype 
Peak amplitude (µm) ns *** ns 
Time to peak (ms) ns *** *** 
R50 (ms) ns *** *** 
R90 (ms) ns ** *** 
Resting sarcomere 
length (µm) 
ns ns  *** 
 
Table 3.1 The effect of gender and genotype on sarcomere shortening parameters 
 
 
The Tukey tests allow more detailed comparisons to be drawn between groups by taking into 
account gender within each genotype. Significant differences determined by these post hoc tests 
are indicated by asterisks on the graphs. Figure 3.1B shows that cells from both male and female 
TG animals displayed a shorter resting sarcomere length than their NTG counterparts (1.66 ± 
0.01 (TG male) vs 1.71 ± 0.01 µm (NTG male), p<0.001); 1.65 ± 0.01 (TG female) vs 1.70 ± 
0.01 µm (NTG female), p<0.001). Figure 3.1C shows that peak contraction amplitude was 
greater in NTG males than NTG females (0.11 ± 0.01 vs 0.09 ± 0.01 µm, p<0.01). TG females 
displayed a prolonged TTP when compared to both NTG females and TG males, as shown in 
Figure 3.1D (107 ± 3 (TG female) vs 91 ± 2 ms (NTG female), p<0.001; vs 96 ± 3 ms (TG male), 
p<0.05). The TG males also displayed a longer TTP when compared with NTG males (96 ± 3 vs 
85 ± 2 ms, p<0.05). Figure 3.1E shows that the TG group within both genders displayed 
prolonged time to 50% relaxation in comparison with their control counterparts (71 ± 4 (TG male) 
vs 54 ± 3 ms (NTG male), p<0.05); 87 ± 5 (TG female) vs 70 ± 4 ms (NTG female), p<0.05). In 
addition, cells from NTG females relaxed more slowly than NTG males (70 ± 4 vs 54 ± 3 ms, 
p<0.05). Figure 3.1F shows that time to 90% relaxation was prolonged in cells from both male 
and female TG animals in comparison to their corresponding NTG group (159 ± 13 (TG male) vs 
107 ± 8 ms (NTG male), p<0.01); 195 ± 13 (TG female) vs 144 ±  10 ms (NTG female), p<0.01).   
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Figure 3.1 Sarcomere shortening in E99K TG and NTG cardiomyocytes. Data are presented as 
mean ± SEM; n = 126 cells from 12 NTG animals, 114 cells from 13 TG animals (A) 
Representative sarcomere shortening measurements normalised to baseline length (B) Diastolic 
sarcomere length (C) Peak amplitude of contraction (D) Time to peak (E) Time to 50% relaxation 
(F) Time to 90% relaxation  
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3.3.2 Ca2+ transients 
Table 3.2 shows that genotype had an effect on the measurements of peak transient amplitude, 
TTP and resting Fura-2 ratio. Figure 3.2B shows that resting Fura-2 ratio was lower in TG cells 
compared with NTG cells (1.29 ± 0.01 vs 1.41 ± 0.01, p<0.001). The peak transient amplitude 
was reduced in TG when compared with the NTG group (0.42 ± 0.02 vs 0.52 ± 0.02, p<0.01), as 
shown in Figure 3.2C. Figures 3.2D shows that TTP was prolonged in cells from TG animals in 
comparison to the NTG group (65.7 ± 0.7 vs 62.8 ± 0.3 ms, p<0.001). The time to 50% and 90% 
baseline were similar between the control and TG groups as shown in Figure 3.2E-F. 
 
Table 3.2 shows that there was no significant interaction found between gender and genotype, 
but there was an effect of gender on all of the Ca2+ transient parameters.  
 
Parameter Interaction Gender Genotype 
Peak transient  
amplitude  
ns ** ** 
Time to peak (ms) ns ** *** 
R50 (ms) ns *** ns 
R90 (ms) ns *** ns 
Resting fura-2 ratio ns *** *** 
 
Table 3.2 The effect of gender and genotype on Ca2+ transient parameters 
 
 
The Tukey tests were then examined. Figure 3.2B shows that cells from TG animals in both 
genders displayed reduced diastolic Fura-2 ratio when compared to the corresponding NTG (1.26 
± 0.02 (TG male) vs 1.38 ± 0.01 (NTG male), p<0.001); 1.31 ± 0.02 (TG female) vs 1.45 ± 0.02 
(NTG female), p<0.001). In addition, cells from NTG female mice showed higher diastolic Fura-2 
ratio than cells from NTG males (1.45 ± 0.02 vs 1.38 ± 0.01, p<0.05). The peak transient 
amplitude was found to be significantly lower in cells from TG females when compared to both 
NTG females and TG males (0.36 ± 0.03 (TG female) vs 0.48 ± 0.03 (NTG female), p<0.05; vs 
0.48 ± 0.04 (TG male), p<0.05), as shown by Figure 3.2C. Figure 3.2D shows that cells isolated 
from TG males display a prolonged TTP when compared to both their NTG counterparts and TG 
females (68 ± 1 (TG male) vs 63 ± 1 ms (NTG male), p<0.05; vs 64 ± 1 ms (TG female), 
p<0.001). Cells from TG females displayed prolonged time to 50% transient decay compared 
with cells from TG males (175 ± 8 vs 148 ± 6 ms, p<0.05), shown by Figure 3.2E. Figure 3.2F 
shows that time to 90% transient decay was also prolonged in cells from TG females when 
compared with the TG male group (583 ± 14 vs 517 ± 18 ms, p<0.05).  
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Figure 3.2 Ca2+ transient parameters in E99K TG and NTG cardiomyocytes. Data are presented 
as mean ± SEM; n = 93 cells from 11 NTG animals, 79 cells from 9 TG animals (A) 
Representative Ca2+ transients normalised to baseline (B) Diastolic Fura-2 ratio (C) Peak 
transient amplitude (D) Time to peak (E) Time to 50% decay (F) Time to 90% decay 
 
„ 
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3.3.3 Function of the main proteins involved in Ca2+ regulation 
Table 3.3 shows that genotype was found to have a significant effect on the measurements of 
NCX function and SR Ca2+ content. Figure 3.3C shows that the efflux of Ca2+ through NCX was 
significantly slower in TG cells compared with NTG cells (1.889 ± 0.111 vs 1.435 ± 0.121 s, 
p<0.01), implying a reduced function of NCX. SERCA function was similar in both TG and NTG 
cells as shown by Figure 3.3D. Figure 3.3E shows that SR load in TG cells was lower than in NTG 
cells (1.09 ± 0.07 vs 1.38 ± 0.07, p<0.01). Fractional release was found to be similar between 
TG and NTG cells, as shown in Figure 3.3F.  
 
Table 3.3 shows that for all of the measurements, no significant interaction was found between 
gender and genotype. In addition to this, no effect of gender was observed.  
 
Parameter Interaction Gender Genotype 
NCX (s) ns Ns ** 
SERCA (s) ns Ns ns 
SR load ns Ns ** 
Fractional release (%) ns Ns ns 
 
Table 3.3 The effect of gender and genotype on NCX, SERCA and SR Ca2+ content 
 
 
After performing the Tukey test, no differences due to gender or genotype were found between 
the groups for SERCA function, SR load or fractional release. Figure 3.3C shows that time to 50% 
transient decay was slower in the cells from TG females when compared to NTG females (1.824 
± 0.152 vs 1.208 ± 0.139 s, p<0.05), indicating a reduced function of NCX in TG females.  
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Figure 3.3 Ca2+ handling in E99K TG and NTG cardiomyocytes. Data are presented as mean ± 
SEM (A) Representative Ca2+ release by application of caffeine (B) Representative Ca2+ release by 
application of caffeine in 0Na+ 0Ca2+ solution (C) Mean time taken for the caffeine-induced 
transient to decay by 50%; n = 50 cells from 10 NTG animals, 48 cells from 8 TG animals (D) 
Mean time constant of the decay in 0Na+ 0Ca2+ solution of the caffeine-induced transient; n = 27 
cells from 10 NTG animals, 21 cells from 6 TG animals (E) SR Ca2+ content; n = 34 cells from 10 
NTG animals, 28 cells from 6 TG animals (F) Fractional release; n = 20 cells from 8 NTG animals, 
20 cells from 7 TG animals 
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3.3.4 Protein and mRNA levels of NCX and SERCA 
The results shows NCX and SERCA expression normalised to the endogenous reference, GAPDH 
(raw data is presented in the Appendix). Table 3.4 shows that there is an effect of genotype on 
the protein expression levels of NCX (1.82 ± 0.25 vs 1.43 ± 0.16 RU, p<0.05) and SERCA (0.83 
± 0.11 vs 1.23 ± 0.08 RU, p<0.01), but no effect of genotype on the mRNA transcript levels 
between TG and NTG hearts. 
 
After performing the Tukey test, TG females were found to show greater NCX protein expression 
than TG males (Figure 3.4A). Figure 3.4B shows that TG females have lower SERCA protein levels 
than their NTG female counterparts.  
 
Parameter Interaction Gender Genotype 
 
NCX 
Protein 
mRNA         
 
 
ns 
ns 
 
 
*** 
ns 
 
 
* 
ns 
 
SERCA 
Protein 
mRNA 
 
 
ns 
ns 
 
 
** 
ns 
 
 
** 
ns 
 
Table 3.4 The effect of gender and genotype on NCX and SERCA levels  
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Figure 3.4 Protein and mRNA levels of NCX and SERCA in E99K TG and NTG heart tissue. Data 
are presented as mean ± SEM; n = 3 hearts per group (A) NCX protein expression (B) SERCA 
protein expression (C) NCX mRNA levels (D) SERCA mRNA levels 
 
 
3.3.5 Ca2+ fluxes 
During electrically-stimulated transients, all of the Ca2+ transport systems are active 
simultaneously, so the values for [Ca2+]i decline of individual systems do not necessarily indicate 
their quantitative contributions during a normal twitch. It would be useful to know what fractions 
of the total Ca2+ in the cytosol (free and bound) are transported by SERCA, NCX and the slow 
systems (sarcolemmal Ca2+ ATPase and mitochondrial Ca2+ uniporter). A method employed by 
Bassani et al., was used to calculate the individual fluxes through these transport processes 
(Bassani et al. 1994). 
 
It is assumed that free [Ca2+]i is in equilibrium with passive buffers in the cell so the total [Ca2+] in 
the cell, [Ca2+]t can be calculated using the following equation: 
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Bmax1, Bmax2, K1 and K2 are constants for cellular Ca2+ buffering derived empirically by Hove-
Madsen & Bers, 1993. The „fura‟ component in the equation accounts for Ca2+ binding to 
intracellular fura-2.  
 
 
 
Bmax1 (µmol/L cytosol) 
 
236 
 
K1 (nM) 498 
 
Bmax2 (µmol/L cytosol) -39 
 
Intracellular Fura-2 (µM) 50 
 
Kfura (nM) 386 
 
 
Table 3.5 Buffering constants for calculation of Ca2+ fluxes 
 
 
Free [Ca2+]I can be converted to total [Ca2+] and the decline in total [Ca2+] differentiated 
(d[Ca2+]/dt) to yield the rate of Ca2+ removal from the cytosol. This rate is the sum of all the fluxes 
(J) through the individual systems: 
 
 
 
 
Each subscript indicates the flux through the designated system and L is a constant Ca2+ leak. 
The flux through SERCA, NCX and the slow systems can be described by the following equation: 
 
 
  
 
 
The fluxes for NCX, other and total were calculated using the experimental data, whereas the 
SERCA flux was calculated using the flux values of the other systems. The two-way ANOVAs 
showed that there were no differences between fluxes in TG and NTG cells. However, there was 
an effect of gender on the uptake through SERCA (p<0.001). SERCA flux was found to be 
reduced in TG females compared with TG males (p<0.01).  
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 NTG female TG female NTG male TG male 
SERCA 173 ± 6 
n = 5 
 
159 ± 5 1 
n = 4 
188 ± 2 
n = 4 
200 ± 11 
n = 3 
NCX 28 ± 2 
n = 6 
n cells = 28 
28 ± 2 
n = 4 
n cells = 28 
29 ± 4 
n = 5 
n cells = 23 
25 ± 4 
n = 5 
n cells = 20 
Other 12 ± 1 
n = 5 
n cells = 9 
13 ± 2 
n = 4 
n cells = 11 
12 ± 1 
n = 4 
n cells = 10 
8 ± 1 
n = 3 
n cells = 6 
Total 
 
220 ± 8 
n = 6 
n cells = 20 
201 ± 7 
n = 4 
n cells = 12 
217 ± 15 
n = 5 
n cells = 16 
232 ± 13 
n = 5 
n cells = 16 
 
Table 3.6 Calculated Ca2+ fluxes (µmol/l cytosol/sec). Mean values presented as ± SEM. n = 
average values calculated for each isolation. 1 SERCA function reduced in TG female compared 
with TG male, p<0.01.  
 
3.4 Discussion 
 
Isolated cardiomyocytes provide an intact system in which to study the effect of mutant actin on 
the alterations that may occur to the physiological control of Ca2+. The myocytes are free from 
possible compounding effects of the extracellular matrix, abnormal whole heart chamber 
geometry, circulating catecholamines and other hormones. This is particularly important in this 
study where ACTC E99K hearts exhibit increased myocardial fibrosis and differences in chamber 
dimensions in comparison to the NTG. The mice studied are a subset of the population that have 
survived the early death window. At 8 weeks old, arrhythmias in the ACTC E99K mouse are 
infrequent under normal conditions and rate of sporadic death is low. Therefore any cellular 
changes would be expected to contribute to the mechanism for hypertrophy and compensation 
rather than arrhythmias.  
3.4.1 Relaxation is slowed in ACTC E99K TG cells 
Alterations in the contractile properties of ACTC E99K TG cells were observed. The resting 
sarcomere length was found to be shorter in both male and female TG cells, suggesting that 
these cells are more contracted at rest (Flagg et al. 2009). This could be caused by a higher 
resting Ca2+ level; however the transient analysis shows that diastolic Fura-2 ratio is lower, 
indicative of reduced Ca2+ in the TG cells. It is possible that more Ca2+ is buffered by the 
myofilaments by binding to troponin C, which may allow cross-bridges to continue to form during 
diastole thus increasing diastolic tension. This could be a contributing factor to the reduced end-
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diastolic volume and the increased end-diastolic pressure which has been found in the ACTC 
E99K in vivo studies. This result is not uncommon in models with increased myofilament Ca2+ 
sensitivity. For example, shorter baseline sarcomere lengths have been a consistent finding in 
myocytes isolated from murine models of HCM expressing TnT mutations, where a higher level of 
myofilament activation at rest has also been observed (Guinto et al., 2009; Haim et al., 2007).  
 
Peak sarcomere shortening was found to be similar in both ACTC E99K and NTG cells. This result 
was surprising, because the studies on papillary muscle showed three to four times greater force 
production in the TG (Song et al., 2013), therefore a larger contraction amplitude would have 
been expected at the cellular level. The level of contraction may not be increased due to the 
reduced Ca2+ transient observed in the TG cells. This discrepancy can be explained by the fact 
the single cell studies are an unloaded system (i.e. not force producing), whereas the muscle 
experiments are loaded; they are stretched to the point of maximum force production. Shortening 
of the myocyte is a measure of the maximum turnover rate of the cross-bridges whereas loading 
from internal viscous elements and by longitudinal and radial elastic elements as well as 
scaffolding proteins, which the cycling cross-bridges are normally working against, does not 
happen in the same way.  It is highly likely that the cross-bridge cycling rate is different compared 
with loaded cells and it has been suggested that the external load on the muscle changes affinity 
of troponin C for Ca2+ (Song et al., 2013).  
 
The relaxation of both male and female ACTC E99K cells was slower at both 50% and 90% time 
to baseline. This result was expected as the increased Ca2+ sensitivity was hypothesised to be 
coupled to a higher Ca2+ affinity for TnC and therefore slower Ca2+ dissociation from TnC. 
Impaired relaxation has been found in many different studies of HCM cells displaying increased 
myofilament Ca2+ sensitivity (Guinto et al. 2009; Coutu et al. 2004). The prolonged Ca2+ binding 
to troponin C would then lead to alterations in cross-bridge cycling; the cross-bridges which have 
already formed during the contraction may remain attached for a longer time or there may be 
additional attachments during relaxation. This would lead to the slower relaxation, which is also 
seen in the ACTC E99K myofibrils and papillary muscle (Song et al., 2013) and whole heart level 
(Song et al. 2011).  
 
These data not only show the effect of the mutation on cell contractility, but also gender 
differences in contraction parameters. Gender differences in murine cardiomyocytes have not 
been explored extensively, so it is important to detect whether there are differences between 
male and female control cells. Normal variation due to gender should be taken into account 
when interpreting these data. Cells from NTG female mice showed significantly smaller 
contraction amplitude and a slower time to 50% relaxation when compared to the NTG male 
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group. Other studies found similar reduced cell contraction in female mouse myocytes (Farrell et 
al. 2010; Kannankeril et al. 2006; Zhang et al. 2003).  
 
There is a distinct gender difference in the sudden death predisposition within the ACTC E99K 
model. Almost twice as many females die between 25 and 45 days old. The rise of oestradiol 
associated with puberty occurs at about 30 days old in C57/Bl6 mice (Nelson et al. 1990) so it is 
possible that the hormone changes occurring at this age are contributing to the female sudden 
death. In cardiovascular research, oestrogen is considered to have a protective effect, as 
mortality and severity of disease is greater in males (Hayward et al. 2000). By using cells from 
animals 8-12 weeks old, the potentially protective hormone may have allowed compensatory 
changes to be made at the cellular level. The gender difference is less apparent in TG, with 
longer TTP in TG females than TG males, explained by a significantly reduced Ca2+ transient size 
in females.  A faster TTP would be expected in TG as the increased Ca2+ sensitivity is thought to 
lead to faster cross bridge cycling and therefore a hypercontractile phenotype (Knöll 2012). A 
slower TTP is more likely to be observed in cells from failing hearts as this parameter is indicative 
of systolic dysfunction (Davies et al. 1995), which is found in the ACTC E99K whole heart only 
after 29 weeks of age.  
3.4.2 Ca2+ transients are smaller in ACTC E99K TG cells 
Several aspects of the Ca2+ transient were altered in the ACTC E99K TG cells.  Firstly, the ACTC 
E99K cells displayed a lower resting Fura-2 ratio in both males and females, indicating a lower 
diastolic Ca2+ level. Other studies attribute the decreased resting Ca2+ to changes in the Ca2+ 
buffering capacity of the myocyte (Belke et al. 2004; Olsson et al. 2004; Haim et al. 2007). 
Although buffering has not been measured within this study, (Huke & Knollmann 2010) have 
demonstrated that Ca2+ buffering is altered as a downstream effect of myofilament Ca2+ 
sensitisation. TnC can bind an estimated 50% of Ca2+ released from the SR during a typical heart 
beat (Shannon et al. 2000). Therefore, increased myofilament Ca2+ sensitivity, if mediated by 
increased Ca2+ affinity of TnC, can decrease free Ca2+. In many studies using HCM cells, 
increased diastolic Ca2+ is more commonly found (Coppini et al. 2013), with previous reports 
linking intracellular Ca2+ elevation as a trigger for arrhythmia and cellular hypertrophy (Bers 
2008). The occurrence of arrhythmias was infrequent in adult ACTC E99K animals; this may be 
due to the low cytosolic Ca2+ reducing the propensity for arrhythmias.  
 
The TTP was prolonged in ACTC E99K cells. Slower Ca2+ transient kinetics (peak and decay times) 
have also been observed in human cardiomyocytes from HCM myectomy samples (Coppini et al. 
2013). In this study, capacitance/volume ratio was reduced indicating loss of T-tubules in these 
hypertrophied cells. A decreased T-tubule density can lead to prolongation of the Ca2+ transient 
rise and decay, due to asynchronous Ca2+ release from the SR. In contrast to the slow transient 
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kinetics in ACTC E99K cells, (Fraysse et al. 2012) found faster Ca2+ transient decay in myocytes 
isolated from a MYBPC3-targeted knock-in mouse model carrying a point mutation frequently 
associated with HCM in humans. This demonstrates that the primary effect of higher myofilament 
Ca2+ sensitivity can lead to contrasting results, dependent on specific mutation or animal species 
used, and more significantly the experimental conditions (Little et al. 2012) and the mouse strain 
(Maguire et al. 2003).  
 
E99K TG myocytes showed a reduced Ca2+ transient amplitude, a change also found in myocytes 
from TnT mutant mice expressing the I79N mutation, which has been linked to HCM and a high 
incidence of SCD without hypertrophy development in patients (Knollmann et al. 2003). In keeping 
with the ACTC E99K mouse, the TnT 179N mouse also displayed enhanced contractility associated 
with higher myofilament Ca
2+
 sensitivity. Knollman et al showed that the smaller transient 
amplitude was coupled with prolonged transient decay and altered Ca2+ buffering, supporting the 
idea that at peak Ca2+ levels, more Ca2+ is bound to the myofilaments. In these experiments, the 
Ca2+ buffering was measured directly using two established techniques (Trafford et al. 1999; 
Bassani et al. 1998). It would be beneficial to provide evidence of enhanced Ca2+ buffering using 
these experimental methods to further support our hypothesis, that increased myofilament Ca2+ 
sensitivity underlies the changes in cellular contractility and Ca2+ handling.  
 
In contrast with prolonged transient decay observed in many studies using mouse myocytes 
displaying increased myofilament Ca2+  sensitivity (Knollmann et al. 2003; Schober et al. 2012; 
Guinto et al. 2009; Haim et al. 2007), the decay of the Ca2+ transient was similar between E99K 
TG and control cells.  However, on further analysis, cells isolated from TG female mice showed 
reduced transient amplitude and prolonged Ca2+ transient decay when compared with their TG 
male counterparts. Consistent with the previously described finding by Knollman et al, reduced 
Ca2+ transient amplitude combined with slower decay  is indicative of more Ca2+ being bound to 
the myofilaments at peak Ca2+ levels, but as [Ca2+] decreases the Ca2+ dissociation from the 
myofilaments becomes the rate limiting factor for Ca2+ transient decline. Therefore the prolonged 
transient decline in cells from TG females could be attributed to the increased Ca2+ buffering of 
the myofilaments, due to the increased Ca2+ affinity and slower dissociation of Ca2+ from troponin 
C. This slower dissociation of Ca2+ from the myofilament would lead to the slower cell relaxation 
and therefore the slower removal of Ca2+ from the cytoplasm. 
 
The differences observed within the TG group between genders could be attributed to the effects 
of oestrogen, which has many cardioprotective effects, including reducing L-type Ca2+ current.  
Larger Ca2+ transients have also been observed in myocytes from ovariectomized rats (Ma et al. 
2009). This finding also explains why there is a longer TTP contraction, occurring more 
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prominently in TG females. As a smaller amount of activator Ca2+ is available, the speed of cross-
bridge formation is affected which slows the rate of tension development (Wolff et al. 1995). If 
the Ca2+ transient had been the same in TG as NTG, the amplitude of contraction would be 
greater due to the higher myofilament Ca2+ sensitivity, which would not be energetically efficient. 
It is possible that there has been a compensatory mechanism which has reduced the size of the 
transient to allow a normal level of cell contraction.  
 
Recent studies have shown female and male mice with HCM display sex dimorphic myofilament 
function (McKee et al. 2013). Ca2+ sensitive tension development in de-membranated cardiac 
trabeculae excised from female mice expressing the HCM-causing R403Q MHC mutation were 
more sensitive to Ca2+ than their wild-type (WT) counterparts and both WT and HCM males . The 
underlying cause of this sex difference in Ca2+ sensitivity was thought to be due to changes in 
Ca2+ handling, sarcomeric proteins and post-translational modifications of myofilament proteins. 
Female HCM hearts showed an elevation of SERCA and β-MyHC protein whereas male HCM 
hearts showed a similar elevation of β-MyHC protein but a reduced level of TnT phosphorylation. 
The distribution of TnI phosphospecies also depended on gender and disease. The effect of 
gender has not been considered in previous studies characterising the ACTC E99K mouse model 
disease phenotype therefore this provides an interesting possibility for explaining sex differences 
in the TG animal. 
3.4.3 SR Ca2+ content is lower in TG cells  
For cardiac relaxation to occur, Ca2+ must be removed from the cytosol by reuptake into the SR 
via SERCA and effluxed via NCX. These processes decrease the intracellular Ca2+ and thus 
promote Ca2+ release from TnC, leading to relaxation. Therefore the following experiments were 
important to elucidate the function of these proteins. However it is important to note that the 
intrinsic properties of the myofilament have an important role in relaxation (Janssen et al. 2002). 
The aim of studying the function of Ca2+ handling proteins was to gain more insight into why the 
alterations in the Ca2+ transient were seen.  
 
In many studies, SERCA function is reduced, often corresponding with an increase in diastolic 
Ca2+ commonly observed in HCM myocytes (Coppini et al. 2013). In contrast, SERCA function was 
found to be the same in NTG and TG cells, supported by the similar mRNA levels in both groups. 
As previous studies using the ACTC E99K model have shown energy efficiency being reduced due 
to the heart muscle producing more work (Song et al., 2013), it would be expected that the 
functioning of SERCA would be affected as it is a highly ATP-dependent process. Regardless of 
this normal functioning of SERCA, the SR load was found to be reduced in the TG cells. The 
reduction in SR Ca2+ content may explain the smaller Ca2+ transient amplitude (Bers et al. 2003). 
When impaired relaxation and reduced SR Ca2+ load are combined, this would result in less 
96 
 
Ca2+ available during contraction, and this could contribute to the prolonged TTP of contraction in 
ACTC E99K myocytes. SR load is the result of the balance between SR Ca2+ uptake via SERCA 
and SR Ca2+ efflux via RyR and the competition for cytosolic Ca2+ between SERCA and NCX. It is 
possible that the reduced SR Ca2+ measured here is due to increased Ca2+ leak via RyR, because 
SERCA function appears normal and NCX function reduced not enhanced. However, this would 
lead to increased diastolic Ca2+ levels, which were not observed in this study. Later experiments 
will assess the leak of Ca2+ occurring through RyRs and their phosphorylation levels which 
modulates their open probability. 
 
Although surprising in this setting, reduced SR load is not an uncommon occurrence. Studies 
using myocytes from a TnT mutant mouse model of HCM showed decreased SR load 
corresponding to a decreased SERCA2 to PLB ratio (Haim et al. 2007; Guinto et al. 2009). The 
SR load and SR uptake capacity can be mediated by phosphorylation status of PLB. In its 
phosphorylated state, PLB releases its inhibition of SERCA activity, resulting in Ca2+ uptake from 
the cytosol into the SR. Low SR load has also been found in patient specific induced pluripotent 
stem cells carrying a HCM missense mutation (Arg663His) in the MYH7 gene (Lan et al. 2013). 
However this was linked to elevated diastolic Ca2+ as retention of Ca2+ in the cytoplasm has been 
shown to decrease SR load by hindering uptake of Ca2+ into the SR (Semsarian et al. 2002).  
 
Transarcolemmal Ca2+ fluxes can also affect the SR load, such as Ca2+ influx via LTCC and Ca2+ 
efflux via NCX. To help explain why SR content is reduced, an enhanced efflux of Ca2+ via NCX 
would be expected, which would reduce the cytoplasmic Ca2+ available for reuptake into the SR, 
thus decreasing SR Ca2+ content and diastolic Ca2+ levels. Often, the expression of NCX is 
increased in models of HCM (Sipido 2002), and indeed, this study demonstrates increased NCX 
protein expression in the E99K ACTC hearts. The function of NCX however, was reduced in TG 
cells, and in particular only the female group. The reduced function may indicate altered 
regulation of NCX or altered intracellular ion gradients which can reduce the forward mode of the 
exchanger (discussed fully in Chapter 4). The altered NCX function should bias Ca2+ uptake/efflux 
mechanisms for the Ca2+ fluxes to remain in balance. As there is no compensatory increase in 
SERCA function, the rate of Ca2+ efflux from the cytosol is slowed, causing the prolongation of the 
transient decay. 
 
NCX will to some extent dictate the Ca2+ transient amplitude, and a reduced function of the 
exchanger may cause SR Ca2+ release in TG cells to be larger, which would in turn lead to 
spurious fractional release values. An alternative method using the integral of both the 
electrically-evoked and caffeine-induced Ca2+ transients to calculate fractional release would be 
better; however due to the two-part nature of the caffeine in 0Ca2+ 0Na+ solution experiments 
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this was not possible. The methods chosen for determining SR Ca2+ content and fractional 
release are commonly used, and in this situation regardless of reduced NCX function, Ca2+ 
transient amplitude and SR Ca2+ content were not overestimated as both were found to be 
reduced in TG cells. The observation of reduced NCX function narrows down the possibilities for 
explanation of the reduced SR content to altered L-type Ca2+ current (not measured within the 
scope of this thesis) and the leak of Ca2+ via RyR (examined in Chapter 5). Although there is a 
reduction in function, the physiological relevance of changes in NCX is difficult to interpret for 
mouse because the relative contribution of NCX in total Ca2+ removal is very low in rodents 
compared with humans (Bers, 2000), correlating with the calculations on Ca2+ flux (Table 3.4) 
3.4.4 Calculated Ca2+ fluxes are not altered in TG cells  
Fluxes were calculated to determine the fractions of total Ca2+ in the cytosol (free and bound) 
transported by SERCA, NCX and the slow systems.  The mean SERCA flux in control and TG 
mouse myocytes ranged from 159 to 200 µmol/l cytosol/sec. This is similar to the SERCA flux in 
rat calculated to be 207 µmol/l cytosol/sec (Bassani et al 1994). The mean NCX flux in mouse 
myocytes ranged from 25 to 29 µmol/l cytosol/sec, again similar to the value calculated using rat 
myocytes, which was determined as 27 µmol/l cytosol/sec. Previous studies have shown the 
combined slow systems, which includes the sarcolemmal Ca2+ ATPase and mitochondrial Ca2+ 
uniporter to efflux Ca2+ at a rate of 4 µmol/l cytosol/sec, which is about 3 times lower than the 
value calculated in this study. The range in mouse myocytes was found to be between 8 and 13 
µmol/l cytosol/sec, indicating these efflux pathways are of greater significance in the mouse 
cardiomyocyte. Overall, the total flux of Ca2+ is similar between rat and mouse, which is expected 
due to their similar cellular Ca2+ handling.  
 
During a normal twitch the proportions of Ca2+ transported by SERCA, NCX and slow systems are 
70, 28 and 2 % respectively in rabbit and 92, 7 and 1% in rat myocytes (Bassani et al 1994). The 
proportions of Ca2+ transported by these systems in the control mouse were calculated to be 82, 
13 and 5%. The percentage of flux through SERCA and NCX in the mouse cardiomyocyte fits 
between the values calculated in rabbit and rat. When compared with the rat fluxes, the 
increased flux through NCX and the slow systems compensates for the reduced flux through 
SERCA. Differences have been observed in flux values within a species due to strain, age and 
methodology; therefore variation between species is expected.  
 
No differences in fluxes were found when comparing NTG and TG, but when male and female 
data were separated, flux through SERCA was found to be lower in TG females compared with TG 
males. In HF, SERCA expression is often downregulated and NCX can be upregulated, leading to 
a situation where SERCA and NCX contribute almost equally to Ca2+ removal.  In the E99K cells, 
the reduced flux through SERCA in TG females is not compensated for by an increase in flux 
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through NCX. This result also does not correspond with the SERCA function data, which showed 
no differences between any of the groups. A similar inconsistency was observed with the NCX 
function, which was experimentally found to be lower in TG females compared with NTG females, 
however this does not translate into the flux calculations. The discrepancies between the 
experimental function and calculated flux data may be caused by several limitations; the main 
being that the calculation assumes Ca2+ buffering is unchanged between TG and NTG cells. In 
this study, the increased myofilament Ca2+ sensitivity is hypothesised to alter Ca2+ buffering. 
However, as buffering was not measured, the formulae used provide the best method for 
determining Ca2+ fluxes. Another assumption is that Ca2+ buffering characteristics are the same 
within mouse, rat and rabbit. Hove-Madsen & Bers showed that the buffering characteristics 
measured in rabbit myocytes could also be used in experiments using rat myocytes, however it is 
possible cytoplasmic buffering properties vary between species.  
 
3.4.5 Overview 
Overall, the changes in Ca2+ handling found in the ACTC E99K cells are consistent with diastolic 
dysfunction and increased myofilament Ca2+ sensitivity. However some aspects are dissimilar to 
common findings in hypertrophy models and do not clearly indicate how Ca2+ fluxes remain 
balanced within the cardiomyocyte. The schematic (Figure 3.6) describes how the changes in 
Ca2+ handling and contractility link together. One unlikely result was the reduced SR Ca2+ 
content, often observed in HF. This may be caused by either reduced uptake by SERCA (most 
predominant in mouse ventricular myocytes), increased SR leak via RyR or enhanced NCX 
function. As two of these have already been tested, it is important to uncover whether there are 
changes in RyR properties allowing increased leak of Ca2+, which could also lead to potentially 
arrhythmogenic release events.  
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Figure 3.5 Ca2+ regulation is altered in cells from TG animals surviving the sudden death window. 
Labels in red indicate parameters measured in this chapter. (A) L-type Ca2+ current may be 
reduced, leading to reduced Ca2+ transient (B) RyR regulation may be altered causing increased 
Ca2+ leak, leading to the reduced SR Ca2+ content (C) Increased function of the slow systems may 
contribute to the reduced diastolic Ca2+.  
 
 
There are several limitations associated with the experiments described. Firstly, contractility was 
measured in unloaded cells, while Fura-2 loaded cells were used to measure Ca2+ transients 
separately. When optimising the protocols, Fura-2 appeared to reduce the contractility of the 
cells due to intracellular buffering of the dye. Therefore contraction was measured separately to 
allow a more physiologically relevant measurement. The second point to note is that there are 
many methods for measuring the function of NCX, SERCA and the content of the SR so 
comparisons between other studies were carefully considered. The use of caffeine and 0Na+ 
0Ca2+ solution for these measurements was most appropriate for the experimental setup.  
 
Although the primary defect may reside in the sarcomere, the development of the HCM 
phenotype also depends on the interaction of signalling pathways, environmental stress and 
gender. It is important to take into account other characteristics of HCM such as fibrosis, 
microvascular dysfunction and altered energy homeostasis (Frey et al. 2012), some of which 
have already been linked with the ACTC E99K model. These, in addition to the changes in Ca2+ 
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handling may lead to the progression of disease, which appears to be specific to each mutation 
and species, and varies between mouse strains. The overall phenotype of adult mice is the end 
product of the complex interaction between genotype and the primary and secondary phenotypic 
changes. 
 
Whilst the comparison of contractile and EC coupling phenotype in different models of HCM in 
different laboratories has not as yet produced a consensus hypothesis, the emergence of two 
populations in the ACTC E99K mice allows us to study two different phenotypes within the same 
model. So far, the adult survivors have been studied; thus an investigation of younger mice in the 
sudden death window (at 4-6 weeks old up to half the females and a quarter of the males die) 
where two phenotypes co-exist may add valuable information about the progress of HCM.  
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Chapter 4: Contractility and 
Ca2+ handling alterations 
during the sudden death 
phase  
 
In this Chapter, the contractility and Ca2+ handling properties of cardiomyocytes isolated 
from 25-45 day old ACTC E99K animals are examined. At this age, there is a high 
occurrence of SCD, especially in females. Sarcomere shortening, Ca2+ transients and 
functions of the main Ca2+ handling proteins are studied. These experiments test the 
hypothesis that the increased myofilament sensitivity leads to pro-arrhythmogenic 
alterations in Ca2+ handling. 
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4.1 Introduction 
 
Sudden cardiac death is an unpredictable complication of HCM, occurring most commonly in 
children or young adults (Maron 2002a). SCD is also a unique characteristic of the ACTC E99K 
mouse model, where there is a high incidence of death when the TG mice are between 25-45 
days old (shown by Kaplan-Meyer plot in Chapter 1).  It is thought that hypertrophy develops 
rapidly over this age range because it coincides with accelerated growth during adolescence. The 
SCD is probably due to arrhythmias. Disturbances in heart rhythm can often be attributed to 
alterations in Ca2+ handling, either directly by causing after-depolarisations to form, or indirectly 
by modulating the action potential profile (Antoons & Sipido 2008). The main hypothesis 
previously described proposes that the increased myofilament sensitivity would lead to 
disturbances in intracellular Ca2+ homeostasis, which could consequently alter the function of 
key regulatory proteins involved in the transport of Ca2+, which may change the properties of the 
Ca2+ transient. Therefore it is essential to study the contractility of, and Ca2+ regulation within, 
cells from young animals most at risk from SCD to determine whether there are alterations which 
may predispose the heart to arrhythmias. Changes in Ca2+ at this stage may also underlie the 
hypertrophic pathways which lead to the hypertrophy characteristic of HCM.  
 
The primary effect of the mutation is the increase in myofilament Ca2+ sensitivity which is present 
from birth regardless of structural changes in the heart. However, the structural changes in HCM, 
such as fibrosis, hypertrophy and myocyte disarray are often thought to increase the propensity 
for arrhythmias. The 4 week old ACTC E99K mouse heart shows myocyte disarray without fibrosis 
(unpublished), but to fully characterise morphological change, it is important to measure myocyte 
size to assess whether cellular hypertrophy is already established at this age. 
 
By studying contraction and Ca2+ cycling within the isolated cell, we may be able to determine if 
mutation-induced alterations in the myocytes could underlie the potentially fatal arrhythmias. The 
experimental protocols were replicated as in Chapter 3, allowing the study of sarcomere 
shortening, Ca2+ transient parameters, the function of NCX and SERCA and the SR Ca2+ content. 
In addition, the shortening-frequency response of the isolated cells was measured to give an 
indication of the force-frequency relationship (FFR), an important intrinsic regulatory mechanism 
of cardiac contractility. Dynamic [Ca2+]i is the primary cellular mechanism responsible for the FFR, 
thus frequency-dependent alterations of contractility and associated Ca2+ transients will indicate 
the effect of the mutation on myocardial contractile dysfunction and cardiac reserve capacity. 
The findings can then be compared to the results from 8-12 week old animals, to determine 
whether there are pro-arrhythmogenic alterations which may potentially lead to SCD, and 
compensatory changes occurring at the cellular level which allow some mice to survive.  
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Aims 
 Measurement and comparison of size of isolated ventricular myocytes 
 Measurement and comparison of sarcomere shortening and shortening-frequency 
relationship using unloaded myocytes  
 Measurement and comparison of Ca2+ transients using Fura-2 loaded myocytes 
stimulated at 1Hz 
 Measurement and comparison of SR Ca2+ content, NCX and SERCA function in Fura-2 
loaded myocytes 
4.2 Materials and methods 
 
4.2.1 Isolated cell experiments 
25-40 day old ACTC E99K male and female mice were used in all experiments. The cells were 
isolated as described in the Methods section. The experiments were carried out using the 
IonOptix system, superfusing the cells with NT containing 1mM Ca2+ at 37ºC. The sarcomere 
shortening, force-frequency and Ca2+ transient protocols were carried out as described in 
Methods 2.3.2, 2.3.3 and 2.4.5 respectively. Fractional release, NCX function and SERCA 
function were calculated as described in Chapter 3.2.  
 
Myocyte size: The apparatus was set up as for sarcomere shortening experiments. Cells were 
visualised using the IonWizard software and screen shots were taken to capture the myocyte 
image. ImageJ was used to measure around the cell edge manually and cell perimeter and area 
were calculated by the program in pixels, and then converted to microns using the IonOptix 
calibration factor. 
4.2.2 Protein expression & mRNA transcript levels 
Hearts from 25-40 day old ACTC E99K male and female mice were collected as described in the 
Methods section 2.1.3. The protein expression and mRNA transcript levels of NCX and SERCA 
were determined using the protocols described in Methods section 2.8 and 2.9 respectively. 
These experiments were carried out by Adam Mills, Imperial College. 
4.2.3 Statistical analysis 
A two-way ANOVA was used to determine the interaction of the two independent variables 
(genotype and gender/stimulation frequency/age) and their individual effect on the parameter of 
interest. The effect of genotype will be examined first to determine whether there are overall 
differences between the TG and NTG groups.  
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Two populations were defined using nonlinear regression analysis to fit an appropriate curve to 
the data, using the least squares fitting method. Two equations were compared (Gaussian and 
sum of two Gaussians) using the extra sum-of-squares F test to determine which equation best fit 
the data. The simpler model (Gaussian) was selected unless the P value was <0.05. 
 
4.3 Results 
4.3.1 Cell size 
Table 4.1 shows that the two independent variables, genotype and gender were found to interact 
for cell perimeter (p<0.05). This interaction indicates that the effect of genotype is different in 
males and females for this measurement. Cell area was affected by both genotype and gender 
(p<0.001). 
 
Figure 4.1A shows that cells isolated from TG female mice had a smaller perimeter than their 
NTG counterparts (173 ± 3 vs 297 ± 4 µm, p<0.001).  Figure 4.1B shows that cells from TG 
females also have reduced cell area when compared to cells from both NTG females and TG 
males (1711 ± 44 (TG female) vs 2201 ± 66 (NTG female), p<0.001; 2138 ± 67 µm2 (TG male), 
p<0.001). 
 
Parameter Interaction Gender Genotype 
Cell perimeter * ns *** 
Cell area ns *** *** 
 
Table 4.1 The effect of gender and genotype on cell size  
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Figure 4.1 Size of isolated ACTC E99K cardiomyocytes. Data are presented as mean ± SEM; n = 
178 cells from 15 NTG animals, 125 cells from 10 TG animals (A) Cell perimeter (B) Cell area  
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4.3.2 Sarcomere shortening 
Table 4.2 shows that genotype had an effect on peak amplitude, R50 and R90. Figure 4.2C 
shows that contraction amplitude was larger in TG cells than NTG cells (0.10 ± 0.004 vs 0.07 ± 
0.003 µm, p<0.001). TG cells display faster relaxation at both 50% (64 ± 2 vs 72 ± 2 ms, 
p<0.05) and 90% time to baseline (139 ± 7 vs 167 ± 7 ms, p<0.05) than the NTG group as 
shown in Figures 4.2E-F. However resting sarcomere length and TTP showed no differences 
between NTG and TG cells as shown by Figures 4.2B and D.  
 
Table 4.2 shows that the independent variables, genotype and gender, were found to interact for 
two contractility parameters; TTP (p<0.01) and time to 50% relaxation (p<0.05). This interaction 
indicates that the effect of genotype is different in males and females for these two 
measurements. The peak amplitude of contraction was the only measurement to be affected by 
gender (p<0.05). 
 
Parameter Interaction Gender Genotype 
Peak contraction 
amplitude (µm) 
ns * *** 
Time to peak (ms) ** ns ns 
R50 (ms) * ns * 
R90 (ms) ns ns * 
Resting sarcomere 
length (µm) 
ns ns ns 
 
Table 4.2 The effect of gender and genotype on sarcomere shortening parameters 
 
The Tukey tests allow more detailed comparisons between groups to be drawn. The diastolic 
sarcomere length is similar between all groups as shown by Figure 4.2B. Figure 4.2C shows that 
peak contraction amplitude is greater in both male and female TG cells than their NTG 
counterparts (0.10 ± 0.007 (TG male) vs 0.08 ± 0.004 µm (NTG male), p<0.01: 0.09 ± 0.005 
(TG female) vs 0.06 ± 0.003 µm (NTG female), p<0.001). Figure 4.2D shows that TTP is faster in 
NTG males than both NTG females and TG males (85 ± 2 (NTG male) vs 92 ± 2 ms (NTG female), 
p<0.05; vs 92 ± 2 ms (TG male), p<0.05). Figure 4.2E shows that the time to 50% relaxation was 
faster in TG female cells than their NTG female littermates (63 ± 3 vs 77 ± 3 ms, p<0.01). This 
was also reflected in the time to 90% relaxation (134 ± 9 vs 179 ± 11 ms, p<0.01) as shown by 
Figure 4.2F. Finally, Figure 4.2E also shows that time to 50% baseline is slower in NTG females 
when compared with their male NTG counterparts (77 ± 3 vs 66 ± 3 ms, p<0.05).  
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Figure 4.2 Sarcomere shortening in young E99K TG and NTG cardiomyocytes. Data are presented 
as mean ± SEM; n = 179 cells from 15 NTG animals, 126 cells from 10 TG animals (A) 
Representative sarcomere shortening measurements normalised to baseline length (B) Diastolic 
sarcomere length (C) Peak amplitude of contraction (D) Time to peak (E) Time to 50% relaxation 
(F) Time to 90% relaxation  
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4.3.2.1 The effect of stimulation frequency on sarcomere shortening parameters 
Sarcomere shortening parameters were measured at a range of stimulation frequencies to 
determine whether the differences observed in contractility between TG and NTG cells occurred 
at different pacing rates. Figure 4.3F shows that there was a significant effect of genotype across 
the range of stimulation frequencies on peak contraction amplitude (p<0.001), time to peak 
(p<0.001), R90 (p<0.01) and resting sarcomere length (p<0.001). 
 
Figure 4.3F shows that the independent variables, genotype and stimulation frequency, were 
found to interact for peak contraction amplitude (p<0.01). This interaction indicates that the 
effect of genotype is different depending on the pacing rate. All of the parameters except for 
resting sarcomere length were affected by stimulation frequency (p<0.001). 
 
Figure 4.3A shows that resting sarcomere length was lower in TG cells than NTG cells at 2Hz 
(1.64 ± 0.01 vs 1.68 ± 0.01 µm, p<0.05) and 5Hz stimulation (1.62 ± 0.01 vs 1.67 ± 0.01 µm, 
p<0.001). TG cells display greater peak contraction amplitude at 0.5Hz (0.14 ± 0.01 vs 0.10 ± 
0.01 µm, p<0.001), 1Hz (0.11 ± 0.005 vs 0.08 ± 0.004 µm, p<0.001) and 2Hz (0.09 ± 0.005 vs 
0.07 ± 0.003 µm, p<0.05) than the NTG group as shown in Figure 4.3B. Figure 4.3C shows that 
TTP was only prolonged in TG cells compared with NTG cells at 1Hz stimulation (85 ± 2 vs 80 ± 2 
ms p<0.05). Time to 50% and 90% relaxation did not show differences between TG and NTG at 
any of the stimulation frequencies tested (Figure 4.3D-E). 
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Figure 4.3 Effect of stimulation frequency on sarcomere shortening in young E99K TG and NTG 
cardiomyocytes. Data are presented as mean ± SEM; n = 80 cells from 8 NTG animals, 80 cells 
from 9 TG animals (A) Diastolic sarcomere length (B) Peak amplitude of contraction (C) Time to 
peak (D) Time to 50% relaxation (E) Time to 90% relaxation (F) Two-way ANOVA results  
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4.3.3 Calcium transients 
Table 4.3 shows that genotype had an effect on diastolic Fura-2 ratio, peak transient amplitude, 
TTP and R90. Figure 4.4B shows that the diastolic Fura-2 ratio in TG cells was lower in 
comparison to NTG cells (1.40 ± 0.02 vs 1.50 ± 0.02, p<0.001). TG cells display a larger Ca2+ 
transient amplitude compared with NTG cells (0.64 ± 0.04 vs 0.39 ± 0.02, p<0.001) as shown in 
Figure 4.4C. Figure 4.4D shows that the TTP was prolonged in the TG group compared with the 
control group (65 ± 1 vs 62 ± 0.3 ms, p<0.001). Time to 50% transient decay was similar 
between the TG and NTG cells (Figure 4.4E), however the time to 90% transient decay was 
reduced in TG cells in comparison with the NTG group (486 ± 14 vs 538 ± 10 ms, p<0.01) as 
shown in Figure 4.4F.  
 
Table 4.3 shows that the independent variables, genotype and gender, were found to interact for 
diastolic Fura-2 ratio (p<0.05). This interaction indicates that the effect of genotype is different in 
males and females for this parameter. The peak transient amplitude was the only measurement 
to be affected by gender (p<0.05). 
 
Parameter Interaction Gender Genotype 
Peak transient 
amplitude 
ns * *** 
Time to peak (ms) ns ns *** 
R50 (ms) ns ns ns 
R90 (ms) ns ns ** 
Diastolic fura-2 ratio * ns *** 
 
Table 4.3 The effect of gender and genotype on Ca2+ transient parameters  
 
The post hoc tests were then examined. Figure 4.4C shows that peak transient amplitude is 
greater in both male and female TG cells than their NTG counterparts (0.68 ± 0.06 (TG male) vs 
0.43 ± 0.03 (NTG male), p<0.001: 0.60 ± 0.04 (TG female) vs 0.36 ± 0.02 (NTG female), 
p<0.001). Figure 4.4D shows that TTP is prolonged in male and female TG when compared to 
their NTG counterparts (65 ± 1 (TG male) vs 62 ± 0.4 ms (NTG male), p=0.01; 66 ± 1 (TG female) 
vs 62 ± 0.4 ms (NTG female), p<0.001). When compared to the NTG male group, TG males have 
a lower diastolic Fura-2 ratio (1.36 ± 0.03 vs 1.51 ± 0.03, p<0.001) and a faster 90% decay time 
(470 ± 20 vs 551 ± 14 ms, p<0.01) as shown in Figures 4.4A and F respectively.  
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Figure 4.4 Ca2+ transient parameters in young E99K TG and NTG cardiomyocytes. Data are 
presented as mean ± SEM; n = 109 cells from 10 NTG animals, 85 cells from 8 TG animals (A) 
Representative Ca2+ transients normalised to baseline (B) Diastolic Fura-2 ratio (C) Peak 
transient amplitude (D) Time to peak (E) Time to 50% decay (F) Time to 90% decay 
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4.3.4 Function of NCX and SERCA 
Table 4.4 shows that genotype only had an effect on NCX function. Figure 4.5C shows that the 
efflux of Ca2+ through NCX was slower in TG cells, implying a reduced function of NCX (1.223 ± 
0.147 vs 0.766 ± 0.067 s, p<0.01). In contrast, there were no differences in SERCA function, SR 
Ca2+ content and fractional release between TG and NTG cells.  
 
For all of the measurements, no interaction was found between gender and genotype. In addition 
to this, gender did not have a significant effect on the parameters.   
 
Parameter Interaction Gender Genotype 
NCX function (s) ns ns ** 
SERCA function (s) ns ns ns 
SR load ns ns ns 
Fractional release (%) ns ns ns 
 
Table 4.4 The effect of gender and genotype on NCX, SERCA and SR Ca2+ content 
 
After performing the Tukey test, Figures 4.5D-F shows that there were no differences found 
between the groups for SERCA function, SR Ca2+ content and fractional release. However, Figure 
4.5C displays a decrease in NCX function in TG females when compared with NTG females 
(1.313 ± 0.143 vs 0.709 ± 0.087 s, p<0.01). 
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Figure 4.5 Ca2+ handling in young E99K TG and NTG cardiomyocytes. Data are presented as 
mean ± SEM (A) Representative Ca2+ release by application of caffeine (B) Representative Ca2+ 
release by application of caffeine in 0Na+ 0Ca2+ solution (C) Mean time taken for the caffeine-
induced transient to decay by 50%; n = 56 cells from 10 NTG animals, 25 cells from 8 TG 
animals (D) Mean time constant of the decay in 0Na+ 0Ca2+ solution of the caffeine-induced 
transient; n = 27 cells from 10 NTG animals, 12 cells from 6 TG animals (E) SR Ca2+ content; n = 
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28 cells from 10 NTG animals, 14 cells from 6 TG animals (F) Fractional release; n = 24 cells 
from 10 NTG animals, 15 cells from 7 TG animals 
 
 
4.3.5 Protein and mRNA levels of NCX and SERCA 
The results shows NCX and SERCA expression normalised to the endogenous reference, GAPDH 
(raw data is presented in the Appendix). Table 4.5 shows that genotype had an effect on NCX and 
SERCA protein expression and SERCA mRNA levels. Figure 4.6A shows that protein expression of 
NCX is higher in TG heart tissue compared with expression in NTG heart (1.98 ± 0.11 vs 1.16 ± 
0.17 RU, p<0.01). The abundance of SERCA mRNA is higher (0.16 ± 0.14 vs -0.78 ± 0.14 ΔCt, 
p<0.01) but SERCA protein levels are lower in TG heart tissue (1.68 ± 0.03 vs 1.98 ± 0.09 RU, 
p<0.01) compared with expression in NTG heart.  
 
The Tukey test shows that only the TG females have increased NCX protein expression (2.03 ± 
0.22 vs 0.87 ± 0.15 RU, p<0.01) and increased SERCA mRNA levels (0.34 ± 0.24 vs -0.79 ± 
0.30 ΔCt, p<0.05) compared with their control females counterparts.  
 
 
Parameter Interaction Gender Genotype 
 
NCX  
Protein 
mRNA 
 
 
 
ns 
ns 
 
 
ns 
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** 
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SERCA  
Protein 
mRNA 
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* 
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Table 4.5 The effect of gender and genotype on NCX and SERCA levels 
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Figure 4.6 Protein and mRNA levels of NCX and SERCA in E99K TG and NTG heart tissue. Data 
are presented as mean ± SEM; n = 3 hearts per group (A) NCX protein expression (B) SERCA 
protein expression (C) NCX mRNA levels (D) SERCA mRNA levels 
 
4.3.6 Two populations in the E99K TG animals 
It is possible that the cellular parameters measured are altered depending on whether the TG 
animal suffers SCD or whether it survives. It is important to determine whether there are two 
groups of results within the data collected from TG animals. All of the cell contractility and Ca2+ 
handling parameters were displayed in a scatter graph but only Ca2+ transient amplitude 
appeared to have a „second population‟ of data points, extending above than the range seen in 
the control group (Figure 4.7A). Almost a quarter of the TG cells displayed Ca2+ transients above 
the threshold (0.9 fura-2 ratio), and were from both male and female isolations (Appendix Table 
4.1). For Ca2+ transient amplitude, the NTG group fit to a Gaussian distribution whereas the 
preferred model for the TG group was the sum of two Gaussians (p=0.03). This indicates that the 
TG animals show a better fit to a bimodal distribution than a normal distribution observed in the 
control cells.  
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Figure 4.7 Ca2+ transient amplitude in E99K TG and NTG cardiomyocytes. Dotted line (red) 
represents the Fura-2 ratio threshold level. Horizontal lines indicate mean with 95% confidence 
intervals (A) Ca2+ transient amplitude range is greater in TG cells from 25-40 day old (young) 
mice. (B) Ca2+ transient amplitude range is the same in NTG and TG cells from 8-12 week old 
mice (C) Ca2+ transient amplitude in NTG cells from young mice fits to a Gaussian distribution 
(dashed line) (C) Ca2+ transient amplitude in TG cells from young mice fits best to the sum of two 
Gaussians equation (solid line) 
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4.3.7 Changes in cellular contractility and Ca2+ handling over time 
Table 4.6 summarises the mutation-induced changes in contractility and Ca2+ handling within 
each age group. However this does not take into account the natural changes which may occur in 
these parameters over time, due to normal development and ageing.  
 
 
 
Parameter 
 
20-45 days 
 
8-12 weeks 
 
 Peak sarcomere shortening Larger in TG ns 
Time to 50% relaxation Faster in TG Slower in TG 
Time to 90% relaxation Faster in TG Slower in TG 
Time to peak contraction 
 
ns 
 
Longer in TG 
 
Diastolic sarcomere length ns Lower in TG 
Ca2+ transient amplitude Larger in TG Smaller in TG 
Time to 50% transient decay ns ns 
Time to 90% transient decay Faster in TG ns 
Time to peak Ca2+ Longer in TG 
Longer in TG 
 
Diastolic fura-2 ratio Lower in TG Lower in TG 
Extrusion of Ca2+ via NCX Slower in TG Slower in TG 
Ca2+ uptake via SERCA  ns ns 
SR Ca2+ content ns Smaller in TG 
Fractional release ns Larger in TG 
 
Table 4.6 Summary of sarcomere shortening, Ca2+ transients and Ca2+ handling parameters in 
myocytes isolated from old and young E99K animals 
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Table 4.7 shows that across both age groups, there was a significant effect of genotype on peak 
contraction amplitude, TTP (contraction and Ca2+ transient), resting sarcomere length, peak 
transient amplitude, diastolic Fura-2 ratio and NCX function. The independent variables, 
genotype and age, were found to interact for 9 out of 13 measurements. This interaction 
indicates that the effect of genotype is different depending on the age of the mouse.   
 
 
 
Parameter 
 
Interaction 
 
Age 
 
Genotype 
 
 
Peak contraction amplitude (µm) 
 
*** 
 
*** 
 
** 
Time to peak (ms) *** ** *** 
R50 (ms) *** ns ns 
R90 (ms) *** ns ns 
Resting sarcomere length (µm) *** ** ** 
 
 
Peak transient amplitude 
 
*** 
 
ns 
 
** 
Time to peak (ms) ns ns *** 
R50 (ms) * *** ns 
R90 (ms) ** ** ns 
Diastolic fura-2 ratio ns *** *** 
 
 
NCX function (s) 
 
ns 
 
*** 
 
*** 
SERCA function (s) ns ** ns 
SR load * ** Ns 
 
 
Table 4.7 The effect of age and genotype on sarcomere shortening, Ca2+ transients and Ca2+ 
handling parameters in TG and NTG ACTC E99K cells 
 
 
Figure 4.8 shows the effect of age within each genotype group. Figure 4.8A shows that diastolic 
sarcomere length in control cells is increased in the old group (p<0.001), while in TG cells the 
sarcomere length is the same at both ages. Both TG and NTG cells show a reduced diastolic Fura-
2 ratio in the old group (p<0.001), in comparison with their young counterparts (Figure 4.8B). 
Time to peak contraction was the same in both age groups of control cells, whereas in TG cells it 
is more prolonged in the old group (p<0.001), as shown by Figure 4.9C. TTP transient did not 
change with age for both control and TG cells (Figure 4.8F). Figure 4.8E shows that peak 
contraction in NTG cells is increased in the old group (p<0.001), however in the TG cells the peak 
amplitude is the same between the age groups. The peak contraction amplitude in young TG cells 
is similar to the amplitude measured in old NTG cells, suggesting that contractility is enhanced at 
an earlier stage in TG cells. Figure 4.8F shows that peak transient amplitude in NTG cells is 
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increased in the old group (p<0.001). In contrast, TG cells show reduced size of Ca2+ transient in 
the old group (p<0.001). For cell relaxation properties in NTG cells, R50 (p<0.05) and R90 
(p<0.001) reduce with age. This contrasts with TG cells where relaxation times are prolonged in 
the old group (Figure 4.8G and I). This effect in TG cells is paralleled in transient decay times as 
shown by Figures 4.8H and J (p<0.001), however the time to 50% and 90% transient decay in 
control cells are the same in both age groups. Figure 4.8K shows that SR Ca2+ content is the 
same in both age groups of control cells, whereas the old TG cells display a significantly reduced 
SR content in comparison with the cells from young TG animals (p<0.01). NCX function in both 
genotype groups is prolonged in cells isolated from the 8-12 week old mice in comparison with 
the corresponding young group (p<0.001)(Figure 4.8L). Finally, SERCA function in the control 
cells was found to be slower in the old group (p<0.001), however in TG cells there was no change 
in SERCA function with age (Figure 4.8M). 
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Figure 4.8 The effect of age on sarcomere shortening, Ca2+ transients and Ca2+ handling 
parameters in ACTC E99K cardiomyocytes. Data are presented as mean ± SEM (A) Diastolic 
sarcomere length (B) Diastolic Fura-2 ratio (C) Time to peak contraction (D) Time to peak 
transient amplitude (E) Peak amplitude of contraction (F) Peak transient amplitude (G) Time to 
50% relaxation (H) Time to 50% transient decay (I) Time to 90% relaxation (J) Time to 90% 
transient decay (K) SR Ca2+ content (L) Mean time taken for the caffeine-induced transient to 
decay by 50% (M) Mean time constant of the decay in 0Na+ 0Ca2+ solution of the caffeine-
induced transient 
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4.4 Discussion  
 
4.4.1 Cells from TG females have smaller perimeter than control cells  
In HCM, the morphology and alignment of cardiomyocytes which are characteristic of healthy 
myocardium becomes distorted by hypertrophic growth, which can produce enlarged and 
irregularly shaped cells (Seidman & Seidman 2001). In conditions of increased functional 
demand (such as physiological stress) cardiomyocytes compensate by increasing in size. This 
increases the ventricular wall thickness while reducing ventricular internal diameter. Cardiac 
hypertrophy is considered a compensatory mechanism as it enhances the contractile capacity of 
the heart. Cellular hypertrophy is caused by the addition of sarcomeres in parallel in response to 
increased force production. Increased myocyte width correlates with compensatory ventricular 
hypertrophy, a hallmark of HCM. After the initial phase of compensatory hypertrophy, addition of 
sarcomeres to cardiomyocytes increases length-to-width ratios, which leads to decreased force 
production. Increased myocyte length produced by end-to-end addition of sarcomeres is 
associated with ventricular dilation in advanced HCM (Harvey & Leinwand 2011). 
In contrast to the expected phenotype, myocytes isolated from E99K animals were reduced in 
size compared to the NTG cells. Specifically, cells from TG female mice were significantly smaller 
when compared to NTG female cells, in both perimeter and area. The reduced cell size could 
suggest that these cells are more contracted at rest, due to increased myofilament Ca2+ 
sensitivity. However, TG cells displayed lower resting Ca2+ and no differences in sarcomere length 
when compared with control cells.  It is also possible that the E99K mutation may make the cells 
susceptible to damage during the isolation protocol. However, the cells isolated from TG males 
were of similar size to NTG males suggesting the E99K mutation has not affected the structural 
integrity of the myocytes. Although, it is possible that there is a differential effect of the mutation 
in males and female animals, which could account for the increased propensity for SCD observed 
in young female mice. As the procedure was isolating cells was carried out consistently, it is 
unlikely that the reduced cell size observed in TG females is due to cellular damage from the 
solutions used in the tissue digestion process.  
 
The measurements of cell perimeter and area are not ideal due to the 3-D structure of a 
cardiomyocyte. In particular, the occurrence of abnormal cell morphology often observed in HCM 
may not be taken into account when measuring surface area. However, this method of 
determining cell size was chosen as it could be carried out simultaneously with recordings of 
cellular contractility, and cells from the same isolation were used for Ca2+ transient 
measurements. This protocol maximised the data acquired from each heart, consequently 
reducing number of animals used. It would be valuable to measure cell volume which would more 
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accurately indicate alterations in cell size. The parameters of cell width, length and cross 
sectional area can all be determined using a variety of methods, such as tissue slices stained 
with wheat germ agglutinin (Coelho-Filho et al. 2013). However, the absence of cellular 
hypertrophy does not necessarily mean the method was inappropriate; it is possible that in 4 
week old animals cellular hypertrophy has not yet developed.  
  
4.4.2 ACTC E99K TG cells are hypercontractile 
Although compensatory cellular hypertrophy was not observed, sarcomere shortening was 
enhanced in cells isolated from both male and female TG mice compared with control cells. This 
contrasts to the findings in 8-12 week old animals, where peak contractility was the same in TG 
and NTG cells. The hypercontractile nature of the cell could underlie the greater force production 
in ACTC E99K TG papillary muscle (Song et al. 2013). As the primary effect of the majority of 
HCM-causing mutations, including ACTC E99K, is an increase in Ca2+ sensitivity, cross-bridge 
turnover and maximal force production are increased. The modulation of cross-bridge cycling rate 
can alter the force response to Ca2+-dependent activation, thus leading to the observed 
functional changes. Consequently, LV systolic function in HCM patients is often found to be 
normal or supranormal, before progressing towards HF in the later stages of the disease (Wigle et 
al. 1995).  
 
The later stages of HCM may be triggered by the initial hypercontractile state of the cells, which 
may directly induce hypertrophy or lead to energy depletion (Cambronero et al. 2009; Ashrafian 
et al. 2003). The studies using ACTC E99K papillary muscle show that the hypercontractile 
muscle is associated with an increased force cost and reduced efficiency of converting the 
energy of ATP hydrolysis to work (Song et al. 2013). Energetic impairment within the myocardium 
can increase the production of reactive oxygen species which can contribute to overactivation of 
CaMKII (Erickson 2011). Increased CaMKII activity can alter cell function and may also activate 
the hypertrophic gene expression programme (Backs 2006), which results in the secondary 
effects of hypertrophy and fibrosis.  
 
Also contrasting to the data acquired from the 8 week old mice, diastolic sarcomere length and 
TTP were the same in both TG and NTG cells. As described in Chapter 3, a shorter sarcomere 
length suggests that the cells are more contracted, possibly caused by more Ca2+ being buffered 
by the myofilaments by binding to TnC, which may allow cross-bridges to continue to form during 
diastole thus increasing diastolic tension. The TTP contraction at the cellular level corresponds 
with rate of force development in ACTC E99K intact papillary muscle being the same in both 
groups. This finding is also consistent with the ACTC E99K myofibril studies which demonstrate 
that activation rate is not dependent on myofilament Ca2+ sensitivity (Song et al. 2013). Although 
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these results link together, the ACTC E99K muscle and myofibrils were studied in samples from 
8-12 week old animals, where the TTP contraction in the TG myocyte was prolonged. This 
discrepancy in TTP may indicate the progressive nature of HCM; slower TTP contraction may 
initially occur at the cellular level and eventually lead to the systolic dysfunction at the whole 
heart level observed in the late stages of the disease.  
 
The relaxation kinetics of the TG cells were found to be faster than NTG, which can be attributed 
to their faster Ca2+ transient decay (time to 90% baseline). This result contrasts the findings in 8 
week old E99K mice and other models of HCM, where slower relaxation has been recorded, 
associated with the slower dissociation of Ca2+ from TnC due to myofilament Ca2+ sensitisation 
(Guinto et al. 2009; Coutu et al. 2004). Only myocytes from TG females relaxed more quickly in 
comparison to NTG females, whereas cells from male mice did not show any differences in their 
relaxation rates. The faster cell relaxation kinetics may contribute to preserving diastolic function 
in the early stages of the disease.  
 
In addition to the effect of genotype on sarcomere shortening parameters, gender also appeared 
to have an effect on cellular contractility. Myocytes from NTG females displayed longer TTP and 
time to 50% baseline than NTG males, consistent with the findings in cells from 8 week old E99K 
mice. Female cardiomyocytes from rat and mouse have been shown by several studies to have 
slower TTP shortening and 50% relaxation than male cells (Curl et al. 2001; Ceylan-Isik et al. 
2011). The changes identified in the E99K cells in this chapter are not associated with prolonged 
kinetics of the Ca2+ transient, as these measurements were similar in both males and females. 
An explanation may lie in there being gender differences in myofilament sensitivity and function, 
as described in Chapter 3 (Bupha-Intr et al. 2007; McKee et al. 2013). 
 
4.4.3 Negative shortening-frequency relationship in ACTC E99K cells 
The contractile force of cardiac muscle is known to change in response to a change in frequency 
of stimulation. The force-frequency relationship is often used to describe the contractile state 
and can be altered in disease. Changes in the response have been implicated in the negative 
force-frequency relationship of the failing human heart (Pieske et al. 1999). In rat cells, the 
response is negative in the lower range of frequencies (Henderson et al. 1974), which is thought 
to be due to high resting SR content in the rat which cannot be increased in this range of 
frequencies. Incomplete recovery of the release channel during stimulation at higher frequencies 
would then result in a negative staircase. In isolated mouse ventricular cells, both positive 
(Antoons et al. 2002) and negative relationships have been described. The E99K TG and NTG 
cells display a negative contraction-frequency relationship; however the TG cells show a steeper 
negative response with higher contraction amplitudes than the control cells. In the separate data 
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collected at 1Hz stimulation, the increased contraction amplitude was linked to an increased 
Ca2+ transient amplitude in the TG cells, which may underlie the increased contractility over the 
range of pacing rates.  
 
The contractile and relaxation properties of the cell were also measured at a range of stimulation 
frequencies. TTP, R50 and R90 all showed a negative linear relationship in both TG and NTG 
cells; the time to contract and relax reduced as stimulation frequency increases. This trend is 
expected as the faster contractile and relaxation properties allow the cell to keep up with the 
increased pacing rate. At the most physiological relevant frequency of 5Hz, the relaxation times 
were almost identical between control and TG cells, indicating that in these young mice, the cells 
are not showing any signs of diastolic dysfunction.  
 
Diastolic sarcomere length was the same in both TG and NTG cells at 0.5Hz and 1Hz. This 
suggests that at low stimulation frequency in the young TG group, the cells can relax fully to their 
resting sarcomere length. TG cells show a reduced diastolic sarcomere length at 2Hz and 5Hz, 
suggesting these cells are more contracted, indicative of incomplete relaxation at higher pacing 
rates. This may be caused by increased resting Ca2+ level at higher pacing rates however these 
recordings were made using unloaded cells, and simultaneous Ca2+ measurements were not 
obtained. Myofilament Ca2+ buffering capacity may also increase with stimulation frequency, by 
more Ca2+ binding to TnC. The results at higher pacing rates are more physiologically relevant, as 
mice have HR above 600bpm. Therefore, in vivo the increased myofilament Ca2+ sensitivity may 
lead to increased myofilament activation at rest, contributing to incomplete relaxation and 
diastolic dysfunction in the whole heart.    
 
4.4.4 Ca2+ transients are altered in ACTC E99K cells 
Myocytes from TG mice have a larger Ca2+ amplitude than the NTG, observed in both males and 
females. The increased Ca2+ sensitivity of the myofilament may be the ultimate cause of this 
alteration, which is also reflected by the contractile performance. The effects of myofilament Ca2+ 
sensitivity and Ca2+ transient are additive in young mice whereas they are compensatory in old 
mice that survive. A larger release of Ca2+ allows more cross-bridges to form, resulting in greater 
contraction. An increase in Ca2+ release may be due to increased SR Ca2+ content, increased L-
type Ca2+ current providing more trigger for release or an alteration to the Ca2+ release process 
itself via RyR. Total SR load was found to be similar between the TG and control group, therefore 
the latter two possibilities are more likely. Although L-type Ca2+ influx was not studied, later 
experiments assess the leak of Ca2+ occurring through RyRs and their phosphorylation levels 
which modulates their open probability. It is possible that the gain of the system may be altered, 
so that for the same L-type Ca2+ current, a larger Ca2+ release through RyR occurs, which 
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produces the larger Ca2+ transient. This may arise from increased phosphorylation of the RyR 
which increases the open probability of the channels (downstream effect of activated 
hypertrophic signalling cascades), or by increased local Ca2+ in the dyadic cleft which primes the 
RyR.  
 
TTP was prolonged in the TG group in both males and females, when compared with NTG. This 
does not correlate with the contractile response, which appears normal regardless of the 
prolongation of the TTP of the Ca2+ transient. However, this finding is consistent with the TTP 
result in cells from 8 week old E99K mice and also human cardiomyocytes from HCM myectomy 
samples (Coppini et al. 2013). In the human myocytes, the capacitance/volume ratio was 
reduced indicating loss of T-tubules in these hypertrophied cells. A decreased T-tubule density 
can lead to prolongation of the Ca2+ transient kinetics, due to asynchronous Ca2+ release from 
the SR. However this does not explain how the decay parameter, time to 90% baseline, was in 
fact faster in the TG cells, specifically in males. A MYBPC3 targeted knock-in mouse  exhibiting 
higher myofilament sensitivity also exhibited a faster Ca2+ transient decay (Fraysse et al. 2012), 
which has been described as a mechanism of compensation. A faster transient decay could be 
attributed to an increased velocity of Ca2+ removal from the cytosol by increased SERCA reuptake 
into the SR or increased efflux via NCX. Enhanced function of these key Ca2+ regulatory proteins 
could also underlie the lower Fura-2 ratio in TG cells, specifically in the male group. A reduced 
ratio implies a reduced diastolic Ca2+ level, a consistent result across both age groups of ACTC 
E99K mice.  It is also possible that increased buffering capacity of the sensitised myofilaments 
contributes to the lower cytoplasmic Ca2+ in diastole (Belke, Swanson, & Dillmann, 2004; Haim et 
al., 2007; Olsson et al., 2004).  
 
4.4.5 NCX function is reduced in ACTC E99K cells 
The alterations in Ca2+ transient properties may be in part, determined by the functioning of key 
Ca2+ regulatory proteins and by Ca2+ available in intracellular stores. SERCA function was found 
to be the same in control and TG cells. However, SERCA at the mRNA level was found to be 
upregulated; this may indicate posttranscriptional modifications occurring, a regulatory process 
of SERCA message which has been demonstrated in neonatal rat cardiomyocytes (Blum et al. 
2005). The normal function of SERCA allows the SR Ca2+ content in TG cells to be maintained at 
a level similar to that of NTG cells. Myocytes isolated from mice carrying the HCM-causing R92L 
mutation in TnT also did not exhibit changes in SR load or SR Ca2+ uptake (Haim et al. 2007), 
which contrasts the majority of studies which display reduced SR Ca2+ content due to a reduction 
in SERCA function in cardiac disease, particularly in HF (Kaye et al. 2008).  
 
126 
 
ACTC E99K cells displayed reduced function of NCX when compared with the NTG cells. As 
described in Chapter 3, NCX proteins are located on T-tubules (ter Keurs 2012), and often in 
diseased states the density of T-tubules can be reduced. This can then lead to a reduced 
expression of the NCX protein leading to the slower efflux of Ca2+ through NCX. However, qPCR 
demonstrated that quantity of NCX mRNA was the same in both control and TG hearts, while the 
protein expressed was found to be greater in mutant hearts.  The discrepancy between quantities 
of NCX message and protein could be caused by a slower turnover of the NCX protein. As protein 
abundances reflect the dynamic balance between translation, localization, modification and 
destruction of the proteins (Vogel & Marcotte 2012), an alteration in the removal process of NCX 
could lead to accumulation of the protein.  
 
Regardless of increased protein level, NCX function is still reduced in TG myocytes. This could be 
indicative of altered regulation by a variety of extracellular and intracellular factors (Shigekawa & 
Iwamoto 2001). One potential mechanism may involve phospholemman, a 72-amino acid 
phosphoprotein highly expressed in the heart, which is involved in regulating ion transport. It has 
been suggested that when phospholemman is phosphorylated at serine-68 it relieves its 
inhibition on the Na+/K+-ATPase and inhibits NCX (Zhang et al. 2006). An alternative explanation 
is that altered intracellular ion gradients may reduce forward mode of NCX. Coppini et al 
observed increased mRNA and protein expression of NCX with slower caffeine-induced 
Ca2+ transient decay in human HCM cardiomyocytes. The dependency of NCX current on 
intracellular Ca2+ was measured during the decay of the caffeine-induced Ca2+ transient, 
indicating an altered NCX electrochemical balance, due to increased intracellular Na+. The 
underlying cause of the intracellular Na+ overload in these HCM cardiomyocytes was found to be 
enhanced late Na+ current leading to increased Na+ entry. Intracellular Na+ accumulation was 
hypothesised to slow the forward mode and enhance the reverse mode of NCX (Ca2+ entry), 
which, combined with the overexpression of NCX, leads to an increased Ca2+ entry during the 
action potential plateau. This process allows HCM cells to maintain normal SR Ca2+ load and 
Ca2+ transient amplitude despite SERCA downregulation (Coppini et al. 2013). This mechanism 
may also be responsible for maintaining normal SR Ca2+ content in E99K cells, but when 
combined with normal SERCA expression and function, produces the enhanced Ca2+ transient 
amplitude.  
 
Slower efflux of Ca2+ through NCX was also found in the older TG mice (Chapter 3), in a guinea 
pig model of hypertrophy (Naqvi & Macleod 1994) and in SR vesicles isolated from post-MI rat 
hearts (Makino et al. 1996). However this finding contrasts the majority of studies which 
demonstrate a higher expression of NCX in cardiac hypertrophy and failure (Sipido 2002). In 
hypertrophied hearts, the cell size is usually increased but this can occur without a compensatory 
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increase in NCX number, thereby reducing the density of the exchanger. However, this 
explanation for reduced NCX function is unlikely for ACTC E99K cells, because the TG myocytes 
were reduced in size, suggesting lack of cellular hypertrophy. Immunohistochemistry experiments 
to determine the density and localisation of NCX, would illustrate whether the NCX protein has 
been transported to the correct membrane location, thus affecting its function.  
 
Further analysis demonstrated that only the function of NCX in cells from TG females was 
reduced in comparison to NTG females. This consistent reduction in function of an important 
Ca2+ handling protein in the female TG cells, may contribute to the more severe phenotype 
(higher rate of SCD) in the females. The altered NCX function should bias Ca2+ uptake/efflux 
mechanisms to favour more SR uptake, however SERCA function and SR load were found to be 
unchanged. For the Ca2+ fluxes to remain in balance another system must be altered, however 
the existing measurements do not identify this. As there is no compensatory increase in SERCA 
function, the rate of Ca2+ efflux from the cytosol may be slowed. Although transient decay was not 
prolonged and diastolic Ca2+ levels were not increased, there may be localised increases in Ca2+ 
which can increase propensity for spontaneous Ca2+ release, thus contributing to arrhythmia risk.  
 
4.4.6 Two populations of ACTC E99K mice 
In humans, the HCM-causing mutation is expressed from birth but is compensated in most cases 
until adolescence, and sometimes symptoms never develop. This variable penetrance indicates 
that genetic background is an important factor for the outcome of HCM mutations. Within the 
ACTC E99K patient population, 5 of the 8 recorded sudden deaths were in a single family, 
suggesting a strong contribution of genetic background to the predisposition for SCD (Monserrat 
et al. 2007). Other triggers and risk factors for SCD in HCM patients have been postulated which 
include the presence of myocyte disarray and fibrosis, youth, ischaemia, unexplained syncope, 
ventricular tachycardia on ambulatory monitoring and severe LV hypertrophy (Ho 2012; Maki et 
al. 1998). 
 
Only a proportion of ACTC E99K TG mice die during a short amount of time, while the survivors 
have mortality rates similar to control animals. Age is clearly a particularly significant risk factor in 
this model, as the SCD only occurs between the ages of 20-45 days old. It is thought that the 
mortality is also partially determined by the hybrid genetic background of these C57/Bl6 x 
CBA/Ca mice. The mice which survive show the characteristic features of HCM with ECG 
abnormalities including spontaneous arrhythmias. This suggests that the mutation induces 
arrhythmias but for SCD to occur, other factors must be involved. Fibrosis, myocyte disarray and 
hypertrophy have all been detected in the ACTC E99K TG mouse (Song et al. 2011) however only 
myocyte disarray was observed in 4 week old animals within the SCD window.  Changes in Ca2+ 
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handling are thought to underlie the pathways leading to these characteristic features of HCM. 
The most striking difference being the higher Ca2+ transient in young E99K mice compared to the 
lower Ca2+ transient amplitude in the old survivors.   
 
Therefore, it is possible that within the data collected from TG animals during the SCD window, 
there are two groups of results: cells from animals which would have died and cells from animals 
that would have survived. When analysing the results, the majority of measurements from TG 
cells show a similar range to that of NTG cells. However, the Ca2+ transient amplitude appeared 
to have a „second population‟ of data points only found in the cells isolated from young animals, 
greater than the range seen in the control group. Hypothetically, the cells which have the 
increased Ca2+ transient amplitude could correspond to animals which could be predisposed to 
SCD. The cells displaying Ca2+ transients above the threshold (0.9 fura-2 ratio), came from both 
male and female isolations (Appendix Table 4.1). Four out of eight isolations included multiple 
cells with large transients, while two out of eight isolations did not contain any cells with 
transients above the threshold limit. This demonstrates the heterogeneity of cell populations. The 
increased transient amplitude may be a contributing factor in the SCD which occurs in both male 
and female mice, while the population with Ca2+ transients below the threshold level may 
contribute to survival.  
 
4.4.7 Compensatory changes in cellular contractility and Ca2+ transients 
By studying the same parameters in both young and old mice, the measurements have shown 
both similarities and differences, which demonstrate how properties of the myocyte alter with 
disease progression. The similarities in TG groups across the age groups may indicate changes 
caused by the mutation and increased myofilament Ca2+ sensitivity while the differences may 
demonstrate the surviving mice adapting and developing compensatory mechanisms to better 
deal with the progression of the disease.  
 
The function of NCX was reduced in TG cells at both ages when compared with the control, but 
the cells isolated from 8 week old TG mice displayed a much slower functioning compared with 
cells from the young TG mice. The slower efflux of Ca2+ from the cell may underlie the prolonged 
sarcomere shortening kinetics (both contraction and relaxation) in the older group, which has 
been associated with the development of diastolic dysfunction. 
 
In the young TG mice, the SR load was normal combined with increased contractility and larger 
Ca2+ transients than the NTG. At 8-12 weeks old, the SR load and transient size was lower in TG 
when compared to both the control group and the young TG group. The reduced transient allows 
contractility to remain at a similar level to that observed in the NTG cells. The reduction in SR 
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load which consequently reduces the transient amplitude may be a compensatory mechanism 
occurring to reduce the cell contractility. A hypercontractile cell is likely to require more energy, 
which may result in increased heat and work production which is a mechanism often seen in 
HCM. An inefficient system can reduce the function of key regulatory proteins which require ATP 
to function, such as SERCA. Therefore, by reducing the Ca2+ transient amplitude, efficiency of the 
system can be increased.  
 
4.4.8 Overview 
The main finding is that the ACTC E99K TG cells isolated from young animals are 
hypercontractile, consistent with increased myofilament Ca2+ sensitivity and higher force 
generation at the muscle level.  This gain of function alteration occurred without corresponding 
increases in diastolic Ca2+ levels or increased SR load. Instead, these changes may be caused by 
either increased Ca2+ influx through LTCC or by increased release of Ca2+ through the RyR. 
Therefore it is important to elucidate properties of the RyR in both TG and control, to determine 
why there is increased Ca2+ release, and also to detect if there is an increase in pro-arrhythmic 
spontaneous Ca2+ leak.  
 
The limitations for these experiments are the same as described in Chapter 3. Using the isolated 
myocyte to study contraction can also be considered a limitation, as there is no effect of load, 
which is known to influence relaxation. The sarcomere length range measured in these 
experiments is lower than in vivo/intact muscle studies which may affect the contractile and 
relaxation properties of the cell. However in this investigation the intact cell is considered 
advantageous as the isolated myocyte is free from possible compounding effects of the 
extracellular matrix, abnormal chamber geometry and circulating hormones. Also, the loading of 
Fura-2 into the cell caused increased intracellular buffering leading to reductions in contractility 
even at optimised dye loading conditions. Therefore the contractility and Ca2+ transients were not 
recorded simultaneously; the cell contraction was recorded in unloaded cells (i.e. without fura) 
for the most physiological contractility measurements. 
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Chapter 5: Spontaneous Ca2+ 
release  
 
In this Chapter, Ca2+ sparks and waves in cardiomyocytes isolated from 25-45 day old 
ACTC E99K animals are examined. At this age, there is a high occurrence of sudden 
death, especially in females. The characteristics of spontaneous Ca2+ sparks and 
frequency of diastolic Ca2+ waves are studied. These experiments test the hypothesis 
that increased myofilament Ca2+ sensitivity underlies the predisposition to arrhythmias 
and sudden death by increased spontaneous Ca2+ release in the transgenic animals. 
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5.1 Introduction 
 
The characteristic pathological features of HCM include cardiac hypertrophy in the absence of 
other cardiac or systemic causes, fibrosis and myocyte disarray. However, the clinical phenotype 
is highly variable and ranges from being asymptomatic to suffering sudden death attributed to 
cardiac arrhythmias (Frey et al. 2012). The precise mechanisms by which sarcomeric mutations 
evoke arrhythmias is not fully understood, although studies in animal models of HCM have 
suggested abnormal ATP use and disturbances in Ca2+cycling (Keren et al. 2008).  
 
A substantial number of experiments have demonstrated that HCM mutations in myofilament 
proteins generally increase Ca2+ sensitivity. For example, (Baudenbacher et al. 2008) produced 
TG mouse models that phenocopy the differential Ca2+-sensitizing effects of three human HCM-
causing TnT mutations but do not exhibit cardiac hypertrophy, fibrosis, or myofibrillar disarray. 
Ca2+ sensitisation changed the shape of the ventricular AP resulting in shorter effective refractory 
periods, increased beat-to-beat variability of APD and increased dispersion of ventricular 
conduction velocities at high heart rates. The effects were most prominent in TG mice with the 
highest Ca2+ sensitivity and the risk of developing ventricular tachycardia was directly 
proportional to the degree of Ca2+ sensitization caused by the TnT mutation 179N. These findings 
could also be reproduced acutely in NTG hearts using the Ca2+-sensitizer EMD57033; a 
compound which acts by enhancing thick filament and thin filament interaction. Within this study, 
blebbistatin was found to rescue the pro-arrhythmic phenotype of the TnT mutant mice. 
Blebbistatin primarily blocks myosin II in an actin-detached state (Kovács et al. 2004) and was 
found to reduce Ca2+ sensitivity in a concentration-dependent manner in all skinned fibers from 
TnT transgenic hearts. This suggests that myofibrillar Ca2+ sensitization is likely to be the 
underlying molecular mechanism of the arrhythmias in this model of HCM and supports the 
hypothesis that the increased Ca2+ sensitivity could underlie the increased propensity for SCD in 
ACTC E99K animals. 
 
TG mice expressing the cardiac TnT I79N mutation have been shown to display increased cardiac 
contractility, which has been associated with myofilament Ca2+ sensitization, suggesting altered 
cellular Ca2+ handling, similar to my observations with ACTC E99K. The mutation has been linked 
to HCM in patients, associated with a high incidence of SCD and little or no cardiac hypertrophy. 
Cardiomyocytes isolated from these mutant mice exhibited depressed and prolonged Ca2+ 
transients compared with control mice, which might trigger DADs or spontaneous Ca2+ 
oscillations responsible for the observed ventricular tachycardia (Knollmann et al. 2003). These 
effects were observed in the absence of hypertrophy and fibrosis, which implies that arrhythmias 
are not simply a secondary effect of structural changes of the myocardium. This suggests that 
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alterations in Ca2+ cycling and homeostasis might also contribute to ventricular arrhythmias in 
patients with HCM.  
 
Spontaneous Ca2+ leak from the SR triggers the formation of DADs, which are thought to underlie 
some of the fatal arrhythmia that occur in HF, CPVT, and HCM. DADs are depolarisations of the 
membrane potential that occur after the repolarisation phase of an AP, initiated by abnormal 
Ca2+ release from the SR. The diastolic Ca2+ release activates NCX which produces a transient 
inward current that depolarises the cell membrane, causing a so-called afterdepolarisation. If the 
threshold for Na+ channel activation is reached, the NCX-dependent current may trigger a 
premature AP, which could be propagated and cause a ventricular arrhythmia (Wehrens et al. 
2000; Kannankeril et al. 2006). 
 
The RyR mediates the release of Ca2+ from the SR. In EC coupling, the RyRs located in the SR are 
activated by a small influx of Ca2+ through the voltage-dependent LTCC, which triggers their 
opening leading to a large Ca2+ release from the SR. The cytoplasmic region of the RyR is located 
in the dyadic cleft, which is a microdomain formed by the SR and sarcolemma, while the 
transmembrane region of the RyR spans the SR membrane and contains the main conduction 
and ion selective components of the channel. During EC coupling, the RyR is exposed to 
continually changing Ca2+ concentrations, both dyadic and luminal, which are critical to RyR 
regulation (Blayney & Lai 2009). In addition to electrically-triggered Ca2+ release during normal 
EC coupling, Ca2+ release from the SR can also occur unpredictably as a result of spontaneous 
openings of the RyR.  
 
The fundamental unit of Ca2+ release from the SR is known as a Ca2+ spark. These can be 
detected under normal cytoplasmic and SR Ca2+ loading conditions and locally elevate 
intracellular Ca2+ concentration. Under increased Ca2+ loading, sparks can activate more Ca2+ 
release via the mechanism of CICR, triggering propagating Ca 2+ waves (Cheng et al. 1993). It has 
been well established that propagating Ca2+ waves cause DADs via Ca2+-activated inward 
currents, which in turn could lead to triggered arrhythmias (Schlotthauer & Bers 2000; Shiferaw 
et al. 2012). Alterations in RyR channel function are likely to influence the properties of 
spontaneous Ca2+release and propagating Ca2+ waves, and thus the occurrence of triggered 
arrhythmias (Scoote 2002).  
 
Altered RyR function has been attributed to several mechanisms, such as enhanced RyR 
phosphorylation and altered RyR regulation at luminal or cytoplasmic sites. Calsequestrin (CSQ), 
triadin and junctin are luminal RyR accessory proteins which have been shown to directly 
regulate the RyR channel sensitivity to luminal Ca2+ (Györke et al. 2004). Chronic PKA 
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hyperphosphorylation is associated with decreased FKBP12.6 binding to RyR, which increases 
the susceptibility to SR Ca2+ leak and triggered ventricular arrhythmias. Another mechanism for 
increased SR leak involves CaMKII which can be activated as a result of increased diastolic Ca2+ 
levels at faster heart rates, or due to direct stimulation by β-adrenergic receptors during exercise 
or stress. The effect of CaMKII phosphorylation of serine-2814 is to increase the open probability 
of RyR at the single channel level (Wehrens 2004).  
 
The next step of the investigation into the disease causing molecular mechanism of HCM in the 
ACTC E99K mouse model is therefore to study spontaneous Ca2+ release within the single cell. 
Chapter 4 showed that cells from ACTC E99K TG animals displayed increased Ca2+ transient 
amplitude, without Ca2+ overload in either the SR or the cytoplasm.  Alterations in RyR function 
may lead to the observed changes in the Ca2+ transient, in addition to affecting the tendency of 
spontaneous Ca2+ release.  It is possible that increased diastolic Ca2+ leak may induce DAD‟s 
which underlie the potentially fatal arrhythmias. The following experiments were designed to 
allow the study of Ca2+ sparks and waves, and to characterise the phosphorylation level of the 
RyR. In addition, the opportunity arose to further study spontaneous Ca2+ release using myocytes 
isolated from a rat model, which displayed a HF phenotype 8 weeks following myocardial 
infarction (MI). The cellular Ca2+ handling properties can be compared and contrasted with those 
from the ACTC E99K mouse model of HCM, providing insight into SR Ca2+ release in different 
diseases.  
 
Aims 
 To measure and compare the properties of spontaneous Ca2+ sparks after stimulating 
myocytes at 0.5Hz 
 To measure and compare the frequency of spontaneous Ca2+ waves occurring after 
stimulating myocytes at 0.5, 1, 2 and 5Hz 
 To measure and compare the phosphorylation of RyR  
 To characterise cellular contractility and Ca2+ transients in the rat HF myocytes, and to 
determine the frequency of spontaneous Ca2+ waves  
 
5.2 Materials and methods 
 
5.2.1 Isolated cell experiments  
25-45 day old ACTC E99K male and female mice were used in the following experiments. The 
cells were isolated as described in section 2.2 of the Methods chapter. Experiments were carried 
out while superfusing the cells with NT containing 2mM Ca2+ at 37ºC. 
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Ca2+ sparks: Confocal microscopy was used to record Ca2+ sparks in isolated myocytes loaded 
with Fluo-4 fluorescent dye. The procedure for loading dye into cells and the experimental 
protocol are fully described in the Methods section 2.5. The parameters measured include Ca2+ 
spark frequency, spark amplitude (F/F0), full width at half maximal amplitude (FWHM), full 
duration at half maximal amplitude (FDHM), time to peak (TTP) and rate of decay (tau) of sparks. 
These measurements were made by the SparkMaster macro in ImageJ, in a manually selected 
region of the line scan. From these parameters, spark mass and SR leak were calculated 
(Hollingworth et al, 2001) using the formulae described in section 2.5.3.  
 
Ca2+ waves: The IonOptix system was used to record Ca2+ waves in isolated myocytes loaded with 
Fura-2 fluorescent dye. Non-stimulated contractions which coincide with the Ca2+ waves were 
also recorded using unloaded cells. The experimental protocols are fully described in the 
Methods section 2.4.9. 
 
5.2.2 Protein expression  
Hearts from 25-40 day old ACTC E99K male and female mice were collected as described in the 
Methods section 2.1.3. The protein expression of RyR was determined using the protocol 
described in Methods section 2.8. The RyR expression experiments were carried out by Adam 
Mills, Imperial College. 
 
5.2.3 MI rat cells 
The rat MI model was produced by Markus Sikkel via surgical ligation of the left coronary artery 
as described previously (Lyon et al. 2009).  Echocardiography was performed for phenotyping 
using a Vevo 770 system to assess LV dimensions and blood flow via pulsed wave Doppler 
measurements of the pulmonary artery. LV hypertrophy and reduced ejection fraction were 
present in HF animals (Sikkel, Kumar & Maioli 2014). Cardiomyocyte isolation was carried out by 
Peter O‟Gara as described previously by (Sikkel et al. 2013). Cells were isolated 8 weeks 
following MI from rats with HF as assessed by echocardiography and also from unoperated age 
matched controls (AMC).  
 
Isolated cardiomyocytes were loaded with 10µM Fura-2 and imaging was performed as for ACTC 
E99K cells. The protocol for recording Ca2+ waves carried out was repeated as previously 
described (Section 2.4.9). Sarcomere shortening and Ca2+ transients were measured 
simultaneously as rat cell contractility was not affected by loading of fluorescent dye. The 
parameters for both of these measurements were analysed as described for ACTC E99K cells.  
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5.2.4 Statistical analysis 
Ca2+ sparks: The measured and calculated spark parameters were averaged per cell. Spark 
frequency was corrected to area and time, giving final units of sparks/100μm2/s. The D'Agostino-
Pearson omnibus test was initially carried out to determine how far the distributions deviate from 
the Gaussian ideal. As the spark parameters did not show normally distributed populations, 
logarithmic transformations were used to produce normally distributed data. Spark mass was 
calculated using the logarithm of both spark amplitude and FWHM. A two-way ANOVA could then 
be carried out on the data. Spark-mediated SR leak was calculated using spark mass x the 
logarithm of spark frequency.  
 
Ca2+ waves: The data collected from Fura-2 loaded cells was separated into two groups, TG and 
NTG. Due to the smaller population size, gender was not taken into account at this stage. The 
two-way ANOVA was used to determine the effect of genotype and pacing frequency on two 
measurements; frequency of Ca2+ waves and quiescent Ca2+ levels. Average wave amplitude was 
calculated per cell. As only a small proportion of cells displayed spontaneous waves, wave amplitude 
values were pooled from all four pacing rates and a t-test was carried out to determine whether 
Ca2+ wave amplitude is different in TG and NTG cells.  
 
The SC data was collected from a larger population of unloaded cells allowing gender as well as 
genotype to be considered. For each stimulation frequency, a two-way ANOVA was used to 
determine the interaction of the two independent variables (genotype and gender) and their 
individual effect on frequency of SCs. To reduce the number of animals used, the same data was 
used to determine whether there is interaction between genotype and the pacing frequency on 
wave frequency. Male and female data were combined and statistically tested using a two-way 
ANOVA. 
 
For both Ca2+ and contraction measurements, Kaplan-Meier survival curves were also produced 
to show the wave-free survival periods, and were analysed using the Log-Rank curve comparison 
test, to detect differences between TG and NTG wave-free survival.  
 
RyR phosphorylation: Two-way ANOVAs were used to determine whether there is an effect of 
genotype and gender on protein expression levels of RyR 
 
MI rat cells: Two-way ANOVAs were used to determine whether there is an effect of HF and pacing 
frequency on cellular contractility parameters, Ca2+ transient parameters and wave frequency. 
The effect of gender was not assessed because only male rats were used for the MI model and 
for the controls.  
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5.3 Results 
 
5.3.1 Ca2+ sparks 
 
Figure 5.1 displays the measured spark parameters, averaged per cell. The D'Agostino-Pearson 
omnibus test was carried out on these data, and the spark parameters did not show normally 
distributed populations.   
 
 
 
Spark parameter 
 
 
NTG F 
 
TG F 
 
NTG M 
 
TG M 
 
Frequency 
(sparks/100μm2/s) 
 
 
0.47 ± 0.11 
 
0.88 ± 0.14 
 
0.31 ± 0.06 
 
0.64 ± 0.15 
 
Amplitude  (F/F0) 
 
0.16 ± 0.01 
 
 
0.18 ± 0.01 
 
 
0.17 ± 0.01 
 
 
0.17 ± 0.01 
 
 
FWHM (µm) 
 
2.20 ± 0.09 
 
 
2.38 ± 0.05 
 
2.21 ± 0.08 
 
 
 2.17 ± 0.10 
 
 
FDHM (ms) 
 
21 ± 2 
 
 
25 ± 1 
 
 
23 ± 1 
 
 
26 ± 2 
 
 
TTP (ms) 
 
10 ± 1 
 
 
14 ± 1 
 
 
11 ± 1 
 
 
13 ± 1 
 
 
Tau (ms) 
 
 
33 ± 6 
 
 
51 ± 11 
 
 
33 ± 8 
 
 
37 ± 6 
 
 
Table 5.1 Spark parameters  
 
 
Table 5.1 displays the logarithm of spark parameters. There was a significant effect of genotype 
on Log FDHM1 (p<0.05) and Log TTP2 (p<0.01); these two parameters were prolonged in TG cells 
compared with NTG cells. The post-hoc tests showed that log TTP3 of sparks in cells isolated from 
TG female mice was greater when compared with log TTP of sparks in cells from NTG females 
(p<0.05). There were no differences detected in spark amplitude, FWHM and tau between cells 
from TG and NTG animals and gender did not have an effect on any of the parameters.   
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Spark parameter 
 
 
NTG F 
 
TG F 
 
NTG M 
 
TG M 
 
Amplitude  (F/F0) 
 
-0.80 ± 0.01 
 
-0.76 ± 0.01 
 
 
-0.77 ± 0.02 
 
 
-0.78 ± 0.02 
 
 
FWHM (µm) 
 
0.33 ± 0.02 
 
 
0.37 ± 0.01 
 
0.33 ± 0.02 
 
 
 0.32 ± 0.02 
 
 
FDHM (ms)1 
 
1.26 ± 0.04 
 
 
1.37 ± 0.03 
 
 
1.33 ± 0.03 
 
 
1.37 ± 0.03 
 
 
Tau (ms) 
 
1.33 ± 0.07 
 
 
1.47 ± 0.06 
 
 
1.35 ± 0.05 
 
 
1.43 ± 0.06 
 
 
TTP (ms)2 
 
0.95 ± 0.03 
 
 
1.09 ± 0.033 
 
 
1.01 ± 0.03 
 
 
1.06 ± 0.04 
 
 
n (cells) 
 
35 
 
51 
 
45 
 
35 
 
 
Table 5.1 Logarithm of spark parameters 
 
 
Table 5.2 shows that spark frequency was significantly affected by genotype (p<0.001). 
Specifically, cells from TG female animals showed a larger log frequency (Figure 5.2A) than the 
cells from NTG female animals, indicating an increased spark frequency. There was no 
interaction between gender and genotype, and no effect of gender individually on any of the 
spark parameters. On observation of the post hoc tests, no differences were found between any 
of the sub-groups, for the calculated measurements of spark mass and spark-mediated SR leak.  
 
 
Spark parameter Interaction Gender Genotype 
Frequency 
(sparks/100μm2/s) 
ns ns *** 
Mass (ΔF/F0* µm3) ns ns ns 
SR leak (mass x 
frequency) 
ns ns ns 
 
Table 5.2 The effect of gender and genotype on spark measurements 
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Figure 5.1 Representative 3-D images of Ca2+ sparks generated from a line scan. Cells isolated 
from TG mice showed an increased frequency of Ca2+ sparks 
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Figure 5.2 Spontaneous Ca2+ sparks in E99K TG and NTG cardiomyocytes. Data are presented as 
mean ± SEM; cells isolated from 6 NTG, 6 TG animals (A) Spark frequency (sparks/100µm/sec); 
n = 117 NTG cells, 112 TG cells (B) Spark mass (ΔF/F0*µm3); n = 80 NTG cells, 86 TG cells (C) 
Spark-mediated SR leak (spark mass x frequency); n = 80 NTG cells, 86 TG cells 
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5.3.2 Ca2+ waves 
 
5.3.2.1 Ca2+ waves in Fura-2 loaded cells 
Overall, wave frequency was affected by both genotype (p<0.01) and stimulation frequency 
(p<0.001) as shown in Table 5.3. Figure 5.4A shows that both groups display more Ca2+ waves 
as field-stimulation frequency is increased, and that TG cells display a higher wave frequency 
than NTG cells. The Tukey tests were then analysed and no differences in wave frequency were 
found between NTG and TG cells at individual pacing rates.  
 
Table 5.3 also shows that quiescent Fura-2 ratio, measured after the field-stimulation and before 
the first wave (if present), was also affected by both genotype and stimulation frequency 
(p<0.05). Figure 5.4B shows that the Fura-2 ratio, indicative of diastolic Ca2+ levels, increases 
with higher pacing rates and was higher in NTG cells than in TG cells.  
 
 Interaction Pacing rate Genotype 
Wave frequency 
(waves/s) 
ns *** ** 
Quiescent Fura-2 ratio 
(360/380) 
ns * * 
 
Table 5.3 The effect of pacing rate and genotype on wave frequency and quiescent Fura-2 ratio 
 
 
Figure 5.4C shows that Ca2+ waves in TG cells are smaller than in NTG cells. Figure 5.5A-D show 
that at all stimulation frequencies, there were no differences in the wave-free survival period 
when analysed using the Log-Rank curve comparison test. 
 
141 
 
1 .5
2 .2
F u ra -2  ra tio
 (3 6 0 /3 8 0  n m )
1 .5
2 .2
F u ra -2  ra tio
 (3 6 0 /3 8 0  n m )
T G
N T G
1 0  s e c
1 0  s e c
 
 
Figure 5.3 Representative Ca2+ waves in E99K NTG and TG cardiomyocytes after 2Hz field 
stimulation. Quiescent Fura-2 ratio (purple line) measured after stimulation when ratio has 
reached steady resting level. Ca2+ waves indicated by arrows (blue) 
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Figure 5.4 Ca2+ waves in Fura-2 loaded E99K cardiomyocytes. Data are presented as mean ± 
SEM; n = 20 cells from 5 NTG animals, 20 cells from 4 TG animals (A) Effect of stimulation rate 
on wave frequency (B) Fura-2 ratio during quiescent period after field-stimulation (C) Wave 
amplitude  
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Figure 5.5 Ca2+ wave-free survival of E99K TG and NTG cardiomyocytes. Data are presented as 
mean ± SEM; n = 20 cells from 5 NTG animals, 20 cells from 4 TG animals. Wave-free survival in 
cells field stimulated at (A) 0.5Hz (B) 1Hz (C) 2Hz (D) 5Hz 
 
 
The Ca2+ waves were observed to correspond with deflections in the sarcomere shortening trace, 
illustrated in the Methods chapter. In unloaded cells, Ca2+ waves could be observed after the 
stimulation protocol by the uncoordinated contraction of the cell, shown in the recordings by the 
deflection in the sarcomere shortening trace.  Preliminary studies showed that the cells loaded 
with Fura-2 showed much fewer waves than the unloaded cells, which may be due to the Ca2+ 
buffering properties of the dye. Therefore, for a more physiological measurement of wave 
frequency, the full data set was completed using unloaded cells.  
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5.3.2.2 Spontaneous contractions in unloaded cells 
Table 5.4 shows that frequency of SCs was increased in TG cells compared to NTG cells at all 
four tested stimulation frequencies (p<0.001). Genotype and gender were not found to interact 
for SC frequency at all of the tested pacing rates. SC frequency was also not affected by gender 
at all the pacing frequencies. 
 
On analysis of the Tukey tests, Figure 5.7A shows that after stimulation at 0.5Hz, frequency of 
SCs is greater in both male and female TG cells than their NTG counterparts (0.044 ± 0.011 (TG 
male) vs 0.007 ± 0.003 SC/s (NTG male), p<0.05: 0.073 ± 0.014 (TG female) vs 0.008 ± 0.005 
SC/s (NTG female), p<0.001). After pacing at 1Hz, SC frequency was higher in TG female cells 
than in NTG female cells (0.092 ± 0.016 vs 0.014 ± 0.005 SC/s, p<0.001) as shown in Figure 
5.7B. Figure 5.7C shows that TG male and female cells have increased SC frequency when 
compared to their NTG counterparts (0.044 ± 0.011 (TG male) vs 0.007 ± 0.003 SC/s (NTG 
male), p<0.01: 0.133 ±0.019 (TG female) vs 0.041 ±0.008 SC/s (NTG female), p<0.001) after 
pacing at 2Hz. Figure 5.7D shows that after pacing at 5Hz, both male and female TG cells show 
greater frequency of SCs than their NTG littermates (0.297 ± 0.024 (TG male) vs 0.190 ± 0.021 
SC/s (NTG male), p<0.01: 0.273 ± 0.026 (TG female) vs 0.161 ± 0.018 SC/s (NTG female), 
p<0.01). 
 
Pacing rate (Hz) Interaction Gender Genotype 
0.5 ns ns *** 
1 ns ns *** 
2 ns ns *** 
5 ns ns *** 
 
Table 5.4 The effect of gender and genotype on spontaneous contraction frequency at different 
pacing rates 
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Figure 5.6 Representative spontaneous contractions in E99K NTG and TG cells after 2Hz field 
stimulation. Spontaneous contractions indicated by arrows (blue) 
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Figure 5.7 Spontaneous contractions in E99K cardiomyocytes. Data are presented as mean ± 
SEM; n = 80 cells from 8 NTG animals, 80 cells from 9 TG animals. Cells were field stimulated at 
(A) 0.5Hz (B) 1Hz (C) 2Hz (D) 5Hz 
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5.3.2.3 Time to first spontaneous contraction 
The „SC-free survival period‟ was measured as the time from the last transient to the first SC. For 
each stimulation frequency, this was represented in a Kaplan-Meier survival curves as shown in 
Figure 5.8. At all pacing rates, the SC-free survival period was significantly reduced in TG cells 
(p<0.001) when analysed using the Log-Rank curve comparison test.  
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Figure 5.8 Spontaneous contraction-free survival of E99K cardiomyocytes at different pacing 
rates. Data are presented as mean ± SEM; n = 80 cells from 8 NTG animals, 80 cells from 9 TG 
animals. Cells were field stimulated at (A) 0.5Hz (B) 1Hz (C) 2Hz (D) 5Hz 
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5.3.2.4 Effect of pacing rate on frequency of spontaneous contractions 
Table 5.5 shows that the two independent variables genotype and pacing rate were found to 
interact for SC frequency (p<0.05). This interaction indicates that the effect of pacing rate is 
different in TG and NTG cells. Figure 5.9 shows that SC frequency increases with increasing 
pacing rate and SC frequency is higher in the TG group at all four stimulation frequencies. 
 
 Interaction Pacing rate Genotype 
Spontaneous 
contraction frequency 
(SC/s) 
* *** *** 
 
Table 5.5 The effect of genotype and pacing rate on frequency of spontaneous contractions 
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Figure 5.9 Effect of pacing rate on the frequency of spontaneous contractions in E99K TG and 
NTG cardiomyocytes. Data are presented as mean ± SEM; n = 80 cells from 8 NTG animals, 80 
cells from 9 TG animals. 
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5.3.3 RyR phosphorylation 
Table 5.6 shows that protein expression levels of phosphorylated RyR are affected by gender in 
the young mice (p<0.001), with greater expression in NTG females compared with NTG males 
(Figure 5.10A). Quantity of phosphorylated RyR in old mice is affected by genotype (p<0.05), and 
overall it is lower in TG animals compared with the control group (Figure 5.10B).  
 
 
 Interaction Gender Genotype 
RyR (young) ns *** ns 
RyR (old) ns ns * 
 
 
Table 5.6 The effect of gender and genotype on protein expression levels of RyR serine-2808 
phosphoprotein  
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Figure 5.10 Protein expression levels of RyR serine-2808 phosphoprotein in E99K TG and NTG 
heart tissue. Data are presented as mean ± SEM; n = 3 hearts per group (A) Quantity of RyR 
serine-2808 phosphoprotein in hearts from 25-40 day old mice (B) Quantity of RyR serine-2808 
phosphoprotein in hearts from 8-12 week old mice 
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5.3.4 MI rat cells 
5.3.4.1 Cellular contractility in the HF rat 
Sarcomere shortening parameters were measured at a range of stimulation frequencies to 
determine whether differences in contractility between MI and AMC cells occurred at different 
pacing rates. Figure 5.11F shows that across the range of stimulation frequencies there was a 
significant effect of HF on peak contraction amplitude (p<0.001), time to 50% (p<0.001) and 
90% baseline (p<0.01). Figure 5.11F shows that the independent variables, HF and stimulation 
frequency, were found to interact for peak contraction amplitude (p<0.05). This interaction 
indicates that the effect of HF is different depending on the pacing rate. All of the parameters 
were affected by stimulation frequency (p<0.001). 
 
Figure 5.11C shows that cells isolated from 8 week MI rats display a greater peak contraction 
amplitude than the AMC cells at 0.5Hz (0.15 ± 0.01 vs 0.11 ± 0.01 µm, p<0.001), 1Hz (0.09 ± 
0.01 vs 0.07 ± 0.01 µm, p<0.05) and 2Hz (0.09 ± 0.01 vs 0.07 ± 0.01 µm, p<0.01). At 0.5Hz, 
MI cells display a faster time to relax by 50% (83 ± 5 vs 99 ± 6 ms p<0.001) as shown by Figure 
5.11D. Resting sarcomere length, TTP and time to 90% relaxation were the same in MI and AMC 
cells at all of the pacing rates (Figure 5.11A, B and E).  
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Figure 5.11 Sarcomere shortening parameters in 8 week post-MI and AMC cardiomyocytes at 
different stimulation frequencies. Data are presented as mean ± SEM; n = 76 cells from 10 AMC 
rats, 79 cells from 10 HF rats (A) Diastolic sarcomere length (B) Time to peak (C) Peak amplitude 
of contraction (D) Time to 50% relaxation (E) Time to 90% relaxation (F) Two-way ANOVA results 
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5.3.4.2 Ca2+ transients in the HF rat 
Ca2+ transient parameters were measured at a range of stimulation frequencies to determine 
whether differences in the Ca2+ transient between MI and AMC cells occurred at different pacing 
rates. Figure 5.12F shows that across the range of stimulation frequencies there was a 
significant effect of HF on peak transient amplitude (p<0.001) and TTP (p<0.001). Figure 5.12F 
shows that there was no interaction of the independent variables, MI and stimulation frequency. 
All of the parameters were affected by stimulation frequency (p<0.001). 
 
At 2Hz, MI cells display a prolonged TTP (59 ± 1 vs 58 ± 0.4 ms p<0.001) as shown by Figure 
5.12B. Figure 5.12C shows that cells isolated from 8 week MI rats display a greater peak 
transient amplitude than the AMC cells at all of the tested stimulation frequencies. Resting 
sarcomere length, time to 50% and 90% relaxation were the same in MI and AMC cells at all of 
the pacing rates (Figure 5.12A, D and E).  
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Figure 5.12 Ca2+ transient parameters in 8 week post-MI and AMC cardiomyocytes at different 
stimulation frequencies. Data are presented as mean ± SEM; n = 76 cells from 10 AMC rats, 79 
cells from 10 HF rats (A) Diastolic Fura-2 ratio (B) Time to peak (C) Peak transient amplitude (D) 
Time to 50% decay (E) Time to 90% decay (F) Two-way ANOVA results 
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5.3.4.3 Wave frequency 
Table 5.7 shows that both pacing rate and HF have a significant effect on wave frequency. Figure 
5.13 shows that wave frequency in both MI and AMC cells increases with increasing pacing rate, 
and wave frequency is significantly higher in the MI cells compared with AMC cells after 
stimulation at 2Hz.  
 
 Interaction Pacing rate HF 
Wave frequency 
(waves/s) 
ns *** ** 
 
Table 5.7 The effect of pacing rate and heart failure on wave frequency in rat cells 
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Figure 5.13 Frequency of spontaneous Ca2+ waves in 8 week post-MI and AMC cardiomyocytes at 
different stimulation frequencies. Data are presented as mean ± SEM; n = 76 cells from 10 AMC 
rats, 79 cells from 10 HF rats  
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5.3.4.4 Time to first wave 
The ‘wave-free survival period’ was measured as the time from the last transient to the first wave. 
For each stimulation frequency, this was represented in a Kaplan-Meier survival curves. Figure 5.14 
shows that at 0.5Hz, 1Hz and 2Hz, the wave-free survival period was significantly reduced in cells 
isolated from MI than AMC rats when analysed using the Log-Rank curve comparison test.  
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Figure 5.14 Wave-free survival of 8 week post-MI and AMC rat cardiomyocytes at different 
stimulation frequencies. Data are presented as mean ± SEM; n = 76 cells from 10 AMC rats, 79 
cells from 10 HF rats. Cells were field stimulated at (A) 0.5Hz (B) 1Hz (C) 2Hz (D) 5Hz 
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5.4 Discussion 
 
5.4.1 E99K cells show increased frequency of spontaneous Ca2+ release  
In the beating heart, most of the Ca2+ required for contraction is released from the SR via the RyR 
in response to Ca2+ entry during the early part of the AP. SR Ca2+ release can occur 
spontaneously rather than being triggered by the AP and this process may be exacerbated in 
disease states e.g. HF. It is accepted that Ca2+ sparks constitute the elementary events of cardiac 
EC coupling. Ca2+ transients triggered by depolarisation arise from the stochastic summation of 
discrete sparks. Ca2+ entry through LTCC is not necessary for spontaneous Ca2+ spark release to 
occur, it is the opening rate of RyRs which is of importance, and this is dependent on cytosolic 
and luminal Ca2+ plus a range of additional co-factors. Many investigations in heart disease 
examine sparks to gain insight into the regulatory features of the RyR, such as alterations in the 
channel and associated proteins, localisation, organisation of their clusters, Ca2+ sensitivity, SR 
Ca2+ content and Ca2+ leak.  ACTC E99K TG myocytes displayed an increased frequency of Ca2+ 
sparks in addition to prolongation of spark duration. Although the amplitude, width and mass of 
sparks recorded in TG cells were not different from spark parameters in NTG cells, an increased 
tendency for the RyR to release sparks of longer duration, may be a contributing factor to the 
increased Ca2+ transient amplitude measured in TG cells.  
 
Diastolic releases in the form of Ca2+ sparks initiate the Ca2+ wave by locally elevating Ca2+ which 
activates further release of Ca2+. Increased sensitivity of the CICR process allows Ca2+ sparks to 
activate neighbouring Ca2+ sparks (Cheng et al. 1996). The propagating diastolic Ca2+ release is a 
Ca2+ wave. Both Fura-2 loaded and unloaded ACTC E99K TG cells displayed increased Ca2+ wave 
frequency compared with NTG cells. It is likely the increased spark frequency underlies this 
finding.  
 
When the spontaneous release occurs and develops to form a Ca2+ wave during diastole, it can 
contribute to arrhythmogenesis by activating the electrogenic NCX (Mechmann & Pott, 
1986),  resulting in an inward current . This could subsequently produce a DAD that may trigger 
APs. Therefore it is important to determine how and why cells from ACTC E99K animals produce 
more Ca2+ waves than their control counterparts, in the aim of elucidating the pathway leading to 
increased arrhythmia susceptibility in ACTC E99K mice. The mechanisms leading to increased 
frequency of sparks and waves are probably linked, and may involve altered cytosolic or luminal 
regulation of RyR. Therefore the balance between SR content, threshold level and RyR properties 
(Trafford et al. 2000) are important in the formation of diastolic Ca2+ waves (Venetucci et al. 
2008; Díaz et al. 1997).  
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5.4.2 Cytoplasmic regulation of RyR 
During normal contraction, the inflow of Ca2+ through LTCC into the cytoplasm activates the RyR 
via their cytoplasmic facing Ca2+-activation sites. The subsequent release of Ca2+ from the SR 
further increases cytoplasmic Ca2+ (by CICR) and hence RyR activation.  A higher cytosolic Ca2+ 
concentration during diastole would therefore be considered a potential mechanism for 
increased spontaneous Ca2+ release. The Fura-2 ratio was measured after the field-stimulation 
protocol, which is indicative of cytoplasmic Ca2+ level during cell quiescence. This was found to 
be lower in TG cells than in NTG cells, corresponding with reduced diastolic Ca2+ measured at the 
baseline of 1Hz electrically stimulated transients (Chapter 4). This suggests that diastolic Ca2+ 
does not rise to a greater extent in TG cells during a period of quiescence to stimulate increased 
Ca2+ release.  
 
The resting Ca2+ measurements do not take into account potential local elevation of Ca2+ 
concentration. Reduced NCX function in ACTC E99K TG cells may allow local diastolic Ca2+ to be 
higher at the junctional cleft, regardless of the reduced global diastolic Ca2+ measured in ACTC 
E99K TG cells. Local elevation of Ca2+ may increase spark frequency directly by sensitising the 
RyR or by activating kinases which can then phosphorylate RyR (Guo et al. 2006). RyR may also 
be sensitised by enhanced Ca2+ release via neighbouring InsP3Rs which would lead to alterations 
in stimulated Ca2+ fluxes and an increase in spontaneous Ca2+ release. Although RyRs are 
predominantly involved in the release of Ca2+, a role for IP3R in cardiac physiology has emerged. 
Harzheim et al found increased expression of the type 2 InsP3R during hypertrophy in myocytes 
from spontaneously hypertensive rats, which was restricted to the junctional SR in close proximity 
to RyRs. Increased InsP3R2 expression has also been observed in hypertrophic hearts from 
patients with ischemic DCM and aortically-banded mice suggesting that increased InsP3R 
expression may often occur during hypertrophy (Harzheim et al., 2010).  
 
In addition to local and global changes in Ca2+, increased spontaneous release may also be due 
to increased expression of RyR. Work by Camors et al used permeabilised myocytes isolated from 
ankyrin-B (AnkB+/-) heterozygous mice to study whether increased Ca2+ sparks were caused by 
altered RyR expression or by changes to the cytoplasmic regulation of RyR. Ankyrin-B is a 
multivalent “adaptor” protein that targets and tethers select membrane proteins, such as NCX 
and Na+/K+-ATPase, to the cytoskeleton. Ankyrin-B loss of function mutations cause ventricular 
arrhythmias and SCD in humans, with the AnkB+/- mouse largely reproducing the human 
phenotype. Myocytes isolated from AnkB+/- mouse hearts showed similarities with the ACTC E99K 
data in Chapter 4, including reduced expression of NCX, normal SERCA expression and larger 
Ca2+ transients. The mutant cells also displayed a higher frequency of sparks (normalised to SR 
content) without differences in other spark characteristics (amplitude, duration, width). As the 
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change in spark frequency is independent of SR content, Camors et al permeabilised the cells to 
equalise cytosolic environment, which showed similar spark frequency between the groups 
(Camors et al. 2012). This indicates that the higher Ca2+ spark frequency in intact AnkB+/-
 myocytes is caused by different RyR regulation at the cytoplasmic side, rather than being due to 
intrinsic differences in RyR expression.  The protein expression level of RyR was not determined 
in the ACTC E99K studies due to the large size of the RyR producing difficulties in Western 
blotting, therefore the permeabilised cell experiments would be useful to carry out in future 
studies, to further elucidate the precise mechanism of increased spontaneous Ca2+ release.  
5.4.3 Ca2+ overload  
Ca2+ can accumulate not only within the cytoplasm, but also within different structures, such as 
the SR and the mitochondria, which can lead to electrical and mechanical alterations in cardiac 
tissue. An elevated amount of Ca2+ in the SR makes the SR unstable, and this increased Ca2+ 
content results in a higher frequency of RyR opening until a Ca2+ wave is produced. This is 
thought to be the arrhythmogenic mechanism underlying digitalis intoxication (Cheng et al. 
1996). Many studies show that Ca2+ waves are linked to high SR Ca2+ content (Wier et al. 1997; 
Lukyanenko & Gyorke 1999; Berlin et al. 1989) and it has been shown to contribute to the 
formation of alternans (Díaz et al. 2004). In the ACTC E99K studies, SR load was determined 
using the application of caffeine in 0Ca2+ 0Na+ solution after pacing at 1Hz, and was found to be 
similar in TG and NTG cells. Therefore it is unlikely that SR Ca2+ overload is the primary 
mechanism causing increased spark and wave frequency.  
 
Wave frequency was observed to increase as stimulation frequency was increased, this could be 
attributed to the higher pacing rate allowing greater SR loading. The ACTC E99K mice displayed a 
negative contraction-frequency relationship, thought to be due to high resting SR content which 
has less capacity to increase with higher pacing rates. Incomplete recovery of the RyR during 
stimulation at higher frequencies would then result in a negative staircase. The higher wave 
frequency at higher pacing rates may occur due to increased SR filling with an already high SR 
Ca2+ content which may lead to SR instability and increased RyR opening. The greatest wave 
frequency at 5Hz is most physiologically relevant, considering the mouse heart rate of 600bpm. It 
is also important to take into account that in the isolated intact cell there is no effect of 
catecholamines so it is possible that SR overload may occur in vivo, especially during times of 
stress. It is possible that an alternative to increased luminal Ca2+ concentration is an altered 
threshold level in the TG mice which would allow increased RyR opening.  
5.4.4 Luminal threshold Ca2+ 
It is thought that Ca2+ release can arise spontaneously when the SR Ca2+ content reaches a 
certain threshold level, and this level can be reduced in disease due to mutations in the RyR 
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(such as in CPVT) (Kashimura et al. 2010) or by acquired alterations in RyR function that lead to 
enhanced activation of the channels by luminal Ca2+ (Györke & Terentyev 2008). Belevych et al 
used a canine model of post MI VF and SCD that showed increased propensity towards Ca2+ 
waves and DADs to test if waves occurred when luminal Ca2+ reached a critical level. The hearts 
in this model displayed abnormally high RyR activity but normal SERCA and NCX function. They 
found that the myocytes did exhibit a critical SR Ca2+ level, which was significantly lower in VF 
cells. However both control and VF myocytes did not produce Ca2+ waves as soon as SR Ca2+ 
recovered to its final baseline level but showed a distinct latency between threshold SR Ca2+ 
being reached and the onset of the diastolic wave. The waves also occurred after a shorter time 
delay after cessation of stimulation in the diseased cells (Belevych et al. 2012). This finding was 
observed with the ACTC E99K cells; the Kaplan-Meier survival curves for all four pacing rates 
showed that wave-free survival periods were much shorter in the TG cells. This could be 
attributed to a lower threshold level, faster refilling of the SR or a shorter time delay once the SR 
Ca2+ reached a steady state. The SERCA function measured in ACTC E99K TG cells was found to 
be the same as function in the NTG, therefore it is unlikely that rate of Ca2+ uptake into the SR is 
affecting latency period. A lower threshold SR Ca2+ required for Ca2+ release, may allow more 
frequent releases, which are smaller due to a lower SR content. This may account for the smaller 
wave amplitude in TG cells compared with NTG cells. 
 
Luminal Ca2+ dependent changes in RyR gating are involved in Ca2+ release termination and 
release refractoriness, which are essential processes for normal EC coupling. Belevych et al used 
a loading protocol to reduce the SR Ca2+ in control cells to the threshold level measured in VF 
cells and regardless of the lower threshold, they observed increased latency and fewer waves. 
This shows that Ca2+ waves do not arise purely due to the critical threshold SR Ca2+ level being 
reached but are associated with the failure of RyRs to remain closed or inactivated during 
diastole. Therefore, shorter time delay combined with lower threshold SR Ca2+ suggests reduced 
ability of the depleted diastolic SR Ca2+ to deactivate RyRs in VF myocytes. This alteration in the 
RyR refractory properties may be caused by excessive oxidation and CaMKII phosphorylation.  
5.4.5 Open probability of the RyR 
RyR open probability can be affected by several factors including phosphorylation of RyR, 
mutations within the RyR itself (usually in CPVT) and mutations or abnormal expression of the 
associated proteins calsequestrin, junctin and triadin (Györke & Terentyev 2008; Györke et al. 
2004). Venetucci et al investigated whether increasing RyR open probability alone could produce 
diastolic Ca2+ release. They observed Ca2+ waves during the first few stimuli after the addition of 
caffeine, however diastolic Ca2+ release in the steady state was not observed. Caffeine increases 
RyR open probability, thus lowering the threshold SR Ca2+ content at which waves occur. 
However, as a result of these waves, the SR loses Ca2+ and the SR Ca2+ content decreases to 
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below the threshold for Ca2+ waves. This shows that larger RyR leak per se due to increased RyR 
open probability is not necessarily arrhythmogenic. When caffeine was applied to cells in the 
presence of isoproterenol, a β-adrenergic agonist, spontaneous diastolic Ca2+ release was 
observed accompanied by an increased SR content (Venetucci et al. 2007).  
 
β-adrenergic agonist stimulation activates adenylyl cyclase, which in turn leads to cAMP 
production and PKA activation. PKA phosphorylates many proteins in cardiac muscle, including 
the LTCC, RyR, and phospholamban (PLB). PKA phosphorylation of PLB prevents its ability to 
inhibit SERCA, therefore SERCA function increases. This has been shown experimentally by Li et 
al, where PKA phosphorylation of PLB increased SR Ca2+ content and consequently increased 
spark frequency in mouse ventricular myocytes (Li 2002). It is important to note that β-adrenergic 
agonists such as isoproterenol can also have an effect on RyR as well as on SR content. In 
situations of chronic activation of β-adrenergic receptors such as in HF, PKA 
hyperphosphorylation at serine-2808 of RyR can cause depletion of FKBP12.6 from the receptor 
complex  (Marx et al. 2000). This destabilizes the closed state of the channel, sensitizing the RyR 
to cytosolic Ca2+, which can lead to diastolic SR Ca2+ leak. Expression of RyR phosphorylated at 
serine-2808 was found to be the same in E99K TG and control cells. This suggests that 
hyperphosphorylation at this specific site is not responsible for the increased diastolic Ca2+ leak. 
Studies using a mouse model in which PKA hyperphosphorylation of the RyR at serine-2808 is 
prevented demonstrated that phosphorylation at this site is irrelevant to the development of 
cardiac dysfunction after MI (Zhang et al. 2012). In 8-12 week old E99K animals, the level of 
phosphorylated RyR was lower in the TG cells compared with the NTG cells.  Thus, conflicting 
results are a consequence of differences in experimental methods, disease models and animal 
species. It is possible that phosphorylation at an alternative site, such as serine-2030, is 
enhanced in TG cells which may underlie the increased frequency of Ca2+ sparks.  
 
In addition to PKA activation, the sympathetic drive of the β-adrenergic system in HF can result in 
activation of CaMKII and down-regulation of protein phosphatases. This leads to increased RyR 
phosphorylation at serine-2814 in failing hearts (Huke & Bers 2008; Ai et al. 2005), which shifts 
the Ca2+ sensitivity of the RyR leading to increased Ca2+ release. In a rabbit model of HF, Curran 
et al observed that spontaneous Ca2+ waves in intact control and failing myocytes are strongly 
dependent on CaMKII activity, with a limited role of PKA activity. With the application of 
isoprenaline, the failing cells produced significantly more waves at a similar SR Ca2+ content 
(Curran et al. 2010) suggesting that when phosphorylated by CaMKII, the RyRs become 
increasingly sensitive to Ca2+ leading to increased probability of opening during the diastolic 
period. Therefore when cells have a similar SR Ca2+ content above the release threshold, those 
with more highly phosphorylated RyRs would exhibit more spontaneous Ca2+ release. Ca2+ 
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extrusion would be continued, until a lower steady-state level of Ca2+ was established, which 
would minimise spontaneous activity. This auto-regulation within the myocyte was shown by 
(Dibb et al., 2007).  
 
Increased activation of CaMKII has also been observed in HCM with corresponding increased 
phosphorylation of its targets (Coppini et al. 2013). Phosphorylation of RyR by CaMKII may be 
more likely to play a role in increasing the RyR sensitivity in E99K cells, thus contributing to the 
increased frequency of Ca2+ sparks and waves observed in ACTC E99K myocytes, without 
differences in the SR load.  
5.4.6 Compensatory stage of HF model shows increased frequency of Ca2+ 
waves 
Reduced Ca2+ transient amplitude, increased Ca2+ transient duration, prolonged Ca2+ transient 
decay time, and reduced SR Ca2+ load have been reported in HF, suggesting that a decrease in 
Ca2+ transient amplitude secondary to reduced SR Ca2+ content was responsible for the 
decreased contractility and reduced cardiac output in HF (Morgan et al. 1990; Marks 2013). 
Impaired SERCA function and enhanced NCX activity have been proposed as causes of reduced 
SR Ca2+ load in HF (Hobai & O‟Rourke 2001).  In contrast, cells isolated from 8 week MI rats 
display greater peak contraction amplitude than the AMC cells at 0.5Hz, 1Hz and 2Hz. This can 
be attributed to the greater peak Ca2+ transient amplitude observed in MI cells at all of the tested 
stimulation frequencies. Therefore at 8 weeks post MI the isolated cells are not characteristic of 
HF.  
 
In both groups, amplitude of contraction and the Ca2 transient were particularly increased at 
0.5Hz, which can be attributed to the long intervals between contractions (Redel et al., 2002). 
This effect is comparable to post-rest potentiation, a process suggested to reflect the amount of 
Ca2+ accumulated within and released from the SR (Bers 1985). From 1Hz to 5Hz, the 
shortening-frequency relationship was found to be slightly positive in AMC cells corresponding 
with an increase in Ca2+ transient amplitude as pacing rate was increased. This positive FFR 
relationship is caused by frequency-dependent loading of the SR with Ca2+, allowing enhanced 
cardiac performance during stress or exercise (Layland & Kentish 1999). The MI cells however 
show a flat shortening-frequency relationship; this is a commonly observed phenomenon in 
human and rodent HF, indicating that the ability of the failing hearts to potentiate their 
contractility in response to increases in heart rate is impaired (Endoh 2004). For example, in 
perfused rat heart, a positive FFR was observed over a frequency range of 3 to 5 Hz which 
flattened after HF (Narayan et al., 1995). As this rat model displays compensated HF 8 weeks 
post-MI, the FFR may become more negative as HF progresses. However, the corresponding Ca2+ 
transient amplitude increases with increasing stimulation, indicating preserved Ca2+ regulation. 
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Lamberts et al have shown frequency-dependent myofilament Ca2+ desensitization in failing rat 
myocardium through increased TnI phosphorylation, contributes to the negative force-frequency 
relation (Lamberts et al. 2007). It is possible therefore that the flat FFR is due to changes in the 
myofilament properties. 
 
Although the surgically-induced MI model of HF is a different disease modelled in a different 
species, all of these changes were observed in the ACTC E99K cells. This suggests that both the 
E99K TG mouse at 25-40 days old and the 8-week post MI rat model display a compensated 
form of their respective disease. It is possible that this gain of function indicated by increased 
cellular contractile amplitude is due to hypertrophy, which is shown in both models by a 
substantial increase in cardiac mass relative to body mass. Cardiac hypertrophy is associated 
with profound remodelling of Ca2+ signalling pathways. Many studies have shown that CaMKII 
activity is increased in hypertrophied myocardium from animal models and patients. The most 
characterized CaMKII mediated hypertrophic pathway is through the phosphorylation of class II 
HDACs, relieving and de-repressing MEF-2 mediated gene expression (Anderson et al. 2011). 
This signalling may therefore be involved in the compensated 8 week MI rat heart and the E99K 
TG heart, which displays increasing hypertrophy as the disease progresses.  
 
Due to the similarities in cellular properties between 8 week MI cells and ACTC E99K cells, there 
may be common mechanisms involved with spontaneous Ca2+ release. Diastolic SR Ca2+ leak has 
been recognized as an important contributor to altered Ca2+ handling in HF, and consistent with 
this finding, wave frequency was found to be greater in the MI cells compared with AMC cells 
after stimulation at 2Hz. The wave-free survival period was also reduced in cells isolated from MI 
than AMC rats at 0.5Hz, 1Hz and 2Hz. Patients with HF show a chronic hyperadrenergic state 
associated with increased RyR-mediated Ca2+ leak. Ca2+ leak reduces SR Ca2+ stores and 
activates the transient inward current that causes DADs (Lehnart et al., 2006; Wehrens et al., 
2003).  
5.4.6.1 Structural remodelling  
The Ca2+ wave experiments in rat MI cells have been included in a paper (Sikkel et al, 
unpublished) which has shown that spark frequency is increased in areas of preserved T-tubule 
organisation in HF. It has been proposed that the organised regions may be responsible for the 
origin of waves, which also occur more frequently in the MI cells. This may be due to an increased 
threshold for spontaneous Ca-2+ release in regions of disturbed T-tubules but with preserved SR 
Ca2+ uptake. If intra-SR diffusion of Ca2+ can occur between detubulated and tubulated regions, 
then increased Ca2+ release would occur in the tubulated region to compensate for the continued 
uptake and reduced release in the detubulated region. A greater proportion of detubulated 
regions in HF might result in the increase in spark frequency. 
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The spatial organization of the Ca2+ release units (CRU) may change in disease and affect the 
likelihood that a Ca2+ spark at one CRU will trigger a Ca2+ spark at a neighbouring CRU. Litwin et 
al observed that in HF myocytes, depolarisation activates a reduced Ca2+ current, but the Ca2+ 
sparks are not synchronised with the depolarisation (Litwin et al. 2000). It has been suggested 
that this dyssynchronisation arises from depletion of T-tubules in HF cells (Balijepalli et al. 2003; 
Louch et al. 2004). Song et al showed that T-tubules in spontaneously hypertensive rat cells 
become increasingly disorganised, while the CRUs and RyR clusters associated with the SR 
remain in place (Song et al., 2006). This increases the separation between the triggering Ca2+ 
current and the RyR, with these orphaned RyRs appearing to be responsible for the 
dyssynchronous Ca2+ sparks. Structural remodelling of this nature is also observed in HCM 
hearts. Reduced T-tubule density has also been observed in cells from human HCM myocytes 
(Coppini et al. 2013; Lyon et al. 2009), suggesting this is another relevant factor which could 
influence the increased diastolic release in ACTC E99K cells.  
5.4.7 Abnormal Ca2+ release can cause potentially fatal arrhythmias 
Previously published studies show that the ACTC E99K TG animals are predisposed to 
arrhythmias (Song et al., 2011).  Chapter 6 further studies the arrhythmias by using whole heart 
electrode array and in vivo ECG recordings before, during and after intravenous isoprenaline 
infusion. These show that young ACTC E99K mice experienced more arrhythmias than the NTG 
mice during adrenergic stimulation. The underlying cause may be linked to the increased 
spontaneous Ca2+ release at the cellular level.  
 
Diastolic Ca2+ waves are considered to be the basis of triggered arrhythmias (Ter Keurs & Boyden 
2007) but the potential for Ca2+ waves within an individual cardiac cell to cause a whole heart 
arrhythmia is unlikely. Therefore, it is important to determine the mechanism by which 
spontaneous Ca2+ release within single myocytes become sufficiently synchronized in both time 
and space to produce enough depolarization to reach voltage threshold. Belevych et al suggested 
that reduced refractoriness of Ca2+ signalling combined with uniform refilling of the SR after 
systolic SR Ca2+ release could provide a mechanism for temporal alignment of waves in multiple 
myocytes (Belevych et al. 2012). Refilling of the SR Ca2+ store has also been shown to contribute 
to synchronization of Ca2+waves and DADs in cardiac muscle during triggered activity induced by 
Ca2+overload (Wasserstrom et al. 2010).  Synchronicity of spontaneous Ca2+ release in multiple 
myocytes may be necessary for triggered activity and arrhythmias.  
 
Cardiac AP repolarization is considered to be linked with intracellular Ca2+, as changes in AP 
profile can influence ICa,L, intracellular Ca2+ transients and the triggering of Ca2+ sparks (Bridge, 
Ershler, & Cannell, 1999; Sah et al., 2001). However, Camors et al have shown that mice display 
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EADs, DADs and extrasysoles during β-adrenergic stimulation but without changes in APD, inward 
Ca2+ current and diastolic Ca2+  (Camors et al. 2012).  In HF and hypertrophy, the ventricular AP 
is often prolonged due to less repolarising K+ current (Lebeche et al. 2006; Näbauer 1998), and 
this prolongation tends to promote Ca2+ loading and Ca2+ spark release (Terracciano et al. 1997). 
Prolonged AP durations and elevated intracellular Ca2+ are also recognized mechanisms for late 
EADs (January & Moscucci 1992). EADs which develop due to prolonged APs are usually 
attributed to reactivation of inward ICa,L late in the AP (Zeng & Rudy 1995), however they can also 
be affected by Ca2+ sparks and Ca2+ waves (Berlin et al. 1989).  
 
Increased myofilament Ca2+ sensitivity is frequently found in HCM and may be associated with 
prolongation of the AP. Schober et al observed pause-dependent AP prolongation, EADs and 
triggered activity in cells isolated from FHC-linked TnT mutant mice, which also displayed 
enhanced myofilament sensitivity with a proportional increase in cytosolic Ca2+ binding (Schober 
et al. 2012). Ca2+ sensitization of myofilaments may promote afterdepolarisations and triggered 
arrhythmias and the degree of Ca2+ sensitization appears to be linked to the inducibility of 
arrhythmia in mouse models (Baudenbacher et al. 2008). Altered cytoplasmic Ca2+ buffering is 
hypothesised to alter the Ca2+ transient size and kinetics, as well as increase the level of 
cytosolic Ca2+ during diastole. All of these changes have been found in cardiomyocytes isolated 
from patients with HCM, in addition to prolonged AP related to increased late Na+ and Ca2+ 
currents and decreased repolarizing K+ currents (Coppini et al. 2013). As intracellular Ca2+ 
regulates membrane currents and directly alters the membrane potential via the electrogenic 
NCX, AP prolongation may occur which can cause afterdepolarizations and triggered activity. 
Although AP has not been measured in this E99K study, it is possible that it could be a 
contributor to the potentially fatal arrhythmias observed, acting as a triggering mechanism when 
combined with structural remodelling of the heart. The cells isolated from old ACTC E99K animals 
displayed the reduced Ca2+ transient amplitude and slower decay expected in a model of HCM 
with increased myofilament sensitivity; therefore knock-on effects to APD are possible.  It would 
be useful to measure APs simultaneously with Ca2+ fluxes to detect whether cellular DADs occur 
which correspond to diastolic Ca2+ release.  
 
It is important to take into account gross structural remodelling which can be involved in 
increasing the occurrence of re-entrant arrhythmias. Arrhythmias in patients with HCM are 
commonly attributed to increased left ventricular muscle mass, myocyte disarray or fibrosis, with 
both interstitial and replacement fibrosis commonly occurring in HCM (Ashrafian et al. 2011). 
Replacement fibrosis occurs when premature death of mutant myocytes occurs, which allows the 
cardiac fibroblasts and extracellular matrix to increase. This focal fibrosis can contribute to the 
distortion of myocardial cell architecture (Seidman & Seidman 2001). Electron microscopy has 
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showed myocyte disarray without fibrosis in the 4 week old ACTC E99K mouse hearts 
(unpublished); therefore the mechanism of re-entry arrhythmia formation cannot be disregarded. 
Microvascular ischemia is also considered a risk factor in patients with HCM because it impairs 
systolic and diastolic function, and promotes the occurrence of arrhythmias (Petersen et al. 
2007). Defects in cellular energetics have also been proposed to contribute to the 
arrhythmogenesis and the LV dysfunction of HCM (Ashrafian et al. 2003). Published studies 
using papillary muscle have demonstrated reduced work efficiency in ACTC E99K muscle but the 
link to arrhythmia susceptibility has not yet been made.  
5.4.8 Overview  
ACTC E99K TG cells display increased frequency of Ca2+ sparks and waves, by a mechanism 
which is not mediated by either Ca2+ overload or PKA phosphorylation of RyR at serine-2808. It is 
possible that the increased spontaneous Ca2+ release can lead to DADs which result in the 
arrhythmias observed in vivo. This proposed mechanism of increased diastolic release underlying 
the increased likelihood of arrhythmias may be the sole cause or may be one of many 
contributing factors.  
 
It would be useful to use the same approach as Baudenbacher et al (described in the 
introduction) to determine whether the underlying increased myofilament sensitivity is linked to 
the increased spontaneous Ca2+ release. The experiments described in the Methods section 
could be repeated with the addition of EMD and blebbistatin perfusion to detect changes in spark 
and wave frequency with changes in myofilament sensitivity. This would support the hypothesis 
that Ca2+ sensitivity is the underlying cause of the altered Ca2+ handling. 
 
It is necessary to link these cellular changes in Ca2+ release to arrhythmias in the whole heart.  
Further experiments would be required to fully elucidate the mechanism for increased 
arrhythmias and higher propensity for SCD in the ACTC E99K HCM mouse model.  
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Chapter 6: Arrhythmogenic 
potential of the ACTC E99K 
heart 
 
In this Chapter, the arrhythmogenicity of ACTC E99K hearts from 3-5 month old and 25-
45 days old animals are examined. Multi-electrode arrays were used to record epicardial 
field potentials while the heart was Langendorff perfused. ECGs were recorded to assess 
myocardial electrical activity in the anaesthetised mouse. These two techniques allow 
many aspects of heart rhythm to be determined. These experiments test the hypothesis 
that the TG mice have a propensity for arrhythmias that may cause sudden cardiac 
death.   
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6.1 Introduction 
 
Patients with HCM can exhibit a range of abnormalities in heart rhythm, including atrial fibrillation 
(AF), atrial flutter, ectopic beats, ventricular tachycardia (VT), and ventricular fibrillation (VF). AF, 
commonly observed in HCM patients, is a disorder of heart rhythm that produces rapid and 
erratic atrial excitation that causes the atria to contract quickly and irregularly. VT is also 
associated with HCM and is a rapid ventricular rhythm usually defined as three or more 
ventricular extrasystoles in succession at a HR of more than 120 beats per minute. Sustained VT 
can lead to the absence of a pulse, loss of consciousness, hypotension and possibly death. VF is 
caused by ventricular muscle fibres contracting randomly due to chaotic excitation which brings 
about complete failure of ventricular function. It leads quickly to cardiac arrest and SCD.  
 
HCM is associated with SCD due to arrhythmias especially in young adults, with the overall risk 
being <1% per year (Maron 2002a). Although hypertrophy and SCD are both caused by HCM 
mutations, the connection between them is unclear. SCD in HCM is caused mainly by ventricular 
arrhythmias, primarily ventricular fibrillation, which can be effectively treated by implantable 
cardioverter defibrillator therapy. Electrograms have shown that the majority of ventricular 
arrhythmias occur while in normal sinus rhythm and are precipitated by premature ventricular 
complexes (O‟Mahony et al. 2012). ECG data collected by chance have shown that VF can be 
triggered by episodes of VT, rapid AF or accelerated atrioventricular conduction (Elliott et al. 
1999; Stafford et al. 1986; Krikler et al. 1980). 
 
There are several potential mechanisms for ventricular arrhythmias. Fibrosis and myocyte 
disarray can increase the dispersion of conduction by providing alternative pathways which 
promote the formation of re-entrant arrhythmias (Janse & Bakker 2001). The conduction of AP 
between cardiomyocytes can be disturbed by disruption of intercalated discs (Sepp et al. 1996). 
Finally, the most relevant mechanism for this study involves changes to the Ca2+ sensitivity of the 
myofilament. Myofilament sensitisation has been shown to cause AP triangulation, shorter 
effective refractory periods and beat-to-beat APD variability. Together, these changes can 
increase dispersion of conduction velocity, thereby generating a substrate for re-entry 
(Baudenbacher et al. 2008).  
 
The ECG is often used to evaluate the presence of HCM. The procedure can detect heart rhythm 
abnormalities as well as underlying hypertrophy. In humans, the ECG may show altered 
components such as prominent Q waves and ST wave abnormalities, which may be the first 
indication of potential ventricular hypertrophy. ECG traces from the patient population carrying 
the ACTC E99K mutation have been recorded. Abnormalities in the ECG were observed in 53 of 
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61 carriers, with atrial fibrillation or flutter being found in 7/53, indicating that patients carrying 
the ACTC E99K mutation are highly predisposed to arrhythmias.  Eight SCDs have been reported, 
with five occurring within a single family (Monserrat et al. 2007). 
 
The ECGs of ACTC E99K mice have also been investigated during the later stages of the disease. 
The animals were injected with a bolus of isoprenaline, a β-adenenergic agonist which promotes 
the occurrence of arrhythmias by increasing intracellular Ca2+, activating CamKII (Wu 2002) and 
leading to afterdepolarisations (Priori & Corr 1990; De Ferrari et al. 1995). Heart rhythm was 
recorded using lead II ECG, which measures the voltage between the right fore-limb and the left 
hind limb, producing a predominantly positive QRS complex. In 21 week old male ACTC E99K 
mice, no significant arrhythmias were observed. Deep S wave and double S waves were observed 
in some ACTC E99K mice, which is an indicator of intraventricular conduction abnormalities as 
the normal S wave represents the final depolarisation of the ventricles at the base of the heart. 
One mouse displayed negative T waves; as the T wave signifies ventricular repolarisation, this 
suggests an alteration in ventricular repolarisation. However, T wave flattening occurred in the 
majority of ACTC E99K mice which prevented the measurements of QT intervals. At 29 weeks old, 
ECG recordings showed frequent episodes of atrial ectopic fibrillation in 7/8 male and 2/5 
female TG mice. Atrial flutter was also present in 2/8 male and 1/5 female ACTC E99K mice. The 
T wave was identifiable in most 29 week old ACTC E99K mice, but corrected QT interval was not 
found to be different from controls (Song et al. 2011). 
 
The surviving ACTC E99K mice showed ECG abnormalities, which suggests that the mutation per 
se may induce arrhythmias while SCD may depend upon additional factors. It is likely that the 
increased probability of arrhythmia in these mice is linked to increased myofibrillar 
Ca2+ sensitivity but the underlying mechanisms are unknown. In the previous chapters, 
alterations in Ca2+ homeostasis have been observed with corresponding changes to the Ca2+ 
transient. Changes to the size and duration of the Ca2+ transient have been hypothesised to 
influence the shape and duration of the AP. If a subset of myocardial cells had changes to their 
Ca2+ transient morphology, this might translate to those cells having different APDs than the cells 
surrounding them. In turn, this could increase the variability of APD in the whole heart and 
increase dispersion of conduction velocities. Differences in conduction velocities are thought to 
create an arrhythmogenic substrate. Although the cellular AP has not been measured in the 
present work, the flexible MEA provides a useful alternative, recording extracellular field 
potentials when it is placed against the beating heart tissue. The MEA observations from hearts 
in vitro can then be compared with the ECG recordings of the electrical activity of the heart in 
vivo. By recording the ECG in young animals, we can determine whether increased Ca2+ sensitivity 
increases propensity for arrhythmias before the changes associated with later stages of HCM 
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have developed. However, to evaluate the role of Ca2+ handling alterations in arrhythmogenesis, 
it is important to determine whether hypertrophy has developed, as structural remodelling is 
known to affect arrhythmia formation. This can be achieved by measuring the HW/BW ratio, 
which allows the heart weight to be normalised to the body weight, and is often used as an 
indicator of hypertrophic growth (Liao et al. 2005).  
 
Aims 
 To record and compare field potential measurements using a flexible multi-electrode 
array in TG and NTG hearts 
 To record and compare ECG measurements in anaesthetised TG and NTG animals 
 Measurement and comparison of heart weights and body weights 
 
 
6.2 Materials and methods 
6.2.1 MEA 
Hearts were excised from both male and female animals aged 13-22 weeks old (3-5months) and 
25-45 days old. Following cannulation of the aortae, the hearts were perfused with NT containing 
1mM Ca2+ at 37ºC using the Langendorff apparatus (as for isolation of cardiac myocytes 
Methods Section 2.2). For each heart, recordings were made using the protocol in Section 2.6.2. 
The following parameters were analysed using the MEA recordings: 
 Baseline heart rate (HR) 
 Percentage increase in HR with isoprenaline 
 QT interval 
 Corrected QT interval (see below) 
 Arrhythmias 
 
Corrected QT interval: For each MEA recording taken at the base of the heart, QT interval was 
measured manually from an average of 6 individual field potential waveforms. The QT interval is 
measured as the time between the peak of the minimum part of the waveform corresponding to 
the Q wave and the end of last part of the waveform corresponding to the T wave designated as 
the point at which it returns to the isoelectric baseline (see Figure 6.1).  QT interval is dependent 
on the HR, therefore it is important to correct for HR to allow determination of disease induced 
differences in QT interval. In patients, Bazett‟s formula is used:  
 
    
  
√  
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However, when using Bazett‟s formula, the corrected QT was not within expected range for mice 
and often was a higher value than the RR interval. Mitchell et al modified the standard equation 
to account for the high resting HR in mice (Mitchell et al. 2013). By using this alternative formula, 
the corrected QT values were within the physiological range of the QT interval in the mouse:  
 
    
  
(
  
   )
  ⁄
 
 
6.2.2 ECG 
Baseline ECG was measured on both 8-12 week old and 25-40 day old animals using the 
protocol described in Methods Section 2.7.1. A two minute section of the baseline ECG was 
selected and the complexes recorded during this period were averaged using LabChart. 
Isoprenaline was injected into animals aged 25-40 days old and ECG recordings were made (as 
described in Section 2.7.2). The ECG recordings and IV injections were performed by Ross 
Wilkinson, Imperial College London. Each ECG recording was examined to manually identify 
arrhythmias. The following parameters were analysed:  
 Baseline HR 
 Amplitude of P, R and T wave 
 QRS 
 QT interval  
 Corrected QT interval 
 Percentage increase in HR with isoprenaline 
 Arrhythmias 
 
Arrhythmia scores have been used to facilitate the quantification of arrhythmias. Curtis and 
Walker examined seven scoring systems to validate the use of arrhythmia scores, and a strong 
positive correlation was present between all seven scores. These scoring systems take into 
account the incidences of VF, VT and ventricular premature beats in early myocardial ischaemia 
(Curtis & Walker 1988). Due to the low incidence of ventricular arrhythmias in the E99K mice, it 
was necessary to include a score for absence of arrhythmias, and the most appropriate 
published arrhythmia scoring system is shown in Table 6.1A (Miller et al. 2012). However, this 
published system does not take into account the less severe arrhythmogenic events which were 
identified in the E99K ECGs. Thus, to quantify arrhythmias in E99K animals, a scoring system 
was specifically designed for the results observed in the mouse ECG experiments. If multiple 
events were identified, the highest score was given.  
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A 
 
Scoring system C (Miller et al. 2012) 
 
 
0 
 
No premature ventricular contractions, VT or VF 
 
1 Premature ventricular contractions 
 
2 1-5 episodes of VT 
 
3 >5 episodes of VT or 1 episode of VF or both 
 
4 2-5 episodes of VF 
 
5 >5 episodes of non-spontaneous converting VF 
 
 
 
 
 
 
B 
 
Adapted arrhythmia scoring system  
 
 
0 
 
No abnormal events 
 
1 Sinus arrhythmia 
 
2 Missing P/R/S wave, Reduced QRS amplitude 
 
3 Increased HRV 
 
4 Heart block 
 
5 Fatal VF 
 
 
Table 6.1 Arrhythmia scoring systems 
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6.2.3 Heart weight and body weight 
The bodies and hearts were weighed as described in Methods section 2.1.3. HW/BW ratio was 
calculated using the following formula: 
 
HW/BW ratio = heart weight/body weight 
 
6.2.4 Statistical analysis 
MEA: A two-way ANOVA was used to determine the interaction of the two independent variables 
(genotype and gender) and their individual effect on the MEA parameters. Arrhythmias recorded 
from the MEA were assessed using the Fisher‟s exact test. Due to low n numbers, male and 
female results were combined to allow comparison of arrhythmia occurrence in TG and NTG.  
 
ECG and HW/BW ratio: Student‟s T-tests were used to compare results from TG with NTG groups. 
The effect of gender was not evaluated because the in vivo studies used whole animals as the n 
number, thus making population size too small to carry out a robust two-way ANOVA which would 
take into account both gender and genotype.  
  
173 
 
6.3 Results 
 
6.3.1 MEA 
Figure 6.1 shows a representative MEA recording from the surface of a 4 month old NTG mouse 
heart, which illustrates how R-R intervals (to calculate HR) and QT intervals were measured. 
Table 6.2 shows that baseline HR, isoprenaline induced percentage increase in HR and QTc in old 
mice were not affected by genotype or gender. There was also no interaction between gender 
and genotype for any of these measurements. Examination of the post hoc tests revealed no 
differences between any of the groups, for all three parameters displayed in Figures 6.2A, C and 
E.  
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Figure 6.1 Representative MEA recording of sinus rhythm. Trace labelled with R-R interval (used 
to calculate heart rate) and QT interval 
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 Gender Genotype Interaction 
Baseline HR (BPM) ns ns ns 
Iso induced increase in HR (%) ns ns ns 
QTC (ms) ns ns ns 
 
Table 6.2 The effect of gender and genotype (3-5month old mice) on HR measurements 
 
Table 6.3 shows that baseline HR, isoprenaline induced percentage increase in HR and QTC in 
young mice were also not affected by genotype or gender. There was also no interaction between 
gender and genotype for any of these measurements. Further examination of the post hoc tests 
for each parameter revealed no differences between any of the groups, as displayed in Figure 
6.2B, D and F. 
 
 
 Gender Genotype Interaction 
Baseline HR (BPM) ns ns ns 
Iso induced increase in HR (%) ns ns ns 
QTC (ms) ns ns ns 
 
Table 6.3 The effect of gender and genotype (25-45 day old mice) on HR measurements 
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Figure 6.2 Heart rate measurements in E99K hearts from 8-12 week and 25-40 day old animals. 
Data are presented as mean ± SEM; n = 12 NTG hearts and 12 TG hearts (A) Baseline HR in 8-12 
week old animals (B) Baseline HR in 25-40 day old animals (C) Isoprenaline induced % increase 
in HR in 8-12 week old animals (D) Isoprenaline induced % increase in HR in 25-40 day old 
animals (E) QTc in 8-12 week old animals (F) QTc in 25-40 day old animals 
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Table 6.4 shows that there was also no interaction between age and genotype for any of these 
measurements. However, when the male and female groups are combined, genotype has a 
significant effect on baseline HR and isoprenaline induced percentage increase in HR.  There is 
also a significant effect of age on QTC within both the NTG and TG groups.  Further examination of 
the post hoc tests for each parameter revealed no differences between any of the groups, as 
displayed in Figure 6.3.  
 
 Age Genotype Interaction 
Baseline HR (BPM) ns * ns 
Iso induced increase in HR (%) ns * ns 
QTC (ms) ** ns ns 
 
Table 6.4 The effect of age and genotype on heart rate measurements 
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Figure 6.3 Effect of age on heart rate measurements in E99K hearts. Data are presented as 
mean ± SEM; n = 12 NTG hearts and 12 TG hearts (A) Baseline HR (B) Isoprenaline induced % 
increase in HR (C) QTc in old animals  
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Table 6.5 and 6.6 shows occurrence of potentially arrhythmogenic events in hearts from old and 
young mice respectively, categorised into two groups; increased heart rate variability (HRV) and 
isolated events. HRV was considered increased when R-R interval varied consistently by 10-30ms 
throughout the recording. When increased HRV was observed, it was consistent throughout the 
30 second recording and did not trigger subsequent arrhythmias. An event was recorded when 
the R-R interval deviated from the mean by >30ms before returning to regular rhythm. The 
isolated events were sinus arrhythmias, and no severe arrhythmias such as VF or VT were 
observed. All the hearts which displayed at least one arrhythmia, returned to regular rhythm after 
the isolated events. Hearts from both young and old animals showed a low incidence of sporadic 
sinus arrhythmia and HRV. In hearts from young mice, the occurrence of HRV was affected by 
genotype but only when measured at the base of the heart and perfused with NT (p<0.05). TG 
and NTG hearts displayed a similar low level of irregular activity, when the MEA was positioned at 
both the apex and base of the heart. In all of the groups, isoprenaline did not lead to increased 
abnormal activity. 
 
 
 
 
Category 
 
NTG female 
 
 
TG female 
 
NTG male 
 
TG male 
Apex + NT Increased HRV 
 
1 1 1 2 
No. abnormal 
events  
0 1 (1) 2 (2) 10 (1) 
Apex + 
Isoprenaline 
Increased HRV 
  
1 1 0 1 
No. abnormal 
events 
0 0 0 1 (1) 
Base + NT Increased HRV 
  
1 0 1 2 
No. abnormal 
events 
1 (1) 0 2 (2) 3 (1) 
Base + 
Isoprenaline 
Increased HRV 
  
0 2 1 0 
No. abnormal 
events 
0 11 (1) 1 (1) 4 (1) 
 n (hearts) 6 6 6 6 
  
Table 6.5 Arrhythmogenic events in hearts from old mice. Increased HRV displayed as number of 
hearts. The number of hearts which displayed abnormal events is shown in brackets.  
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Category 
 
NTG female 
 
 
TG female 
 
NTG male 
 
TG male 
Apex + NT Increased HRV  
 
1 1 1 2 
No. abnormal 
events 
2 (2) 0 0 0 
Apex + 
Isoprenaline 
Increased HRV 
  
1 0 0 1 
No. abnormal 
events 
2 (1) 1 (1) 1 (1) 0 
Base + NT Increased HRV1  
 
0 2 0 3 
No. abnormal 
events 
5 (3) 2 (1) 0 0 
Base + 
Isoprenaline 
Increased HRV  
 
1 1 0 1 
No. abnormal 
events 
0 0 0 2 (1) 
 n (hearts) 6 6 6 6 
 
Table 6.6 Arrhythmogenic events in hearts from young mice. Increased HRV displayed as number 
of hearts. The number of hearts which displayed abnormal events is shown in brackets. 1Fisher‟s 
exact test p<0.05.  
 
 
6.3.2 ECG 
Figure 6.4C-D shows representative HR traces from an NTG and TG animal, calculated from the 
ECG recordings by LabChart in real time. These clearly display the different effects of 
isoprenaline on the HR between the two groups. The representative ECG trace displaying sinus 
rhythm clearly shows defined P waves, QRS complex and the T wave joined onto the end of the 
QRS complex (Figure 6.4A). The examples of arrhythmias (sinus arrhythmia, heart block, VF 
shown in Figures 6.4B,E and F respectively) demonstrate the changes to the ECG when an 
abnormal event occurs, and how it coincides with a change in HR.  
 
Table 6.7 shows that no severe arrhythmias, such as heart block or VF, occurred during baseline 
conditions. The sporadic occurrence of sinus arrhythmias, reduced QRS amplitude and missing P 
waves were isolated events and did not have any lasting effect on the ECG or HR. There were no 
differences in arrhythmia score between NTG and TG animals for both age groups. In contrast, 
many forms of arrhythmia were observed in young animals after the infusion of 2.5mg/kg 
isoprenaline (Table 6.8), but there was no difference in arrhythmia score between TG and control 
animals (p=0.07). However, the more severe arrhythmias, including heart block and VF, were 
observed in TG but not in NTG animals. Increased HRV also occurred more frequently in TG 
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animals than in their control littermates. NTG animals displayed 100% survival rate, whereas one 
TG animal died several minutes after IV isoprenaline injection.  
 
 
 
Age group 
 
Arrhythmogenic event 
 
 
NTG 
 
TG 
8-12 weeks old Sinus arrhythmia 1 3 
Reduced QRS amplitude 0 1 
Arrhythmia score 0.3 ± 0.3 1.3 ± 0.3 
25-40 days old Sinus arrhythmia 2  3 
Missing p wave 0 1 
Arrhythmia score 0.3 ± 0.2 0.5 ± 0.3 
 
Table 6.7 Number of animals which displayed arrhythmogenic events in baseline ECG recordings. 
Arrhythmia score ± SEM. 8-12 week old animals: n = 3 NTG, 3 TG. 25-40 days old animals: n = 6 
NTG, 8 TG.  
 
 
 
 
Arrhythmogenic event 
 
 
NTG 
 
TG 
Sinus arrhythmia 5 3 
Missing P wave 2 3 
Reduced/missing R wave amplitude 1 2 
Missing S wave 1 0 
Reduced QRS amplitude 1 1 
Increased HRV 1 3 
Heart block 0 2 
Fatal VF 0 1 
Arrhythmia score 1.7 ± 0.4 2.9 ± 0.4 
 
Table 6.8 Number of animals which displayed isoprenaline induced arrhythmogenic events in 25-
40 day old ACTC E99K mice. Arrhythmia score ± SEM. n = 6 NTG animals, 8 TG animals.  
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Figure 6.4 Representative ECG traces from E99K TG and NTG animals (A) Representative sinus 
rhythm (B) Example of sinus arrhythmia due to breathing (C) Representative heart rate recording 
in NTG animal (D) Representative heart rate recording in TG animal (E) Example of heart block (F) 
Example of ventricular fibrillation (G) Lack of electrical activity  
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Table 6.9 shows that baseline HR was slower in mature TG animals compared with NTG animals. 
QRS, QT and QTC intervals were similar between the two groups. P and R wave amplitudes also 
were not different between NTG and TG animals. The T wave amplitude was lower in TG animals, 
which may be due to 1/3 animals displaying a negative T wave.  
 
 
 
ECG Parameters 
 
NTG 
 
TG 
 
Baseline HR (BPM) 573 ± 18 
 
521 ± 31 
 
QRS (ms) 11 ± 0.4 
 
11 ± 0.9 
QT interval (ms) 17 ± 1 19 ± 2 
 
QTC (ms) 17 ± 1 
 
18 ± 2 
 
P wave amplitude (mV) 0.11 ± 0.03 
 
0.08± 0.01 
 
R wave amplitude (mV) 1.33 ± 0.01 
 
1.24 ±0.07 
 
T wave amplitude (mV) 0.32 ± 0.02 
 
0.035 ± 0.062 
 
n (animals) 3 3 
 
 
Table 6.9 Baseline ECG parameters in 8-12 week old mice. 1 Baseline HR lower in TG animals 
compared with NTG animals, p<0.05. 2 T wave amplitude lower in TG than NTG, p<0.05.  
 
 
Table 6.10 shows that there were no differences in baseline HR, QRS interval and P wave 
amplitude between young TG animals compared with NTG animals. QT interval and QTC (Figure 
6.5A) were prolonged in TG animals when compared with their NTG littermates. The R wave and T 
wave amplitudes were smaller in TG animals than in the NTG group.  4/8 young TG animals 
displayed a negative T wave, contributing to the significantly lower T wave amplitude. Figure 6.5B 
shows that the 2.5mg/kg isoprenaline injection caused a greater percentage increase in HR in 
the NTG animals than in the TG animals. The ECG parameters after the isoprenaline injection 
were not included as the T waves were not clearly identifiable.  
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ECG parameters 
 
 
NTG 
 
TG 
Baseline HR (BPM) 494 ± 25 
 
516 ± 22 
QRS (ms) 9 ± 1 
 
10 ± 1 
QT interval (ms) 22 ± 1 
 
26 ± 11 
QTC (ms) 20 ± 1 
 
24 ± 12 
P wave amplitude (mV) 0.14 ± 0.01 
 
0.18 ± 0.01 
R wave amplitude (mV) 1.44 ± 0.04 
 
1.14 ± 0.073 
T wave amplitude (mV) 0.27 ± 0.04 
 
-0.09 ± 0.094 
n (animals) 6 8 
 
Table 6.10 Baseline ECG parameters in 25-40 day old mice. 1QT interval and 2QTc longer in TG 
animals than in NTG animals, p<0.05. 3R wave amplitude and 4T wave amplitude lower in TG 
compared with NTG animals. 
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Figure 6.5 Parameters derived from ECG in young E99K animals. Data are presented as mean ± 
SEM; n = 6 NTG animals and 8 TG animals (A) Corrected QT interval (B) Isoprenaline induced % 
increase in heart rate 
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6.3.3 Heart weight/Body weight ratio 
Table 6.1 shows that the old TG mice displayed a larger heart weight than their NTG counterparts 
(p<0.001). There were no differences in body weight when comparing TG with NTG mice, at both 
age groups. Heart weight to body weight ratio was greater in the TG animals of both age groups 
when compared to their NTG littermates (p<0.001), as displayed by Figure 6.6. 
 
 
 Heart weight (mg) Body weight (g) 
Old NTG 109.1 ± 3.8 25.5 ± 1.0 
Old TG 135.4 ± 5.5 1 26.0 ± 1.0 
Young NTG 91.97 ± 3.1 19.7 ± 0.6 
Young TG 100.2 ± 6.2 17.8 ± 1.1 
 
Table 6.11 Heart weights and body weights. 1TG heart weight in old animals was greater than 
NTG, p<0.001 
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Figure 6.6 Heart weight/body weight ratios from E99K TG and NTG animals. Data are presented 
as mean ± SEM (A) 25-40 day old mice; n = 15 NTG animals, 16 TG animals (B) 8-12 week old 
mice; n = 21 NTG animals, 18 TG animals 
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6.4 Discussion 
6.4.1 ACTC E99K animals have increased HW/BW ratio from 4 weeks old 
In previously published data using mice at 29 and 38 weeks old, ACTC E99K mice show body 
weight loss, and the hearts were enlarged compared with their littermates with a significantly 
increased heart/body weight ratio. At this late stage of the disease, the body weight loss is 
associated with diastolic dysfunction and progression to HF. Hypertrophy evaluated using the 
HW/BW ratio correlates with supporting functional studies. At 29 weeks old, the increased 
HW/BW ratio observed is associated with increased wall thickness and reduced end diastolic 
volume, measured in vivo using echocardiography and conductance catheter. In humans, 
increased cardiac mass is also associated with left ventricular wall thickening, which is often 
asymmetric and shows particular involvement of the interventricular septum. Therefore, the 
HW/BW ratio measurement appears to be a valuable indicator of hypertrophy in this model. 
 
At 25-40 days old, there were no differences in either body weight or heart weight between 
control and E99K animals; however E99K animals displayed a 22% greater HW/BW ratio. This 
indicates enlargement of the heart from as early as 4 weeks old. At 8-12 weeks old, mean body 
mass was similar between E99K and control animals but heart weights were greater in the TG, 
thus producing an increased HW/BW ratio. The presence of greater heart mass as well as an 
increased ratio is indicative of further hypertrophic growth. In HCM patients, hypertrophy usually 
develops during adolescence, where it may increase dramatically until the end of this accelerated 
growth phase. The period of SCD in the mouse occurs just after weaning at 3 weeks old; it is 
likely this age corresponds to adolescence in humans and therefore increased growth. Hence, 
hypertrophic growth can be detected at this young age in the mouse. 
 
Despite the presence of hypertrophy, systolic function in HCM can often appear preserved or 
enhanced (Seidman & Seidman 2001). This corresponds with the findings in Chapter 4 where 
isolated myocytes from 25-40 day old TG animals display greater contractile amplitude, and 
further supported by greater force production in isometric twitches in papillary muscle from 8 
week old E99K mice (Song et al. 2013). Cardiac hypertrophy can occur as an adaptive response 
to the actin mutation, and it is believed to have a compensatory function (usually in situations of 
pressure overload-induced hypertrophy) by normalising systolic wall stress and oxygen 
consumption to facilitate ejection performance.  
 
The increased heart mass (HW/BW ratio) is not associated with either increased myocyte size 
(described in Chapter 4) or fibrosis. This may point towards cardiomyocyte hyperplasia instead of 
cellular hypertrophy, a process which has been observed in engineered HCM-associated human 
junctophilin-2 mutations (Landstrom et al. 2007). However, it is not sufficient to conclude the 
186 
 
presence of cardiomyocyte hyperplasia based only on increased heart weight. The occurrence of 
hyperplasia should be based on quantitative determination of cardiomyocyte number, typically 
performed by counting α-sarcomeric actin-staining cells and determining cell number per 
myocardial area.  
 
6.4.2 Characteristic features of HCM are not observed on the ECG 
In apical HCM, the ECG typically shows repolarization changes and giant inverted T waves in the 
anterolateral leads (Caglar et al., 2013). The most consistent changes in the ECG was the greater 
amplitude of the QRS complexes, particularly the R waves of the precordial leads, due to 
increased ventricular mass (Madias 2013). However, in contrast to the HW/BW ratios, R wave 
amplitude in old TG animals was found to be the same as NTG, while in the young group the TG 
animals displayed smaller R wave amplitude. This suggests that hypertrophy is present from as 
early as 25 days old but the increased ventricular mass could be attributed to non-excitable 
tissue, such as interstitial fibrosis and collagen accumulation. The T wave amplitude in ACTC 
E99K TG mice was found to be lower than in NTG in both age groups studied. All of the NTG 
animals displayed positive T waves, whereas 1/3 old TG mice and 4/8 young TG mice displayed 
negative T waves. Due to the variation of the mouse T wave, the negative T waves cannot be 
considered „giant‟, however the presence of a negative T wave may be associated with disease in 
the mouse ECG. 
 
In addition to the typical features of apical HCM, prominently larger atria in ACTC E99K TG mice 
were observed during dissection. Atrial depolarisation is represented by the P wave, which is the 
initial component of the normal ECG. Peaked, notched or enlarged P waves may represent atrial 
hypertrophy; however the ECG recordings showed that P wave amplitude was similar in NTG and 
TG. This could be attributed to the atria being enlarged due to dilation rather than hypertrophy. 
Missing P waves were observed on several occasions in both control and TG animals, and did not 
appear to cause further disruption to the sinus rhythm. This may signify a junctional escape beat, 
which occurs when the rate of depolarisation of the SA node falls below the rate of the AV node, 
causing the AV node to start the beat.  These can occur in normal individuals with a high degree 
of vagal tone manifested by marked sinus arrhythmia, which were commonly observed in the 
anaesthetised mice.  
 
6.4.3 Prolonged QT interval in young ACTC E99K mice 
The QT interval shows the time needed for the ventricular depolarisation-repolarisation cycle and 
can be considered a clinical marker of electrophysiological instability and ventricular arrhythmias. 
The ECG in young TG mice displayed a prolongation of the QT interval, a finding often exhibited by 
HCM patients. The incidence of QT prolongation ranges from 1 in 8 to 1 in 4 (Martin et al. 1994) 
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HCM patients compared with <1 in 200 healthy adults (Johnson et al. 2011). Several studies 
have suggested that increased ventricular mass may be a cause of the prolongation of the QRS 
and QT interval in cardiomyopathy (Barletta et al., 2004; Martin et al., 1994) and corrected QT 
has been found to partly reflect the degree of cardiac hypertrophy and LVOTO (Dritsas et al., 
1992; Johnson et al., 2011). This is supported by both NTG and TG groups showing longer QT 
intervals at 8-12 weeks old than in their genotype-matched young group. This is most likely linked 
with ventricular mass increasing due to normal growth and therefore with age. QT prolongation 
has also been shown to be associated with mechanical dyssynchrony and LV dysfunction in HCM 
(Badran et al. 2012). Longer QT intervals suggest prolonged ventricular repolarisation, and 
disturbances in ventricular repolarisation are known to be pro-arrhythmic (van Noord et al. 
2010). As QT prolongation was not observed in the ECG of older TG mice, this finding could 
indicate a feature of the young mice which makes them more susceptible to arrhythmias.  
 
In contrast, QT interval was not found to be prolonged in ACTC E99K ex vivo heart preparations. 
The spontaneously beating Langendorff heart, even when perfused with isoprenaline did not 
reach a physiological HR for a mouse. The baseline HR of the ex vivo heart was about 300 bpm, 
whereas in vivo the HR of a mouse is usually 500-800 bpm. Abnormalities in ventricular 
repolarization may not be present at rest but may become apparent under certain conditions, 
such as stress.  A recent study has demonstrated that exercise led to QT prolongation 
accompanied by shortening in TQ interval in HCM patients (Coppini et al. 2013). This was 
proposed to reduce diastolic filling time, impair ventricular relaxation, and reduce myocardial 
perfusion. These effects may contribute to the reduced exercise tolerance and stress-induced 
angina often experienced by patients with HCM. Therefore, the low HR may explain why QTC 
differences were not found in the ACTC E99K hearts. The baseline ECG recordings in 8-12 week 
old  and 29 week old (Song et al. 2011) ACTC E99K animals also did not show differences in QTC 
between TG and NTG groups. The ECG measurements were made during minimal anaesthesia to 
allow HR to be as close to the physiological as possible. It is possible that the lack of change in 
QTc from mature animals reflects a normal population, as only a proportion of human HCM 
patients present with prolonged QT interval, thus more animals would need to be studied to 
observe any differences.   
 
6.4.4 ACTC E99K mice show a blunted positive chronotropic response to 
isoprenaline 
During the MEA recording protocol, the hearts were perfused with NT containing isoprenaline. 
This increased the spontaneous beating rate in all hearts by 20-40% however there were no 
significant differences between the groups. This contrasts with the ECG findings in the young 
ACTC E99K TG mice which showed a significantly smaller increase in HR with isoprenaline 
infusion compared with control mice. The ECG data is considered a more robust result, as it 
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correlates with published echocardiography data which showed that 21 week old 
male ACTC E99K mice revealed a less pronounced increase in HR, wall thickening, and fractional 
shortening compared with NTG mice, after β-agonist infusion (Song et al. 2011).  The same 
response was also found in 29 week old female and 38 week old male TG mice compared with 
NTG mice. In addition, upon β-agonist infusion QTC was prolonged in the control group but was 
unaltered in ACTC E99K animals. The blunted positive chronotropic response to β-adrenergic 
stimulation is consistent in ACTC E99K mice throughout the progression of HCM.  
 
ACTC E99K TG mice have shown a distinctive phenotype of increased myofilament 
Ca2+ sensitivity and a reduced response to PKA phosphorylation of troponin I at the single 
filament level. The uncoupling of Ca2+ sensitivity from the troponin I phosphorylation level in 
the ACTC E99K mouse resembles recent findings with familial DCM mutations (Song et al. 2010). 
Song et al proposed that HF due to DCM mutations is due to uncoupling causing a blunted 
response to β-adrenergic stimulation leading to a reduced cardiac reserve. Thus, uncoupling due 
to the ACTC E99K HCM mutation may contribute to the development of HF in older mice.  
 
6.4.5 Higher incidence of arrhythmias in E99K TG mice  
Previous ECG measurements on ACTC E99K animals during the late stages of the disease 
displayed sporadic arrhythmias without associated SCD. Therefore at 3-5 months old, where SCD 
is also reduced, spontaneous but not life threatening arrhythmias would be expected. The MEA 
recordings from both age groups displayed few arrhythmogenic events, even during perfusion 
with isoprenaline. Several isolated events were observed, followed by an immediate return to 
regular rhythm. There were no incidences of VF or VT which are the hypothesised arrhythmogenic 
mechanisms for causing SCD. Again, these findings may be due to the intrinsic beating rate of 
the isolated heart being too low to induce and maintain arrhythmias.  
 
The ECG measurements are considered more useful to analyse due to the much higher baseline 
HR. The baseline ECG traces from animals in both age groups display very regular rhythms. 
Several sinus arrhythmias were observed in both NTG and TG mice, which were accompanied by 
artefacts due to breathing (short episodes of noise derived from skeletal muscles associated with 
respiration). These occur sporadically due to the mice occasionally breathing more deeply due to 
the anaesthesia.  The young ACTC E99K TG mice display a high level of SCD compared with the 
NTG animals, therefore increased incidence of arrhythmias was expected. After injection of 
isoprenaline the TG animals showed an increased propensity to arrhythmias, while no severe 
ventricular arrhythmias were observed in NTG animals. 3/8 TG animals displayed a period of 
increased HRV while in normal sinus rhythm and 2/8 TG animals displayed multiple occurrences 
of heart block.  A missing QRS complex, which represents depolarisation of the ventricles 
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signifying intraventricular conduction time, in the presence of P waves indicates specifically the 
occurrence of AV block. One TG animal died after experiencing recurring episodes of VF. As 
described in section 6.1, VF can lead to complete failure of ventricular function. This recording 
provides the first evidence that ventricular arrhythmias can cause SCD in ACTC E99K TG mice.  
 
 All of these mice which displayed the aforementioned isoprenaline induced rhythm 
abnormalities were female. This corresponds with the increased rate of SCD in female mice 
compared with males. This may be due to ACTC E99K female mice being more susceptible to 
arrhythmias than males during β-adrenergic stimulation. Although SCD in humans is more 
common in men than women, female gender is considered an independent risk factor due to 
prolonged QT intervals (Nakagawa et al. 2005). This gender difference is absent at birth and in 
young children (Stramba-Badial et al., 1995), but as puberty progresses, the QT interval in males 
shortens whereas the QT of females remains unchanged. Both endogenous and exogenous sex 
hormones have been shown to affect the QT interval. Endogenous testosterone and progesterone 
shorten the AP and oestrogen lengthens the QT interval in animals (Sedlak et al., 2012).  Saito et 
al compared the QTC of mice with high endogenous oestrogen to the QTC of ovariectomized mice 
with no detectable endogenous oestrogen. A significantly shorter QTC was found in the 
ovariectomized group, and when oestradiol was added back to the ovariectomized group the QTC 
lengthened to pre-surgical values (Saito et al. 2009). Therefore, prolonged QTc in female TG mice 
may contribute to their higher predisposition to arrhythmias during β-adrenergic stimulation.  
 
6.4.6 Overview 
The key finding is that the propensity for arrhythmias after β-agonist injection is higher in TG 
animals than in NTG animals. In particular, TG female animals displayed the most severe 
arrhythmogenic events, which may be attributed to prolonged QT interval.  
 
 The ECG data was more useful to interpret than the MEA data as the more physiological HR of 
the anaesthetised mouse has allowed differences between NTG and TG animals to be examined. 
The main limitation of the MEA studies was the use of spontaneously beating hearts, instead of 
pacing the hearts at the required frequency. The intrinsic rhythm of the heart was chosen 
specifically as it should provide a more accurate representation of the electrical patterns 
occurring at the epicardium through physiological activation.  The activation pattern represents 
electrical activity travelling through the intra-epicadrial plane and from the endocardium to the 
epicardium. Although the MEA only measured the field potentials at the epicardium, by allowing 
the natural pacemaker activity of the heart to determine HR, a more representative insight into 
possible arrhythmogenic mechanisms occurring in vivo would be obtained. Future work using the 
MEA could make use of epicardial pacing to reach a more physiological HR found in the mouse. 
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Another potential drawback was the concentration of isoprenaline used in the MEA experiments. 
The chosen dose was intended to have a reversible effect without causing any permanent 
damage to the heart, whilst being high enough to induce arrhythmia. Whilst the isoprenaline 
concentration used did have a reversible effect, it did not appear to induce arrhythmias.  
 
The most relevant additional experiments would be to implant telemetry devices into young mice, 
so the actual arrhythmia mechanism during natural SCD could be observed. A telemetric ECG 
recording from a mouse model of DCM has shown sudden death by VF preceded by torsades de 
pointes, demonstrates the usefulness of telemetry to capture fatal arrhythmias without the need 
for anaesthetising or stressing the animal (Du et al. 2007). This method was considered during 
the project but is associated with many drawbacks, especially the small size of 25 day old mice 
making implantation of the device difficult. Another potential investigation, derived from the 
findings in this chapter would be to study the β-adrenergic system further. It would be interesting 
to determine why the effect of isoprenaline appears more arrhythmogenic in the TG females, 
which could be linked, for example, to alterations in β-adrenergic receptor expression. 
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Chapter 7: General discussion 
 
7.1 Overview of key findings 
 
HCM is the most common monogenic heart disease, affecting an estimated 2% of the 
population. It is also the most common cause of SCD in young adults. The pathogenic 
mechanisms by which mutations cause HCM and SCD remain unclear and controversial. Many 
studies have shown that HCM mutations lead to increased Ca2+ sensitivity of the myofilament. 
The major common paths leading to the anatomic and functional characteristic of HCM include 
energy deficiency and altered Ca2+ handling. We therefore believe that the constitutively high 
myofilament Ca2+ sensitivity is the trigger for the major symptoms of HCM, potentially lethal 
arrhythmias and development of hypertrophy. The aims of this thesis were to investigate if basic 
mechanisms of EC coupling and Ca2+ regulation are different in the ACTC E99K mouse model of 
HCM and if these alterations provide a setting for arrhythmogenesis that may lead to SCD of the 
mouse. 
 
7.1.1 Cellular hypercontractility combined with increased spontaneous Ca2+ 
release may contribute to increased propensity to arrhythmia and the 
development of hypertrophy 
 
The main finding is that the ACTC E99K TG cells isolated from young animals are 
hypercontractile, consistent with increased myofilament Ca2+ sensitivity and higher force 
generation at the muscle level. The underlying cause of the higher peak contraction was the 
additive effect of increased myofilament Ca2+ sensitivity and increased Ca2+ transient amplitude 
(the latter being absent in older mice), which would allow more cross bridges to form, resulting in 
greater contraction. The enhanced contractility of the myocyte may be energetically inefficient; a 
feature of E99K papillary muscle which has already been associated with increased force cost 
and reduced efficiency of converting energy of ATP hydrolysis to work (Song et al. 2013). The 
later stages of HCM involving hypertrophy and diastolic dysfunction may be triggered by this 
hypercontractile state of the cells.   
 
As this gain of function alteration occurred without corresponding increases in diastolic Ca2+ 
levels or increased SR load, these changes may be caused by either increased Ca2+ influx 
through LTCC or by increased release of Ca2+ through the RyR. E99K TG cells displayed increased 
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frequency of Ca2+ sparks and waves, indicating increased leak during diastole, without a 
corresponding increase in SR load. It is possible that the increased spontaneous Ca2+ release 
can lead to DADs which result in the arrhythmias observed in vivo.  
 
Arrhythmias were not observed in the MEA studies or in baseline ECG recordings. However, TG 
animals did display arrhythmias after isoprenaline injection, particularly the TG female mice 
which displayed the most severe arrhythmogenic events, leading to SCD in one case. It is 
possible that the alterations in Ca2+ regulation and increased diastolic Ca2+ release provide a 
setting for arrhythmogenesis in the mutant mouse. The ACTC E99K mice also showed a blunted 
response to β-adrenergic stimulation, consistent with the published findings in the late stages of 
the disease.  
 
 
Figure 7.1 Ca2+ regulation is altered in cells from TG animals within the sudden death window. 
Labels in red indicate parameters measured in Chapter 4. (A) Larger Ca2+ transient could be 
caused by  increased L-type Ca2+ current (B) RyR regulation may be altered causing increased 
frequency of diastolic Ca2+ release (C) Reduced NCX function may allow localised increases in 
[Ca]I, which, combined with increased spontaneous Ca2+ sparks and waves, could contribute to 
DAD formation.   
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7.1.2 E99K mice which survive the sudden death window show cellular 
hypocontractility 
 
The changes in Ca2+ handling found in the 8-12 week old ACTC E99K cells are consistent with 
diastolic dysfunction and increased myofilament Ca2+ sensitivity which are characteristic features 
of HCM, however the amplitude of the Ca2+ transient was now less than NTG. TG cells displayed a 
significantly slower Ca2+ transient decay accompanied by slower relaxation of ACTC E99K cells at 
both 50% and 90% time to baseline. This result was expected as increased Ca2+ sensitivity was 
hypothesised to be coupled to a higher Ca2+ affinity for troponin C and therefore slower Ca2+ 
dissociation from troponin C. The resting sarcomere length was found to be shorter in TG cells, 
suggesting that these cells were more contracted and diastolic tension was greater at rest. 
Diastolic Ca2+ level was found to be reduced in the TG cells, so it is possible that more Ca2+ is 
buffered by the myofilaments by binding to troponin C. This may allow cross-bridges to continue 
to form during diastole, thus increasing diastolic tension. The SR load was found to be reduced in 
TG cells which may underlie the reduction in Ca2+ transient amplitude in TG myocytes. It is 
possible that the reduced size of the transient is a compensatory mechanism to allow a normal 
level of cell contraction in the surviving E99K mice. 
 
7.1.3 Multiple populations  
 
The most striking characteristic of the ACTC E99K transgenic mouse is that up to 50% of mice die 
within a short period of time,  between 28 and 40 days old (Song et al. 2011).  The fact that they 
do not all die indicates two populations of mice, which is likely to be related to the hybrid 
background of the animals.  It was found that ACTC E99K bred onto pure BL6 did not die (Katja 
Gehmlich); moreover, when ACTC E99K are crossed with CaN KO all the mice die in this time 
window (Sara Al-Saud unpublished observation).  Therefore the question arises as to whether the 
older mice studied here represent a second stage in the development of the HCM phenotype or a 
separate population resistant to SCD.  It seems likely that the latter is the case since the older 
population are all mice that survived the death window. The observation of a bimodal distribution 
of Ca2+ transient amplitude provides strong evidence for this proposition; one population 
resembles NTG whilst the other population has a higher Ca2+ transient amplitude and probably 
represents the population that is likely to suffer sudden cardiac death. 
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7.2 Clinical relevance  
 
Clinical management of HCM is currently focused on relieving the symptoms by using β-
adrenergic inhibitors and LTCC blockers to lower HR, prolong diastolic filling and diminish left 
ventricular outflow tract gradients. In patients with extensive outflow tract obstruction, surgical 
septal myectomy or percutaneous alcohol ablation is carried out to reduce symptoms and risk of 
SCD (Marian, 2005). β-blockers are used extensively to treat symptomatic HCM (Spoladore et al., 
2012). The beneficial effects are due to a decrease in HR, leading to improved ventricular 
relaxation by increasing the time for diastolic filling. The reduction in inotropic response may also 
decrease oxygen demand and decrease the outflow gradient (Spirito et al., 1997). β-blockers are 
also used for the management of arrhythmias, and the importance of their use as an anti-
arrhythmic is highlighted by the increase in arrhythmias in TG animals after infusion of 
isoprenaline.  
 
LTCC blockers such as verapamil are also commonly used to treat symptomatic patients with 
non-obstructive HCM, with the effects being largely mediated by their negative inotropic and 
chronotropic effects, leading to prolonged LV filling time.  LTCC antagonists may be beneficial in 
the young E99K animals, by reducing the enlarged Ca2+ transients. This in turn would reduce 
hypercontractility at the cellular level and consequently decrease cardiac workload.  
 
The enhanced contractility of cells from young TG mice corresponds with greater contraction of 
papillary muscles, which has been associated with reduced energy efficiency in the TG muscle 
(Song et al. 2013). Thus, energy-sparing drugs such as perhexiline may have a beneficial effect 
and may represent an effective therapy for HCM (Abozguia et al. 2010). Perhexiline was 
originially developed as an anti-anginal, and acts by reducing fatty acid metabolism by inhibiting 
carnitine palmitoyltransferase, the enzyme responsible for mitochondrial uptake of long-chain 
fatty acids (Ashrafian et al. 2007). This shifts muscle substrate utilisation from fatty acids 
towards glucose which increases myocardial efficiency (work done per unit oxygen consumption); 
this oxygen-sparing effect explains its efficacy in angina, and has also been shown to improve 
symptoms in HCM (Abozguia et al. 2010).  
 
In addition to treatment of symptoms, the risk assessment of sudden death is a central aspect of 
HCM management.  It is necessary to consider all of the recognized risk factors (Table 7.1) for 
the comprehensive risk stratification of HCM patients.  In patients carrying the E99K mutation, 
sudden death is an exception that occurs in patients with more severe hypertrophy. The E99K 
mice display cardiac hypertrophy from 4 weeks old, and more extreme myocardial growth could 
be associated with the animals which suffer premature death. The E99K mouse highlights the 
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importance of early onset of clinical manifestations as a risk factor for SCD, due to the specific 
time frame of SCD occurrence at a young age. This study indicates that genetic background plays 
a key role in the penetrance of the disease and therefore introduces an additional variable that 
may make prognosis particularly difficult.  
 
 
 
Established 
 Prior episode of sudden cardiac arrest 
 Strong family history of sudden cardiac death 
 Causal mutations 
 Syncope due to cardiac arrhythmias 
 Sustained and repetitive non-sustained ventricular 
tachycardia 
 Severe cardiac hypertrophy  
 
 
Less established 
 Exercise-induced hypotension 
 LVOTO 
 Severe interstitial fibrosis and myocyte disarray 
 Early onset of clinical manifestations  
 Myocardial ischaemia 
 
 
Table 7.1 Risk factors for sudden death in patients with HCM. Table adapted from (Marian 2009) 
 
 
Although effective, the current management approach only applies to clinically overt HCM. It 
would be useful to prophylactically treat HCM before the disease has progressed to a severely 
symptomatic stage. The first predictive human genetics and prevention trial in HCM, “Treatment 
of Preclinical Hypertrophic Cardiomyopathy With Diltiazem” illustrates the strategy to target 
sarcomere mutation carriers without hypertrophy. This trial is based on studies using mouse 
models of HCM treated with the L-type Ca2+ channel blocker diltiazem, which caused the early 
restoration of Ca2+ homeostasis, thereby limiting disease development. The inhibition of plasma 
membrane LTCC by diltiazem normalized aberrant levels of Ca2+ storage proteins (calsequestrin, 
junction, and triadin) and prevented fibrosis and cardiac dysfunction (Semsarian et al. 2002; 
Westermann et al. 2006).  
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Targeting the primary defect in Ca2+ sensitivity might attenuate ventricular remodelling and 
reduce symptoms. Increased myofilament Ca2+ sensitivity has been shown to render the heart 
susceptible to ventricular tachyarrhythmias. As increased myofilament Ca2+ sensitivity is often 
observed in HCM mutations, including in the E99K mouse model, a useful therapeutic approach 
might therefore be to recalibrate myofilament Ca2+ sensitivity. The protective effects of 
blebbistatin demonstrated by Baudenbacher et al raises the prospect of normalising myofilament 
Ca2+ sensitivity as an antiarrhythmic therapy in HCM. In DCM, where decreased myofilament 
sensitivity has been observed, levosimendan has been suggested as a beneficial therapy by 
myofilament Ca2+ sensitisation (Brixius et al. 2002). Levosimendan is a drug used in the 
treatment of HF, and acts by sensitizing troponin C to Ca2 thereby increasing cross-bridge 
formation and enhancing contractility. At present however, there are no equivalent clinical 
desensitisers available.  
 
EGCg, a green tea catechin, has also recently been shown to decrease cardiac myofilament 
Ca2+ sensitivity through its interaction with cardiac troponin C. Studies showed that EGCg 
restored cardiac output in isolated working hearts by improving diastolic dysfunction caused by 
increased myofilament Ca2+ sensitivity in a mouse model of HCM (Tadano et al. 2010). Recent 
work in the Marston lab has shown that in addition to being a Ca2+ desensitiser, EGCg can 
restore TnI phosphorylation-Ca2+ sensitivity in HCM and DCM mutant thin filaments that have 
been uncoupled due to the mutation (Messer et al,  2014 abstract). This compound may be 
useful in the development of new therapeutic compounds. However, these biologically active 
polyphenols in green tea have been shown to have many pleiotropic effects, which may affect its 
suitability for use in HCM treatment. Another method of decreasing myofilament Ca2+ sensitivity 
is by the phosphorylation of troponin I at serine residues S23/S24 (Zhang et al., 1995). 
Reproducing this post-translational modification may also represent a molecular target for HCM 
therapy. Although myofilament desensitisation in HCM is a potential therapeutic target, it has to 
be considered that excessive desensitisation could lead to DCM. Therefore the recalibration of 
myofilament sensitivity must be precisely adjusted. 
 
7.3 Limitations 
 
Several unforeseen issues were revealed during the optimisation of experimental protocols. 
Firstly, fura-2 appeared to reduce the contractility of mouse myocytes, probably due to 
intracellular buffering of the dye. This meant sarcomere shortening was measured in unloaded 
cells, while fura-2 loaded cells were used to measure Ca2+ transients separately, preventing the 
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plotting of hysteresis loops. These loops could potentially provide additional evidence for the 
increased myofilament Ca2+ sensitivity acting at the cellular level. It is possible that the increased 
Ca2+ buffering may have had an effect on the properties of the Ca2+ transients measured, but as 
the loading protocol was consistent throughout the study, the differences in Ca2+ parameters 
between TG and NTG cells could be accurately determined.  
 
The use of spontaneously beating hearts appeared to be a limitation in the MEA experiments. 
The MEA recordings displayed a much lower HR than would be measured in vivo, which may 
underlie the lack of differences in QTC and arrhythmia production between control and TG 
animals. The intrinsic rhythm of the heart was chosen specifically as it should provide a more 
accurate representation of the electrical patterns occurring at the epicardium through natural 
pacemaker activity, giving a more representative insight into possible arrhythmogenic 
mechanisms occurring in vivo. Future work using the MEA should make use of epicardial pacing 
to reach a more physiological HR found in the mouse.  
 
The main limitation however, is the application of these findings to the human disease. Murine 
and human cardiac electrophysiology differ substantially (London 2001), and cellular Ca2+ 
handling changes in response to expression of mutant actin may be different in humans. If a 
biopsy could be obtained from a patient carrying the E99K mutation, and viable myocytes 
isolated, then the effect of the mutation on cellular Ca2+ handling could be studied and compared 
with the data acquired from mice.  
 
7.4 Future directions 
 
Further experiments could be carried out to further support the findings of this thesis. It would be 
ideal to measure action potential shape and duration to provide the link between Ca2+ handling 
alterations and arrhythmia occurrence in the animal.  Changes to the shape of the ventricular AP 
can result in shorter effective refractory periods, greater beat-to-beat variability of APD, and 
increased dispersion of ventricular conduction velocities at high HR (Huke & Knollmann 2010). 
These changes would provide a setting for the formation of after-depolarisations. E99K cells 
displayed increased spontaneous Ca2+ release which could potentially elevate cytosolic Ca2+ 
enough to activate inward current. This can then lead to the formation of DAD which occurs after 
the complete repolarization of an AP. When DADs are of a sufficient magnitude, an AP is induced, 
which can propagate throughout the myocardium to cause additional heartbeats, 
tachyarrhythmias and fibrillation. 
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It would also be beneficial to repeat the measurements of cellular contractility and Ca2+ handling 
in the presence of a myofilament Ca2+ sensitiser (EMD57033) and desensitiser (blebbistatin). 
Using the same principle as Knollmann et al, by applying a Ca2+ sensitiser to the NTG cells, and a 
desensitiser to TG cells, the effect of the mutation can be linked to the underlying Ca2+ sensitivity 
of the myofilament. To fully elucidate the mechanism for HCM in this model, future studies could 
measure the histopathological changes and the function of the heart in vivo during the SCD 
window. By completely characterising the E99K model during the sudden death window, more 
definite conclusions can be drawn about the role of Ca2+ handling in the development of HCM.  
7.5 Final conclusion 
The basic mechanisms of EC coupling and Ca2+ regulation were altered in the ACTC E99K mouse 
model of HCM. During the SCD window, cells isolated from TG animals were hypercontractile, 
with larger Ca2+ transients and increased spontaneous Ca2+ release from the SR. These 
alterations may provide a setting for arrhythmogenesis, with TG animals being more susceptible 
to arrhythmias during β-adrenergic stimulation.  
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Appendix 
 
Chapter 3: As the single cell data is nested or hierarchical, it was also analysed by grouping cells 
per isolation. This provides support for the significant findings calculated using n=cells. 
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Chapter 4: As the single cell data is nested or hierarchical, it was also analysed by grouping cells 
per isolation. This provides support for the significant findings calculated using n=cells. 
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Isolation Transgenic 
female 
Transgenic 
male 
1 0.74 
0.64 
0.96 
0.84 
0.45 
1.04 
1.33 
0.41 
1.23 
0.62 
0.33 
0.95 
0.66 
 
0.64 
0.89 
0.42 
0.45 
0.66 
0.97 
1.06 
0.71 
0.49 
0.27 
0.24 
0.99 
0.3 
 
2 0.42 
0.37 
1.01 
0.44 
0.38 
0.68 
0.23 
0.41 
0.69 
0.62 
0.62 
0.72 
0.64 
 
0.61 
1.09 
1.33 
1.36 
1.13 
0.98 
0.24 
0.39 
0.38 
1.23 
 
3 0.43 
0.26 
0.49 
0.42 
0.53 
0.60 
 
0.60 
1.58 
0.43 
1.43 
1.04 
0.36 
0.63 
0.24 
0.83 
0.65 
0.27 
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Isolation Transgenic 
female 
Transgenic 
male 
4 1.06 
0.24 
0.55 
0.27 
0.58 
0.42 
0.52 
0.31 
 
0.30 
0.43 
0.64 
0.21 
0.38 
0.84 
0.79 
0.77 
0.36 
0.44 
0.26 
 
 
 
Table A4.1 Distribution of Ca2+ transients above threshold limit within raw data 
 
 
 
Chapter 6: For each MEA recording, QT interval was measured manually from an average of 6 
individual field potential waveforms. QT interval is dependent on the HR, therefore it was 
important to correct for HR using Bazett‟s formula (QTB) and the modified equation (QTC) from 
(Mitchell et al. 2013) which accounts for the high resting HR in mice. 
 
 
  
NTG female 
 
 
TG female 
 
NTG male 
 
TG male 
QT interval (ms) 108 ± 8 
 
109 ± 14 94 ± 11 
 
144 ± 28 
 
QTB (ms) 252 ± 8 
 
248 ± 29 
 
221 ± 28 
 
293 ± 42 
 
QTC (ms) 60 ± 3 56 ± 6 
 
54 ± 6 
 
61 ± 6 
 
 
Table A6.1 QT intervals and corrected QT intervals in hearts from 3-5 month old mice 
 
  
NTG female 
 
 
TG female 
 
NTG male 
 
TG male 
QT interval (ms) 90 ± 16 
 
76 ± 6 
 
84 ± 13 
 
 90 ± 11 
 
QTB (ms) 203 ± 32 
 
184 ± 17 
 
 186 ± 21 
 
198 ± 27 
 
QTC (ms) 46 ± 7 
 
45 ± 5 
 
43 ± 6 
 
48 ± 6 
 
 
Table A6.2 QT intervals and QT intervals corrected for HR in hearts from 25-45 day old mice 
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